Time Independent Viscoelastic Analysis Parameter for Prediction of Patient Outcome

Abstract
In some embodiments, the invention provides an in vitro method for identifying a patient as likely as likely to require a transfusion of at least six units of blood in six hours or less. The method comprise, consists essentially of, or consists of (a) analyzing a sample of blood from a patient with a viscoelastic analysis assay to obtain a coagulation characteristic value that is independent of time of the patient; and (b) comparing the coagulation characteristic value of the patient to a coagulation characteristic value that is independent of time of a control, wherein the coagulation characteristic value of the patient that is lower than the coagulation characteristic value of the control identifies the patient as likely to require a transfusion of at least six units of blood in six hours or less.
Description
BACKGROUND OF THE INVENTION

The present invention relates to the fields of medicine and surgery, and emergent and chronic critical care for traumatic injury.


Following a traumatic injury (e.g., gunshot wound, car accident, or during surgery), uncontrolled hemorrhage (i.e., uncontrolled bleeding) is a leading cause of early death (Eastridge et al., J. of Trauma. 71(1 Suppl): S4-8, 2011; Gonzalez et al., J. of Trauma. 62(1):112-9, 2007; Kashuk et al., J. of Trauma 65(2):261-71, 2008). Trauma induced coagulopathy (TIC) is an exacerbating phenomenon observed in many cases of massive hemorrhage, and current practice emphasizes hemostatic resuscitation with blood components (Brohi et al., Current Opinion in Critical Care 13(6): 680-685, 2007; Brohi et al., Annals of Surgery 245(5): 812-818, 2007; Brohi et al., J. of Trauma, 64(5): 1211-1217, 2008; Cohen et al., Annals of Surgery 255(2): 379-385, 2012; Cotton et al., J. of Trauma and Acute Care Surgery 73(2):365-70, 2012; Dunn et al., Surg. Forum. 30:471-3, 1979). This practice is geared at not only replacing lost oxygen carrying capacity, but in reestablishing normal coagulation and forestalling the “bloody vicious cycle” of hemorrhagic shock, acidosis/hypothermia and coagulopathy (Kashuk et al., J. of Trauma 22(8):672-9, 1982; Cohen et al., Surg. Clin North Am. 92(4):877-91, 2012). Establishment, by hospital blood banks, of massive transfusion protocols (MTPs) to aid in efficient hemostatic resuscitation of patients with life-threatening hemorrhage, represents an important development in trauma systems management and has been shown to reduce mortality in massively bleeding patients.


Triggering a massive transfusion protocol (MTP) activation, however, is not without potentially negative consequences. Transfusion of blood or blood broducts consume large amounts of scarce medical resources (e.g. universal donor blood components either transfused or wasted) as well as exposing patients to the risks of transfusion of multiple units of blood products, empirically and potentially needlessly unless patients who truly require an MTP activation are chosen accurately (Johnson et al., Archives of Surgery 145(10):973-7, 2010; Moore et al., Archives of Surgery 132(6):620-4, 1997; Watson et al., J. of Trauma. 2009 August; 67(2):221-7; discussion 8-30, 2009; Neal et al., Archives of Surgery. 147(6):563-71, 2012).


Thus, there is a need to distinguish patients in massive hemorrhage who truly need a transfusion protocol from those patients who do not.


Viscoelastic analysis methods such as thrombelastography (TEG) and thromboelastometry (TEG) are robust and versatile diagnostic systems for point-of-care diagnosis of coagulopathy. However, application of these analysis methods in high acuity settings such as trauma and emergency surgery has been limited by the time it takes the test to yield a result with regard to clot strength, a key parameter for interpretation of the overall clotting performance of the patient's blood.


It would be useful to have rapid methods and parameters to accurately predict final clot strength and/or identify those patients who need transfusion of blood or blood products.


SUMMARY OF THE EMBODIMENTS

The invention provides new parameters from viscoelastic analyses of blood that are not dependent upon time.


In a first aspect, the invention provides an in vitro method for identifying a patient as likely to require a transfusion of at least six units of blood in six hours or less, the method comprising, consisting essentially of, or consisting of obtaining a coagulation characteristic value that is independent of time by using a viscoelastic analysis assay to analyze a sample of blood from the patient, wherein the coagulation characteristic value of the patient that is lower than a coagulation characteristic value that is independent of time of a control (such as a healthy volunteer) identifies the patient as likely to require a transfusion of at least six units of blood in six hours or less.


In some embodiments, the coagulation characteristic value that is independent of time of a control is obtained by analyzing a sample of blood from the control with a viscoelastic analysis assay. In some embodiments, the the control is a healthy volunteer. In some embodiments, the control is a population of patients and the coagulation characteristic value of the control is the mean coagulation characteristic value of the population.


In some embodiments, the sample of blood is not supplemented with a clotting factor or an enhancer of clot formation. In some embodiments, the coagulation characteristic value that is independent of time is Acrit. In some embodiments, the coagulation characteristic value that is independent of time is dAmax.


In some embodiments, the coagulation characteristic value that is independent of time is obtained not more than twenty minutes after the start of the viscoelastic analysis of the sample of blood from the patient. In some embodiments, the coagulation characteristic value is obtained not more than fifteen minutes after the start of the viscoelastic analysis of the sample of blood from the patient. In some embodiments, the coagulation characteristic value that is independent of time is obtained not more than ten minutes after the start of the viscoelastic analysis of the sample of blood from the patient. In some embodiments, the coagulation characteristic value that is independent of time is obtained not more than fifteen minutes after the start of clot formation in the sample of blood from the patient. In some embodiments, the coagulation characteristic value that is independent of time is obtained not more than ten minutes after the start of clot formation in the sample of blood from the patient. In some embodiments, the coagulation characteristic value is obtained not more than five minutes after the start of clot formation in the sample of blood from the patient.


In some embodiments, the patient is human. In some embodiments, the patient is a trauma patient.


In some embodiments, the viscoelastic analysis assay is performed using a thromboelastography analyzer system. In some embodiments, the viscoelastic analysis assay is performed using a thromboelastometry analyzer system.


In some embodiments, the coagulation characteristic value that is independent of time of the patient that is at least 1.5 times lower than the coagulation characteristic value that is independent of time of the control (e.g., a healthy volunteer or a population of patients) identifies the patient as likely to require a transfusion of at least six units of blood in six hours or less. In some embodiments, the coagulation characteristic value of the patient that is at least 1.5 times lower than the coagulation characteristic value of the control (e.g., a healthy volunteer or a population of patients) identifies the patient as likely to require a transfusion of at least ten units of blood in six hours or less.


In some embodiments, the coagulation characteristic value that is independent of time is obtained by fitting a tracing from the viscoelastic analysis assay of the same sample of blood from the patient to a tracing from the model dA/dT=aA2/(ebA−1). In some embodiments, the coagulation characteristic value that is independent of time is obtained by taking an area under a tracing from the viscoelastic analysis assay of the same sample of blood from the patient from a start of clot formation to a maximum amplitude.


In another aspect, the invention provides an in vitro method for identifying a patient as likely as likely to require a transfusion of at least six units of blood in six hours or less, the method comprising, consisting essentially of, or consisting of (a) analyzing a sample of blood from a patient with a viscoelastic analysis assay to obtain a coagulation characteristic value that is independent of time of the patient; and (b) comparing the coagulation characteristic value of the patient to the coagulation characteristic value of the control, wherein the coagulation characteristic value of the patient that is lower than the coagulation characteristic value of the control (e.g., a healthy volunteer) identifies the patient as likely to require a transfusion of at least six units of blood in six hours or less.


In some embodiments, the coagulation characteristic value that is independent of time of a control is obtained by analyzing a sample of blood from the control with a viscoelastic analysis assay. In some embodiments, the the control is a healthy volunteer. In some embodiments, the control is a population of patients and the coagulation characteristic value of the control is the mean coagulation characteristic value of the population.


In some embodiments, the sample of blood is not supplemented with a clotting factor or an enhancer of clot formation. In some embodiments, the coagulation characteristic value that is independent of time is Acrit. In some embodiments, the coagulation characteristic value that is independent of time is dAmax.


In some embodiments, the coagulation characteristic value that is independent of time is obtained not more than twenty minutes after the start of the viscoelastic analysis of the sample of blood from the patient. In some embodiments, the coagulation characteristic value that is independent of time is obtained not more than fifteen minutes after the start of the viscoelastic analysis of the sample of blood from the patient. In some embodiments, the coagulation characteristic value is obtained not more than ten minutes after the start of the viscoelastic analysis of the sample of blood from the patient. In some embodiments, the coagulation characteristic value that is independent of time is obtained not more than five minutes after the start of the viscoelastic analysis of the sample of blood from the patient.


In some embodiments, the coagulation characteristic value that is independent of time is obtained not more than fifteen minutes after the start of clot formation in the sample of blood from the patient. In some embodiments, the coagulation characteristic value that is independent of time is obtained not more than ten minutes after the start of clot formation in the sample of blood from the patient. In some embodiments, the coagulation characteristic value that is independent of time is obtained not more than five minutes after the start of clot formation in the sample of blood from the patient.


In some embodiments, the patient is human. In some embodiments, the patient is a trauma patient.


In some embodiments, the viscoelastic analysis assay is performed using a thromboelastography analyzer system. In some embodiments, the viscoelastic analysis assay is performed using a thromboelastometry analyzer system.


In some embodiments, the coagulation characteristic value that is independent of time of the patient that is at least 1.5 times lower than the coagulation characteristic value that is independent of time of the control (e.g., a healthy volunteer or a population of patients) identifies the patient as likely to require a transfusion of at least six units of blood in six hours or less. In some embodiments, the coagulation characteristic value of the patient that is at least 1.5 times lower than the coagulation characteristic value of the control (e.g., a healthy volunteer or a population of patients) identifies the patient as likely to require a transfusion of at least ten units of blood in six hours or less.


In some embodiments, the coagulation characteristic value that is independent of time is obtained by fitting a tracing from the viscoelastic analysis assay of the same sample of blood from the patient to a tracing from the model dA/dT=aA2/(ebA−1). In some embodiments, the coagulation characteristic value that is independent of time is obtained by taking an area under a tracing from the viscoelastic analysis assay of the same sample of blood from the patient from a start of clot formation to a maximum amplitude.


In yet another aspect, the invention provides an in vitro method for determining an amount of fibrinogen in a patient comprising: (a) obtaining a coagulation characteristic value that is independent of time of a sample of blood from the patient using a viscoelastic analysis assay and (b) plotting the patient coagulation characteristic value against a standard table of coagulation characteristic values of blood samples of healthy volunteers with known amounts of fibrinogen to determine the amount of fibrinogen in the sample of blood from the patient.


In some embodiments, the coagulation characteristic value that is independent of time is dAmax. In some embodiments, the patient is human.


In still another aspect, the invention provides an in vitro method for determining a quantity of platelets in a patient comprising: (a) obtaining a coagulation characteristic value that is independent of time of a sample of blood from the patient using a viscoelastic analysis assay and (b) plotting the patient coagulation characteristic value against a standard table of coagulation characteristic values of blood samples of healthy volunteers with known quantities of platelets to determine the quantity of platelets in the sample of blood from the patient.


In some embodiments, the coagulation characteristic value is a product of dAmax and Acrit. In some embodiments, the patient is human.





BRIEF DESCRIPTION OF THE DRAWINGS

The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee


The foregoing features of embodiments will be more readily understood by reference to the following detailed description, taken with reference to the accompanying drawings, in which:



FIG. 1 is a schematic diagram showing the clotting cascade that leads eventually to the formation of a blood clot. The contributions of the intrinsic and extrinsic pathway to the blood clot are shown.



FIG. 2A is a schematic diagram showing a thromboelastography (TEG) tracing or curve. As the upper and lower portions of the tracing are mirror images of each other, TEG tracings are sometimes depicted as just the upper half of the tracing. The time from assay initiation is the dependent variable (on the x-axis) and the amplitude of coupling of the motion of the reaction cup to a centrally suspended pin (a proxy for viscoelastic clot strength) is the readout variable, on the y-axis, as reported in FIG. 1A in units of millimeters. The events leading up to maximum amplitude (MA) of the clot are the clot formation stage, and following the MA is the clot dissolution stage or fibrinolysis stage.



FIG. 2B is a schematic diagram showing a TEG tracing from a healthy human volunteer. Note that in a healthy volunteer, fibrinolysis is very gradual.



FIG. 3 is a schematic diagram showing a thromboelastometry (TEM) tracing or curve. As the upper and lower portions of the tracing are mirror images of each other, TEM tracings are sometimes depicted as just the upper half of the tracing. The events leading up to maximum clot firmness (MCF) of the clot are the clot formation stage (or coagulation stage), and following the MA is the clot dissolution stage or fibrinolysis stage.



FIG. 4 is a schematic drawing showing a side-by-side comparison of a TEG tracing (top half of figure) and a TEM tracing (bottom half of figure). As is clear from FIG. 4, the R value in a TEG tracing is equivalent to a clotting time (CT) value in a TEM tracing, the K value in a TEG tracing is equivalent to a clot formation time (CFT) value in a TEM tracing, the MA value in a TEG tracing is equivalent to a MCF value in a TEM tracing.



FIGS. 5A and 5B are two TEM tracings. FIG. 5A is a TEM tracing in the presence of the EXTEM reagent, which allows assessment of clot formation, fibrin polymerization, and fibrinolysis via the extrinsic pathway. FIG. 5B is a TEM tracing the presence of the FIBTEM reagent, which blocks platelets. Thus, FIG. 5B shows an assessment of the clot firmness of a fibrin clot. As FIGS. 5A and 5B show, platelet and fibrinogen contribution to clot strength are not additive.



FIG. 5C is a schematic diagram showing a TEG tracing from a functional fibrinogen assay (green line) compared to the TEG tracing from a functional fibrinogen assay for a sample treated with tranexamic acid (TXA), an antifibrinolytic agent that blocks the action of plasminogen (blue line). As can be seen, in the presence of hyperfibrinolysis (as simulated by the addition of TXA) may obscure and lower the MA, as depicted in red parallel bars in FIG. 5C by the difference between the peaks of the green line and the blue line.



FIGS. 6A-6C is are variations of TEG tracings from a healthy human volunteer. FIG. 6A shows the classic TEG tracing. Note that this tracing in FIG. 6A is the upper half of the full TEG tracing, with amplitude (in mm) on the Y axis and time (in minutes) on the X axis. The point at which the amplitude is increasing most rapidly is depicted as the Acrit parameter. In FIG. 6A, the Acrit occurs when A (the amplitude) is 11.64. The derivative of this new parameter Acrit, namely dA, is 0.68. FIG. 6B is a curve showing the dA (derivative of amplitude) on the Y axis plotted against amplitude (in mm) on the Y axis. FIG. 6C shows the position of Acrit on the tracings of FIG. 6A and FIG. 6B. Thus, FIG. 6C shows that the Acrit parameter is when dA is 0.68 mm and A is 11.74 mm.



FIG. 6A is a TEG tracing from a healthy human volunteer (namely, patient no. 20074B). FIG. 6A shows the Acrit (with a dA at 0.66 and an A (amplitude) at 13.65 mm) which occurs at approximately 17.0 minutes. Additionally, FIG. 7A shows the split time (at t (time)=13.166667 minutes), A5 (at t=18.17 min and A=20.82 mm), A10 (at 5=23.17 min and A=43.18 mm, and Amax (i.e., the MA) at A=59.02 mm). In the patient shown in FIG. 7A, Amax occurs at approximately 42 minutes.



FIG. 7B is a line graph plotting dA/dT against amplitude for dA/dT=aA2/(ebA−1) with coefficient a=0.011 and coefficient b=0.104 when A goes from 0 to 60.



FIG. 7C is a line graph plotting dA/dT against amplitude for dA/dT=aA2/(ebA−1) with coefficient a=0.022 and coefficient b=0.104 when A goes from 0 to 60.



FIG. 7D is a line graph plotting dA/dT against amplitude for dA/dT=aA2/(ebA−1) with coefficient a=0.011 and coefficient b=0.208 when A goes from 0 to 60.



FIG. 7E is a customized model line graph showing the a and b coefficients of patient 20074B (patient data shown as red squares) to create a custom model fitting the patient dA/dT data points against amplitude.



FIG. 8 is a dot plot, showing the dAmax plotted as a function of Acrit. The populations shown are healthy volunteers (light green triangles), trauma patients with negative significant hemorrhage (dark green squares), and trauma patients with massive hemorrhage (needing 10 units of blood in 6 hours, or dying of exsanguination in 6 hours) (orange diamonds).



FIG. 9 is a dot plot, showing the dAmax plotted as a function of Acrit. The populations shown are healthy volunteers (light green triangles), trauma patients with negative significant hemorrhage (dark green squares), trauma patients with significant hemorrhage (needing 6-10 units of blood in 6 hours) (yellow circles), and trauma patients with massive hemorrhage (needing 10 units of blood in 6 hours, or dying of exsanguination in 6 hours) (orange diamonds).



FIG. 10 is a histogram showing the area under the model curve at infinity. The area under the curve (AUC) from the split to the critical amplitude (i.e., the highest dA) is 5.39. Thus, the time-independent TEG AUC (TITAUC) is calculated in the amplitude domain and measures catalysis in the “launch phase” of clotting.



FIG. 11 is a line graph plotting the percent sensitivity versus the percent specificity for the receiver operating characteristic curve (ROC) of the time-independent TEG area under the curve (TITAUC) for patients with significant hemorrhage (i.e., trauma patients who need between 6 to 10 units of blood in 6 hours). As that data shows, quantitation of early catalysis predict those patients with significant hemorrhage.



FIG. 12 is a line graph plotting the percent sensitivity versus the percent specificity for the receiver operating characteristic curve (ROC) of the time-independent TEG area under the curve (TITAUC) for patients with massive hemorrhage (i.e., trauma patients who need at least 10 units of blood in 6 hours or less, or bleed to death within 6 hours). As that data shows, quantitation of early catalysis predict those patients with massive hemorrhage.



FIG. 13 is the tracing of the derivative of the amplitude of FIG. 7A fitted to the Amax curve (green line) and the Acrit curve (red line). As can be seen, with these two parameters, the fit is extremely close.



FIG. 14 is a scatter plot showing the convergence of the fit with increasing data, plotting time offset from Acrit (min) on the x-axis and normalize difference between model and empirical area (mm2) on the y-axis.



FIG. 15 is a fitting of the data to the model, even when the fit is only to Acrit. This yields the very simple prediction that MA is approximately equal to 15 (ln Q)+12 mm.



FIG. 16 is a scatter plot demonstrating sigmoid relation of dAmax to the amount of fibrinogen is a blood sample.



FIG. 17 is a scatter plot showing that a product of dAmax multiplied by Acrit (the “critical product”) is correlates linearly with the number of platelets in a blood sample.



FIG. 18 is a line graph showing receiver operating characteristic curve (ROC) of the time-independent TEG area under the curve (TITAUC) for patients with massive hemorrhage as compared to conventional TEG parameters. As can be see, the area under the curve (AUC) for time-independent TEG (blue line) has a higher identity for predicting massive hemorrhage than the AUC for MA (red line), the AUC for the alpha angle (purple line), the AUC for activated clotting time (ACT) (brown line) and the AUC for the International Normalization Ratio (INR) (green line).





DETAILED DESCRIPTION OF SPECIFIC EMBODIMENTS

The invention stems, in part, from the discovery of very rapid in vitro methods to reliably and accurately identify patients who are likely need a blood transfusion. The publications (including patent publications), web sites, company names, and scientific literature referred to herein establish the knowledge that is available to those with skill in the art and are hereby incorporated by reference in their entirety to the same extent as if each was specifically and individually indicated to be incorporated by reference. Any conflict between any reference cited herein and the specific teachings of this specification shall be resolved in favor of the latter.


The further aspects, advantages, and embodiments of the invention are described in more detail below. The definitions used in this specification and the accompanying claims shall following terms shall have the meanings indicated, unless the context clearly otherwise requires. Any conflict between an art-understood definition of a word or phrase and a definition of the word or phrase as specifically taught in this specification shall be resolved in favor of the latter. As used in this specification, the singular forms “a,” “an” and “the” specifically also encompass the plural forms of the terms to which they refer, unless the content clearly dictates otherwise. The term “about” is used herein to mean approximately, in the region of, roughly, or around. When the term “about” is used in conjunction with a numerical range, it modifies that range by extending the boundaries above and below the numerical values set forth. In general, the term “about” is used herein to modify a numerical value above and below the stated value by a variance of 20%.


Haemostasis is a tightly regulated process which causes bleeding to stop. In the body, circulating blood remains fluid under normal conditions, but forms localized clots when the integrity of the vascular system is breeched. Trauma, infection, and inflammation all activate the blood's clotting system, which depends on the interaction of two separate systems: enzymatic proteins in a clotting cascade (e.g., clotting factors such as Factor VII or Factor IX) and activated platelets. The two systems work in concert to plug defects in the broken vessels.


A blood clot (also called a thrombus) that forms during haemostasis is made of two parts—a platelet plug and a mesh of cross-linked fibrin protein. The fibrin results from cleavage of fibrinogen into fibrin by thrombin which is activated during the clotting cascade (see FIG. 1). A blood clot needs to be of sufficient strength to resist dislodgement by circulating blood or mechanical movement. If a particular clotting factor is dysfunctional or absent, as in hemophilia, an insufficient amount of fibrin forms. Similarly, massive consumption of clotting factors in a trauma situation decreases the amount of fibrin formed and can lead to uncontrolled hemorrhage. Inadequate numbers of platelets resulting from trauma, surgery, or chemotherapy also decrease platelet aggregation, as do genetic disorders, uremia, or salicylate therapy. Ultimately, reduced fibrin formation or platelet aggregation results in clots of inadequate tensile strength. This hypocoagulable state makes the patient prone to bleeding. Conversely, endothelial injury, stasis, cancer, genetic diseases, or other hypercoagulable states lead to thrombosis (i.e., blood clot) formation, exemplified in deep-vein thromboses, pulmonary emboli, and arterial occlusions such as stroke and myocardial infarction.


When a trauma patient is brought into a treatment center such as an emergency room, uncontrolled hemorrhage can lead to death. However, a recent analysis of data from a three year study of resuscitation strategies of patients (whose inclusion criteria included activation of an MTP) revealed that only 46% of patients, for whom an MTP was activated based upon the judgment of the attending trauma surgeon, actually went on to require a massive transfusion (defined as ≥10 units or packed red blood cells [PRBCs] in 6 hours). It is clear that clinician judgment leaves much to be desired in terms of accuracy of prediction of massive transfusion requirement. Additionally, recent experience with the design of several prospective trials related to trauma resuscitation have highlighted the difficulty in early, prospective selection of patients truly at high risk of major hemorrhage and coagulopathy (Brasel et al., Journal of the American College of Surgeons. 2008 February; 206(2):220-32, 2008; Bulger et al., Archives of surgery. 2008 February; 143(2):139-48; discussion 49); Bulger et al., Annals of surgery. 2011 March; 253(3):431-41; and Raab et al., Critical care medicine. 2008 November; 36(11 Suppl): S474-80).


Given the scarcity of donor blood (and blood products) and the potential risks associated from receiving a donor blood product (e.g., recipient immune response to the donor blood or recipient exposure to pathogens or contaminants in the donor blood), attempts have been made to develop new parameters, or repurpose existing parameters, in order to rapidly and accurately predict which patients are in need of a blood transfusion (e.g., with blood or a blood product). Such patients can be identified, for example, by determining clot strength of a blood sample taken from the patient.


Thus, in some embodiments, the invention provides in vitro methods for identifying a patient likely to suffer a massive hemorrhage (i.e., those patients who will require a transfusion of at least 10 units of blood in 6 hours or less, or who will bleed to death). In some embodiemtns, the method comprises obtaining a coagulation characteristic value that is independent of time using a viscoelastic analysis assay to analyze a sample of blood taken from the patient, wherein the coagulation characteristic value of the patient that is lower than a specified threshold (e.g., to some degree lower than that of a healthy volunteer or lower than the mean coagulation characteristic value of a population of patients) predicts that the patient is likely to suffer a massive hemorrhage. Early prediction of massive hemorrhage can be lifesaving as it allows the clinician to initiate massive transfusion protocol or other resuscitative interventions in a timely manner.


In some embodiments, the methodology described herein can be used to rapidly discriminate the origin of the coagulopathy leading to the massive hemorrhage as being with a defect in platelet or fibrinogen function.


The invention stems, in part, from the identification of a coagulation characteristic value derived from data obtained from analyzing patient blood samples using viscoelastic analyses. Such viscoelastic analyses include, without limitation, thromboelastography (TEG) and thromboelastometry (TEM).


As used herein, by “blood sample” or “sample of blood” is meant a sample of blood taken, for example, from a patient. The patient may be a human, but may also be any other animal (e.g., veterinary animal or exotic animal). Blood is the circulating tissue of an organism that carries oxygen and nutritive materials to the tissues and removes carbon dioxide and various metabolic products for excretion. Blood (often called whole blood) consists of a pale yellow or gray yellow fluid, plasma, in which are suspended red blood cells, white blood cells, and platelets. Some practitioners consider blood to be an organ. However, all agree that how quickly blood will clot is discernible from a sample of blood. It is a matter of analyzing the sample correctly to determine how the blood (e.g., cells and proteins in the blood) will clot. While current technology is limited by how quickly such information can be deduced from a sample of blood, in some embodiments, the present invention allows for such information to be obtained very quickly.


In some embodiments, as the term is used herein, by “blood” is meant whole blood, or a portion of whole blood, or a blood product (e.g., packed red blood cells). The blood in the blood sample taken from a patient (e.g., a trauma patient or a healthy volunteer) may thus be a sample of whole blood or a sample of a portion of blood or a sample of a blood product. The blood (e.g., blood in a blood sample) may be untreated, or may be treated. For example, a blood sample may be citrated blood (e.g., whole blood collected into a 3.5 mL container containing 3.2% citrate). The blood (e.g., blood in a blood sample) may also be a sample of platelet rich plasma. The blood (e.g., blood in a blood sample) may also be heparinized blood or may be a blood sample treated with protamine to reverse the effects of heparin. In some embodiments, the blood sample is not supplemented with a clotting factor (e.g., thrombin) and/or is not supplemented with an enhancer of clot formation (e.g., kaolin). The blood (e.g., blood in a blood sample) may be fresh, frozen, or stored according to standard methods (e.g., stored at 4° C. in a blood storage solution such as the storage solution described in U.S. Pat. No. 8,709,707). Thus, whenblood refers to one or more components of whole blood, any of these components may be treated. Thus, blood (e.g., blood in a blood sample) may be platelets, packed red blood cells, heparinized packed red blood cells, citrated blood, plasma or platelet-free plasma taken from the blood of the patient. In some embodiments, the blood (e.g., blood in a blood sample) may be a sample that has reduced platelet function. For example, the blood (e.g., blood in a blood sample) may be treated with an inhibitor of platelet function such as cytochalasin D.


Note that by “blood transfusion” or simply “transfusion” is meant administration (e.g., by intravenous route) of blood (as defined above) to a recipient patient. The blood transfused to the patient can be fresh, or frozen, and can be whole blood, citrated blood, packed red blood cells, platelets, and so forth. Typically, blood is administered in units, where one unit of blood is roughly equal to one pint of whole blood. Note that the unit of blood may be a unit of packed red blood cells, but that unit of packed red blood cells is still equivalent to approximately one pint of whole blood for the donor. In some embodiments, the transfusion given to the patient is matched to the patient's ABO profile (e.g., O type blood donated to A patient, B patient, or AB patient, or B type blood donated to B or AB patient).


By “viscoelastic analysis” or “viscoelastic analysis assay” is meant any in vitro analysis method that measures the characteristics of elastic solid (e.g., fibrin solids) and fluids. In other words, viscoelastic analysis allows the study of properties of a viscous fluid, such as blood or a blood sample taken from a patient (e.g., a human patient). By using viscoelastic analysis, the mechanical strength of an evolving blood clot can be measured in vitro.


In some embodiments, the viscoelastic analysis is performed under conditions that mimic the conditions in vivo that govern hemostasis. Hemostasis is a tightly regulated, extremely complex process involving many interacting factors, which include coagulation and fibrinolytic proteins, activators, inhibitors and cellular elements, such as platelet cytoskeleton, platelet cytoplasmic granules and platelet cell surfaces, that controls bleeding in the body of an individual (e.g., a human individual). Hemostasis includes and comprises the balance between two processes: (1) the coagulation process, namely blood coagulation by formation of a fibrin-containing blood clot, and (2) the fibrinolysis process, namely the process involved in the breakdown of that clot, for example, by activation of plasmin to dissolve the fibrin mesh holding the clot together.


For example, the condition may include a temperature that mimics a body temperature (e.g., a temperature of 37° C.). The condition may also include clot formation and dissolution at flow rates that mimic those found in blood vessels.


Various devices that perform thromboelastography, and methods for using these devices, are described in U.S. Pat. Nos. 5,223,227; 6,225,126; 6,537,819; 7,182,913; 6,613,573; 6,787,363; 7,179,652; 7,732,213, 8,008,086; 7,754,489; 7,939,329; 8,076,144; 6,797,419; 6,890,299; 7,524,670; 7,811,792; 20070092405; 20070059840; U.S. Pat. No. 8,421,458; US 20120301967; and U.S. Pat. No. 7,261,861, the entire disclosures of each of which are hereby expressly incorporated herein by reference.


Thromboelastography (TE) monitors the elastic properties of blood as it is induced to clot under a low shear environment resembling sluggish venous blood flow. The patterns of changes in shear elasticity of the developing clot enable the determination of the kinetics of clot formation, as well as the strength and stability of the formed clot; in short, the mechanical properties of the developing clot. As described above, the kinetics, strength and stability of the clot provides information about the ability of the clot to perform “mechanical work,” i.e., resisting the deforming shear stress of the circulating blood. In essence, the clot is the elementary machine of hemostasis. Hemostasis instruments that measure hemostasis are able to measure the ability of the clot to perform mechanical work throughout its structural development. These hemostasis analyzers measure continuously all phases of patient hemostasis as a net product of whole blood components in a non-isolated, or static fashion from the time of test initiation until initial fibrin formation, through clot rate strengthening and ultimately clot strength through clot lysis.


In some embodiments, the viscoelastic analysis and/or the hemostais analyzer comprises a container which is in contact with the blood.


As used herein, by “container” is meant a rigid surface (e.g., a solid surface), a portion of which contacts a portion of a blood sample placed into the container at any point during the viscoelastic analysis. The portion of the container that contact the portion of blood sample may also be referred to as the “interior” of the container. Note that the phase “into the container” does not mean that the container has a bottom surface which is in contact with the portion of the blood sample. Rather, the container can be a ring-shaped structure, where the inside of the ring is the interior of the container, meaning that the inside of the ring is the portion of the ring-shaped container that contacts a portion of the blood sample. A blood sample can flow into the container and be held there, for example, by vacuum pressure or surface tension.


Still additional types of containers that are included in this definition are those present on plates and cassettes (e.g., a microfluidic cassette), where the plate or cassette has multiple channels, reservoirs, tunnels, and rings therein. Each of the contiguous channels (comprising, for example, a channel, a reservoir, and a ring) is a container, as the term is used herein. Hence, there may be multiple containers on one cassette. U.S. Pat. No. 7,261,861 (incorporated herein by reference) describes such a cassette with multiple channels or containers. Any of the surfaces in any of the channels or tunnels of the cassette may be an interior of the container if that surface comes into contact with any portion of the blood sample, at any time during the viscoelastic analysis.


Additional non-limiting hemostasis analyzer instruments are described in U.S. Pat. No. 7,261,861; US Patent Publication No. US20070092405; and US Patent Publication No. US20070059840.


A non-limiting analyzer instrument that performs viscoelastic analysis using thromboelastography is the TEG thromboelastograph hemostasis analyzer system sold commercially by Haemonetics, Corp. (Braintree, Mass.).


Thus, the TEG assay may be performed using the TEG thromboelastograph hemostasis analyzer system that measures the mechanical strength of an evolving blood cloth. To run the assay, the blood sample is placed into a container (e.g., a cup or a cuvette), and a metal pin goes into the center of the container. Contact with the interior walls of the container (or addition of a clot activator to the container) initiates clot formation. The TEG thromboelastograph hemostasis analyzer then rotates the container in an oscillating fashion, approximately 4.45 degrees to 4.75 degrees, every 10 seconds, to imitate sluggish venous flow and activate coagulation. As fibrin and platelet aggregates form, they connect the inside of the container with the metal pin, transferring the energy used to move the container in the pin. A torsion wire connected to the pin measures the strength of the clot over time, with the magnitude of the output directly proportional to the strength of the clot. As the strength of the clot increases over time, a classic TEG tracing curve develops (See FIG. 2A, where clot strength is reflected on the Y axis and time is on the X axis).


Where there is a pin in the TEG analyzer, the rotational movement of the pin is converted by a transducer to an electrical signal, which can be monitored by a computer including a processor and a control program. The computer is operable on the electrical signal to create a hemostasis profile corresponding to the measured clotting process. Additionally, the computer may include a visual display or be coupled to a printer to provide a visual representation of the hemostasis profile. Such a configuration of the computer is well within the skills of one having ordinary skill in the art. As shown in FIG. 2A, the resulting hemostasis profile (i.e., a TEG tracing curve) is a measure of the time it takes for the first fibrin strand to be formed, the kinetics of clot formation, the strength of the clot (measured in millimeters (mm) and converted to shear elasticity units of dyn/cm 2) and dissolution of clot. See also Donahue et al., J. Veterinary Emergency and Critical Care:15(1): 9-16. (March 2005), herein incorporated by reference


The descriptions for several of these measured parameters shown in FIG. 2A are well known and have been described elsewhere (see, e.g., Kouerinis et al., Interactive Cardiovascular and Thoracic Surgery 7: 560-563, 2008; Walsh et al., J. of Extracorporeal Tech. 43(3): 162-167, 2011; and Galvez and Cortes, Revista Colombiana Anestesiol. 40: 224-230, 2012; all incorporated by reference herein in their entireties).


Briefly, ACT (or R) is the time is the period of time of latency from the time that the blood sample is placed in the TEG analyzer until the initial clot formation. This is typically takes about 4-8 minutes in a healthy person. For patients in a hypocoagulable state (i.e., a state of decreased coagulability of blood), the ACT (or R) number is longer (i.e., higher), while in a hypercoagulable state (i.e., a state of increased coagulability of blood), the ACT (or R) number is shorter.


K value (measured in minutes) is the time from the end of ACT until the clot reaches 20 mm. The K value represents the speed of clot formation. This K value is about 0 to about 4 minutes (i.e., after the end of ACT) in a healthy person. In a hypocoagulable state, the K number is longer, while in a hypercoagulable state, the K number is shorter.


α measures the rapidity of fibrin build-up and cross-linking (clot strengthening). Thus, it shows the rate at which a solid clot is formed. It is angle between the line formed from the split point tangent to the curve and the horizontal axis, and represents the kinetics of clot development. This angle is typically about 47° to 74°. In a hypocoagulable state, the a degree is lower, while in a hypercoagulable state, the α degree is higher.


MA or Maximum Amplitude in mm, is a direct function of the maximum dynamic properties of fibrin and platelet bonding and represents the ultimate or maximum strength of the clot. The MA number (also referred to herein as Amax) is the greatest diameter of the clot and a measure of the clot's elasticity. This number is typically from about 54 mm to about 72 mm in a normal individual, and the MA occurs typically between about 15 to about 35 minutes after the start of the viscoelastic assay. Note that if the blood sample tested has a reduced platelet function, this MA represents the strength of the clot based on fibrin only. Decreases in MA may reflect a hypocoagulable state (e.g., with platelet dysfunction or thrombocytopenia), whereas an increased MA (e.g., coupled with decreased R) may be suggestive of a hypercoagulable state.


LY30 measures the rate of amplitude reduction 30 minutes after MA and represents clot retraction, or lysis. The LY30 is, therefore, the percentage of lysis of the clot or a percentage decrease in amplitude 30 minutes after the MA. The LY30 can also be described as the loss of potential area of under the TEG curve. For example, if the amplitude of the curve did not decrease following the peak at MA, the LY30 would be 0%. In healthy individuals, this LY30 number is typically 0% to about 8% (see FIG. 2B). In some embodiments, a hypocoagulable state is present if the LY30 is greater than 7.5%. In some embodiments, an LY30 that is greater than 6%, or greater than about 5%, or greater than about 4%, or greater than about 3.5%, or greater than about 3% identifies a patient with a hypocoagulable state.


Another viscoelastic hemostasis assay that can be used is the thromboelastometry (“TEM”) assay. This TEM assay may be performed using the ROTEM Thromboelastometry Coagulation Analyzer (TEM International GmbH Munich, Germany), the use of which is well known (See, e.g., Sorensen, B., et al., J. Thromb. Haemost., 2003, 1(3): p. 551-8. Ingerslev, J., et al., Haemophilia. 2003. 9(4): p. 348-52. Fenger-Eriksen, C., et al. Br J Anaesth, 2005. 94(3): p. 324-9]. In the ROTEM analyzer, the blood sample is placed into a container (also called a cuvette or cup) and a cylindrical pin is immersed. Between pin and the interior wall of the container there is a gap of 1 mm which is bridged by the blood. The pin is rotated by a spring to the right and the left. As long as the blood is liquid (i.e., unclotted), the movement is unrestricted. However, when the blood starts clotting, the clot increasingly restricts the rotation of the pin with rising clot firmness. The pin is connected to an optical detector. This kinetic is detected mechanically and calculated by an integrated computer to the typical tracing curves (TEMogram) and numerical parameters (see FIG. 3).


In the ROTEM Thromboelastometry Coagulation Analyzer, the movement of the pin can be monitored by a computer including a processor and a control program. The computer is operable on the electrical signal to create a hemostasis profile corresponding to the measured clotting process. Additionally, the computer may include a visual display or be coupled to a printer to provide a visual representation of the hemostasis profile (called a TEMogram. Such a configuration of the computer is well within the skills of one having ordinary skill in the art. As shown in FIG. 3, the resulting hemostasis profile (i.e., a TEM tracing curve) is a measure of the time it takes for the first fibrin strand to be formed, the kinetics of clot formation, the strength of the clot (measured in millimeters (mm) and converted to shear elasticity units of dyn/cm 2) and dissolution of clot. The descriptions for several of these measured parameters are as follows:


CT (clotting time) is the period of time of latency from the time that the blood was placed in the ROTEM analyzer until the clot begins to form. In some embodiments, the CT time is the period of time from when the blood is placed on the ROTEM analyzer to when the amplitude reaches 1 mm wide.


CFT (Clot formation time): the time from CT until a clot firmness of 20 mm point has been reached. In FIG. 3, this CFT time is depicted as the time immediately following CT. CFT is reflective of the speed of clot formation.


alpha-angle: The alpha angle is the angle measured between the midline of the tracing and a line drawn from the 1 mm point tangential to the curve. This parameter is reflective of the speed of clot formation.


MCF (Maximum clot firmness): MCF is the greatest vertical amplitude of the trace. MCF reflects the absolute strength of the fibrin and platelet clot.


A10 (or A5, A15 or A20 value). This value describes the clot firmness (or amplitude) obtained after 10 (or 5 or 15 or 20) minutes after the clotting time (CT). In other words, and provide a forecast on the expected MCF value at an early stage.


LI 30 (Lysis Index after 30 minutes). The LI30 value is the percentage of remaining clot stability in relation to the MCF value at 30 min after CT.


ML (Maximum Lysis). The ML parameter describes the percentage of lost clot stability (relative to MCF, in %) viewed at any selected time point or when the test has been stopped.


A low LI 30 value or a high ML value indicates hyperfibrinolysis. While in normal blood fibrinolysis activity is quite low, in clinical samples a more rapid loss of clot stability by hyperfibrinolysis may lead to bleeding complications which can be treated by the administration of antifibrinolytic drugs.


Thus, parameters of interest in TEG or TEM assays include the maximum strength of the clot which is a reflection of clot strength. This is the MA value in the TEG assay, and the MCF value in the TEM assay. The reaction time (R) in TEG (measured in sec) and clotting time (CT) in TEG is the time until there is first evidence of clot; clot kinetics (K, measured in minutes) is a parameter in the TEG test indicating the achievement of clot firmness; and α in TEG or alpha-angle in TEM is an angular measurement from a tangent line drawn to the curve of the TEG tracing or TEM tracing starting from the point of clot reaction time that is reflective of the kinetics of clot development. (See Trapani, L. M. Thromboelastography: Current Applications, Future Directions”, Open Journal of Anesthesiology 3(1): Article ID: 27628, 5 pages (2013); and Kroll, M. H., “Thromboelastography: Theory and Practice in Measuring Hemostasis,” Clinical Laboratory News: Thromboelastography 36(12), December 2010; instruction manuals for the TEG instrument (available from Haemonetics, Corp.), and the instruction manual for the ROTEM instrument (available from TEM International GmbH), all of which documents are herein incorporated by reference in their entireties.


In some embodiments, the parameters (and hence the coagulation characteristics) are recorded by observation of different excitation levels of the sample as coagulation occurs. For example, where the container is a microfluidic cassette, or a particular channel in the cassette, the blood sample may be excited at a resonant frequency and its behavior observed by an electromagnetic or light source as coagulation occurs. In other embodiments the sample's coagulation characteristics may be observed for changes with a light source without exciting the sample.


Because a single cassette may have multiple containers (e.g., different channels in the cassette), the sample in a container contacted with an inhibitor of fibrinolysis is easily directly comparable to a sample in a container (e.g., in an adjacent channel in the same microfluidic cassette) that is not contacted with the inhibitor of fibrinolysis.


When no fibrinolysis occurs, the amplitude value at the MA on a TEG tracing and the amplitude value at the MCF on a TEM tracing stays constant or may decrease slightly due to clot retraction. However, as fibrinolysis occurs (e.g., in a hypocoagulable state), the curve of the TEG tracing and the TEM tracing starts to decay. The resultant loss in potential area-under-the-curve in the 30 minutes following Maximum Amplitude in the TEG assay is called the LY30 (see FIG. 2A). LY30, the percentage of lysis 30 minutes after the maximum amplitude point (expressed as a percentage of the clot lysed) and clot firmness (G, measured in dynes/cm2), indicates the rate of clot lysis. The corresponding value in the TEM assay is the LI30 value (see FIG. 3).


The LY30 is the usual metric of fibrinolysis. However, this parameter has some limitations including lack of sensitivity and specificity. Most importantly, the LY30 parameter takes at least 30 minutes to obtain. In normal patients, obtaining the LY30 in at least thirty minutes (because the 30 minutes must be added to whatever the time it took the clot to form in the first place) is adequate. However, in trauma patients, waiting the at least 30 minutes to determine if the patient's blood is clotting normally may be detrimental to the patient's outcome (e.g., the patient may bleed to death).


Thus, viscoelastic assays such as TEG and TEM measure the mechanical strength of the evolving blood clot over time. As the strength of the blood clot increases over time, a classic TEG curve (FIG. 2A) or classic TEM curve (see FIG. 3) develops. FIG. 4 provides a convenient side by side comparison of the TEG curves (upper part of the figure from a TEG apparatus) and TEM curves (lower part of the figure from a ROTEM apparatus). Note that for both TEG and TEM, sometimes only the upper half of the curve is depicted (see, for example, the TEG curve depicted in FIG. 7A).


There are, however, drawbacks to using the standard TEG and TEM assays. For example, it is difficult to measure the contributions of platelets and fibrinogen to the clot. Currently, the assays such as EXTEM and platelet-inhibitor containing FIBTEM (see FIGS. 5A and 5B, respectively) are run to try to determine the contributions of platelets and fibrinogen to clot strength. However, simple subtraction of assays run with and without platelet inhibitors is not an accurate measure of the contributions of platelets and fibrinogen because as FIGS. 5A and 5B show, platelet and fibrinogen contribution to clot strength is not additive.


Furthermore, perhaps the biggest drawback of all of the above listed parameters of TEG and TEM is the amount of time needed to obtain them. For example, while the MA (or MCF) and the LY30 (or LI30) in TEG and the MCF in TEM are considered two of the more important measurements of the clot in their respective assays, they are by definition obtainable only after the assay has been running for some time. For example, the LY30 and LI30 parameters are obtainable thirty minutes after the MA or MCF which, themselves, are obtainable after the R/ACT time and K time in the TEG assay, and after the CT time and the CFT time in the TEM assay. In the healthy volunteer whose data is depicted in FIG. 7A, Amax (i.e., MA) is not obtainable until 42 minutes after the start of the TEG analysis. During treatment of an individual with a traumatic injury (e.g., a person who has been in a car accident), minutes can make the difference between a positive outcome and a negative one.


Additionally, as FIG. 5C shows, if the patient has hyperfibrinolysis, an accurate reading of MA may be impossible. In this FIG. 5C, the antifibrinolytic agent tranexamic acid (TXA) is added to a blood sample to simulate a hyperfibrinolytic condition. As FIG. 3C shows, the true MA (i.e., Amax) is never reached in the hyperfibrinolysis sample, because the clot starts breaking down too soon. Yet accurate reading of the MA is very important for determining patient outcome.


The invention therefore stems, in part, from the desire to develop parameters that predict MA on a rational physical basis and encompass enough of the early TEG tracing to accurately predict its future trajectory. Results of earlier observational studies indicated that a major source of noisiness in the predictive value of early TEG parameters was the position of the parameters with respect to time as the dependent variable. As the rate of clot formation feeds back into the independent variable, the TEG curve shape is difficult to model over a wide dynamic range. Moreover, the inherent physics of clot formation are in essence time independent but are describable by the instantaneous state of the clot structure and concentration of the catalytic and stoichiometric participants in clot formation.


Thus, in some embodiments, the invention provides a model of clot formation in a time-independent domain, wherein TEG amplitude (A) is a proxy for clot strength and thus instantaneous clot structure and the instantaneous rate of clot formation at that state (dA/dT) becomes the dependent variable, such that:






dA/dT=f(A)


This function clearly defines the “accelerative” versus “coasting” phases of clot formation, a novel reconstitution of the traditional notions of initiation versus propagation in a non-temporal domain.


The implied function dA/dT=f(A) is then modeled using a physical model that bore a resemblance to the data derived from the human healthy volunteers. That physical model is:






dA/dT=aA
2/(ebA−1)


which is a lower order modification of Planck's equation which contains only two fitting coefficients, namely a and b. Note that the values for a and b will vary in each patient. The values for a and b are how the fitting is done.


In some embodiments, A is the value of the Amplitude, e is a mathematical constant that is approximately 2.71828, a is a patient-specific coefficient derived from fitting that patient's data to the empirically derived equation using a least squares method (a well-established data fitting method), and b is also a patient-specific coefficient derived from fitting that patient's data to the empirically derived equation using a least squares method. In some embodiments, coefficient a=0.011 and coefficient b=0.104. In some embodiments, A goes from 0 to 60.


The invention, in some embodiments, therefore provides time-independent parameters. One such parameter is dAmax for the maximum in the rate of change of A. Thus, just as MA is the maximum amplitude is the time-domain TEG curve (see, e.g., FIG. 1A), the global maximum in the time independent TEG curve is dAmax. Note that “Amax” and “MA” are interchangeable terms and both refer to the maximum amplitude. The corresponding amplitude of dAmax called the critical amplitude or Acrit. In taking a derivative of the TEG curve, the derivative of Acrit appears at the peak of a curve plotting dA versus amplitude (in mm). Acrit occurs when dA is at its maximum value (i.e., Acrit occurs at dAmax). See, for example, FIG. 6C.


Accordingly, in a first aspect, the invention provides a method for identifying a patient likely to require a transfusion of at least six units of blood in six hours, the method comprising obtaining a coagulation characteristic value that is independent of time by using a viscoelastic analysis assay to analyze a sample of blood from the patient, the coagulation characteristic value obtained not more than fifteen minutes after the start of clot formation in the sample of blood from the patient, wherein the coagulation characteristic value of the patient that is lower than the coagulation characteristic value that is independent of time of a control (e.g., a healthy volunteer) identifies the patient as likely to require a transfusion of at least six units of blood in six hours.


The invention stems, in part, from the development of the model






dA/dT=f(A)


which is based on taking the derivative of the TEG amplitude (A) parameter over the derivative of Time such that the function f(A) is arrived at. The modeling of this f(A) function allows the prediction of the maximal value of A (MA) based upon the trajectory during the accelerative phase of clot formation.


In some embodiments, the examples below describe the development of this model for f(A).


Thus, in some embodiments, the term “coagulation characteristic value” is meant any value obtained from viscoelastic analysis (e.g., maximum amplitude, LY30, A15).


One non-limiting coagulation characteristic value is Acrit, namely the point at which the rate of change of amplitude is at the maximum. In other words, Acrit is the amplitude at dAmax. Note that Acrit is not the same as MA (or Amax) because just as a moving vehicle does not immediately come to a halt once it stops accelerating, so too the amplitude does not immediately start declining once the rate of change of amplitude stops accelerating.


In some embodiments, the Acrit is obtained at least 10 minutes before the MA is obtained. In some embodiments, the Acrit is obtained at least 15 minutes before the MA is obtained.


As described below, in the examples, the blood of healthy volunteers have fairly high Acrit and modest dAmax. Patients who have significant hemorrhage (i.e., need 6 to 10 units of blood transfused in 6 hours) or massive hemorrhage have lower Acrit than the healthy volunteers. Patients who are injured (e.g., trauma patients) but who do not need more than 6 units of blood transfusion in 6 hours have moderate Acrit but high dAmax.


It should be noted that blood sample of the patient that is being analyzed should be kept on the viscoelastography analyzer, even after the Acrit parameter is taken.


Thus, in some embodiments, the invention uses information based on mathematical analysis of data emitting from a viscoelastic assay device (e.g., a thromboelastograph or a thromboelastometer) to predict whether a patient will require a blood transfusion.


In Example I below, an explanation of the mathematical derivation of Acrit and dAmax is described. Examples II-V describe working embodiments on healthy human volunteers and human patients (e.g., trauma patients).


Example I

In this Example I, a thromboelastoograph (TEG) device commercially obtained from Haemonetics, Corp. (Braintree, Mass.) is used.


Thromboelastography (TEG) is a diagnostic procedure that uses a thin wire probe to measure the strength of blood clots. This measurement is obtained by rotating a sample of blood around the thin wire probe. As the TEG machine rotates the blood, blood clots form and the wire probe adheres to the clot. When the wire probe adheres to the clot, it begins to move with the clot. The movement of the wire probe is recorded as an amplitude in millimeters. Therefore, a patient's clotting ability is directly related to the measured maximum amplitude. Understanding a patient's clotting ability is especially desirable in emergency trauma settings. Disclosed herein is the surprising discovery that the maximum amplitude can be accurately modeled in less time than it takes to measure the maximum amplitude. This can be done by measuring data to a point known as the critical amplitude and deriving the maximum amplitude from this data. An example of data obtained using TEG on a real patient sample is shown in FIG. 7A.



FIG. 7A shows a TEG curve for a healthy human volunteer, namely patient 20074B. As can be seen from FIG. 7A, the amplitude at time t=0 min until t=13.16 min is 0 mm. This is because the blood has not sufficiently clotted to adhere to the wire probe until the split at t=13.16 minutes. Until clotting forms, the wire probe remains motionless, and thus the amplitude is 0. In the art, this period of 0 amplitude may be known as the reaction time or “R value.” As the blood sample begins to clot, the wire probe adheres to the moving blood sample and starts moving. As the wire probe moves, the amplitude becomes non-zero.


The amplitude of the wire probe's motion is directly proportional to the strength of the clot. The Amax value is an important factor of a TEG analysis because it indicates the strength of the blood clot i.e., the overall stability of the clot. A computer may record and store the amplitude data as it is collected. The frequency with which amplitude data measurements are taken or sampled is known as the “sampling rate.” The sampling rate is easily modified by one having skill in the art, and frequently is a changeable parameter that is part of the data collection software. However, during a single set of data collection, a constant sampling rate is preferable. In other words, the time elapsing between measurements (τ) is preferably consistent. For example, the sample rate may be per minute, every second (hertz) or every millisecond (kHz), based on the number of data points and specificity desired. The sample rate may be limited by the maximum sample rate of the device. Alternatively, the sample rate may be dictated by the amount of data that we want to collect. Realistically, time measurements on the plot are shown to fractions of a minute. For example, a split point where the clot starts to form can be measured to t=13.166667 min. The time scale accuracy shows that the sample rate may be fractions of a second.


As data points are collected, it is possible to obtain the rate of change of amplitude (dA/dT). The collection of amplitude data points may be conceptualized as follows:


Amplitude data=[A0, A1, A2, A3, . . . , AN−1, AN] where A1 is the first amplitude data point collected, A2 is the second amplitude data point collected and so on until N data points have been collected. In this case A0 is the baseline amplitude immediately prior to data collection, e.g. 0.


Each amplitude data point is taken at a corresponding time interval.





Time data=[T0,T1,T2,T3, . . . TN−1,TN]


Because we can assume that the sampling rate is consistent throughout the entire period of data collection, it should be understood that the time between each measured sample is consistent. Specifically,





τ=T1−T0=T2−T1=T3−T2=TN−TN−1


In other words, if one records 5 samples per second over the course of 30 seconds, 150 data points are obtained with ⅕th of a second between each data point. It should be understood that the time units are dependent upon the sample rate chosen (amplitude values may be collected every millisecond, every second, every minute, etc.).


The rate of change of amplitude per time (dA/dT) for any N-th data point may be conceptualized as follows:








dA
N

dT

=

[



A
N

-

A

N
-
1





T
N

-

T

N
-
1




]





When sampling rate is consistent, the denominator is the same in every equation because the time intervals between all measurements are the same as a result of a consistent sampling rate. The rate of change of amplitude per time (dA/dt) for any N-th data point may be simplified as follows:








dA
N

dT

=

[



A
N

-

A

N
-
1



τ

]





where τ is a constant equal to the inverse of the sampling rate, i.e. the time between sampling.


Thus, the parameter dAN/dT is independent of time.


As shown in FIG. 7A, amplitude rapidly increases after the “split.” The rate of change of the amplitude continues to increase until a point labeled Acrit. At Acrit, amplitude increases at the fastest rate. After Acrit, amplitude continues to ascend, but at a slower rate than at Acrit. As the rate of change is calculated over the course of data collection by the computer, it is possible to identify at what time the maximum rate of change (Acrit) occurs. For example, rate of change (dA/dT) values will continue to increase until a maximum rate of change is reached (Acrit), and then rate of change (dA/dT) will decrease. However, just because the rate of change (dA/dT) decreases, it should be noted that amplitude may still be increasing, albeit at a slower rate. A routinely skilled practitioner can review the data emitting from the TEG analysis of a blood sample and detect Acrit, the point at which the rate of change of A stops accelerating and starts slowing down. Of course, a computer can detect that the maximum rate of change (dA/dT) has occurred and identify point Acrit as it occurs.


The amplitude eventually reaches a maximum value, shown as Amax on FIG. 7A. This Amax value provides valuable diagnostic data about the strength of the clot and is also referred to as maximum amplitude (MA) or maximum clot firmness (MCF). In healthy patients, fibrinolysis occurs after Amax, as the wire probe begins to slip, resulting in an amplitude decrease as shown.


In FIG. 7A, Amax occurs approximately 42 minutes after starting the thromboelastography analysis (i.e., putting the blood sample into the TEG machine). The Amax value is approximately 59.02 mm. Because Amax dictates blood clot strength as well as other physiological parameters, in certain emergency patient care situations the sooner Amax can be determined the better. Thus in emergency trauma settings, it is desirable to determine the value for Amax well before the 42 minutes required to reach Amax. As discussed below in Example II, the health and well-being of a trauma patient is assessed at six hours. Therefore, 42 minutes is a very long time to have to wait to determine patient outcome.


Thus, embodiments of the present invention use an empirically derived equation to model Amax from values of Acrit. As a result, Amax (i.e., MA) can be estimated within an accuracy level appropriate to determine relevant physiological factors at the time of Acrit, approximately half the time required to measure Amax.


In some embodiments of the invention, a computer may record amplitude and dA/dT data as discussed above in real time. The data collection may, for example, look something like Table 1 below.












TABLE 1








dA/dT



Amplitude
(mm/time



(mm)
unit)



















10
0.60135



11
0.622166



12
0.637843



13
0.648832



14
0.655564



15
0.658451




(Acrit)



16
0.657884










As can be seen, when the Amplitude is 15 mm, the rate of change (dA/dT) has reached its maximum (Acrit) at 0.658451 mm/time unit. When the Amplitude is 16 mm, dA/dT begins to descend (note that Amplitude does not descend, only its rate of change (dA/dT) has slowed). In FIG. 7A, Acrit occurs when Amplitude reaches 15 mm at approximately 17 minutes. That is all the time and data that needs to be collected to obtain a calculated Amax using the empirically derived equation described below. As should be understood, obtaining an Amax value from an Acrit value provides a substantial benefit in terms of the time necessary to obtain a value for Amax.


In accordance with the present invention, the inventors have discovered that patient data collected from 161 healthy volunteers could be modeled with empirically derived equation: dA/dT=aA2/(ebA−1) This equation represents the derivative, or rate of change, of the Amplitude in respect to time. A is the value of the Amplitude, e is a mathematical constant that is approximately 2.71828, a is a patient-specific coefficient derived from fitting that patient's data to the empirically derived equation using a least squares method (a well-established data fitting method), and b is also a patient-specific coefficient derived from fitting that patient's data to the empirically derived equation using a least squares method. To accurately model dA/dT, in some embodiments, the data is collected all the way to point Acrit. After Acrit, the dA/dT equation can be solved for the missing coefficients a and b by a computer in seconds.



FIG. 7B is a graph of dA/dT=aA2/(ebA−1) with coefficient a=0.011 and coefficient b=0.104 when A goes from 0 to 60:


Theoretically, Amax should be the point that dA/dT reaches 0. The rate of change (dA/dT) should then become negative to indicate that amplitude is dropping after Amax. Because of the empirical equation chosen, dA/dT=aA2/(ebA−1), dA/dT will never achieve a negative value unless one of the coefficients is negative. However, in order to fit the model shown, coefficients a and b should both be positive values. A potential issue arises with the use of positive coefficients. Since Amax is the maximum amplitude, all amplitude measurements thereafter should be less than Amax. In other words, the derivative after Amax should be negative. However, as a result of the simplistic equation used to model Amax behavior, certain embodiments of the model may not achieve a negative value for dA/dT. This particular graph of dA/dT v. Amplitude shown in FIG. 7B will only approach dA/dT=0 as Amplitude approaches infinity. However, as we know, Amplitude never actually reaches infinity. Therefore, there may be some specific cutoff threshold value. This value may be set by a computer, for example. For example, setting the requirement that Amax occurs when the change of Amplitude over time eventually slows down to some value, e.g. when dA/dT=0.1.


The coefficients a and b are responsible for determining where the graph of dA/dT will peak, and how quickly it will return to 0 after it peaks. In general terms, coefficient a is responsible for raising the peak of the graph, while coefficient b is responsible for determining how quickly the peak will descend towards 0. Both coefficients are relevant because they influence when dA/dT will reach the cutoff threshold for determining the calculated Amax value. A larger a value will result in a correspondingly larger peak value. A larger b value will result in a graph that descends more rapidly. For example, when coefficient a doubles to 0.022, there is a correlated elevation in the peak value, and the calculated Amax value, as shown in FIG. 7C.


If a calculated Amax threshold occurs when dA/dT=0.1, the graph shown in FIG. 7C does not extend far enough along the amplitude axis to show what calculated Amax would be i.e. Amax would be greater than 60. The patient having coefficient a value of 0.022 has a quantitatively greater clotting strength than the patient having coefficient a value of 0.011.


When coefficient b doubles to 0.208, the graph approaches 0 more quickly as shown in FIG. 7D.


In this case, if calculated Amax were to occur at a threshold when dA/dT=0.1, Amax would occur well before Amplitude=60. In other words, the patient with coefficient b value of 0.208 has significantly weaker clotting than the patient with coefficient b value of 0.104. Noticeably, this increase in coefficient b has dropped the value of Acrit as well. As can be understood, the coefficients do not operate on isolated segments of the graph, but rather work together to produce the entire waveform, including the values for Amax and Acrit. However, as a general concept, a larger a coefficient makes the plot peak larger, and a larger b coefficient brings the plot peak down and causes a more rapid descent towards dA/dT=0. Each a and b coefficient may vary from patient to patient. The a and b coefficients of each patient allow us to create a custom model for each patient based on the Acrit data acquired. For example, as shown in FIG. 7E, data points may be obtained as shown by the squares up until point Acrit.


A program, such as MatLab (commercially available from The MathWorks Inc., Natick, Mass.), may be used to fit the dA/dT data points to the empirically derived equation for dA/dT using the least squares method. Again, the dA/dT data points may be obtained by using the Amplitude data acquired from the TEG procedure. A computer may automatically calculate the dA/dT values.





Amplitude data=[A0,A1,A2,A3,A4, . . . ACRIT−1,ACRIT,ACRIT+1]


The rate of change of A1 for example is (A1-A0) divided by τ, the time between data acquisition measurements.







dA
dT

=

[




A
1

-
0

τ

,



A
2

-

A
1


τ

,



A
3

-

A
2


τ

,










A
CRIT

-

A

CRIT
-
1



τ


,



A

CRIT
+
1


-

A
CRIT


τ


]





The values for dA/dT, that may be obtained using the above equation, are plotted against the Amplitude values up to Acrit. This produces the first part of the waveform up to the peak of the plot. The empirical equation:







dA
dT

=


a
·

A
2




e
bA

-
1






is then fit to the data points up to Acrit using the least squares method. By fitting the data to the empirical equation, coefficients a and b are determined. This may be done by a computer. Fitting the data to the equation gives coefficients a and b values that produce the best fit to the dA/dT equation using the least squares method. Once the a and b coefficients are obtained from the collected data points up to Acrit, the equation may be extended to Amax. A graph may be used to find the calculated Amax by simply plugging in the best fit a and b coefficients into the dA/dT equation and seeing when the Amax threshold level is reached. As discussed above, the derivative, dA/dT value will approach 0 as Amplitude goes to infinity. This is a property of the model equation chosen. As a result, a trigger threshold dA/dT value may be used to determine when Amax occurs. This trigger threshold can be determined based on empirical data, or when the derivative has reached an adequately low level, for example when dA/dT drops to less than 0.1 mm/time unit.


Example II

The dAmax and Acrit values were obtained from four classes of patients, namely healthy volunteers, trauma patients with no significant bleeding (i.e., hemorrhage), trauma patients with significant hemorrhage needing 6-10 units of blood in 6 hours, and trauma patients with massive hemorrhage needing 10 units of blood in 6 hours or dying of exsanguination in 6 hours.


Blood was collected and analyzed according to standard methods. By way of example, from healthy volunteers, citrated whole blood samples were obtained from healthy volunteers accordingly to standard methods. Similar techniques are performed on blood samples from trauma patients.


Briefly, venipuncture is performed with a 21-gauge needle in an antecubital vein, and blood is collected into evacuated containers containing 3.2% citrate (e.g., a 3.5 mL plastic Vacutainers® containing 3.2% citrate). By a “healthy individual” or “healthy volunteer” is meant a healthy individual who is of reproductive age. For example, if the patient is a human, a healthy volunteer is man or woman between the ages of about 14 years old to about 44 years old, or between about 18 years old to about 40 years old. For each sample of blood, 340 uL of the citrated whole blood (i.e., from the Vacutainers that contained 3.2% citrate) are added to a cup containing 20 μL 0.2 mol/L of CaCl2 and the assay performed on a TEG 5000 Thrombelastograph system (commercially available from Haemonetics, Inc., Braintree, Mass.). Note that if a multi-channel cassette is used, the channel for the particular sample is pre-loaded with 20 μL 0.2 mol/L of CaCl2, to which 340 uL of the citrated whole blood is added.


Table 2 provides the raw data (CRD) from healthy volunteers. Note that in the tables, “CFF” stands for citrate functional fibrinogen TEG, where the extrinsic pathway is activated by the addition of tissue factor and calcium, while the platelet aggregation is inhibited (due to the presence of a monoclonal glycoprotein GPIIb/IIIa receptor antagonist in the Functional Fibrinogen reagent, commercially available from Haemonetics Inc., Braintree, Mass.). Therefore, the CFF number represents the amount of fibrinogen contribution to the strength of the clot. “CFT” is the citrated rapid TEG, which adds kaolin to activate the intrinsic pathway. Thus, the CFT number represents the clot strength as contributed by both platelets and fibrinogen. “CN” is simply native blood or native blood that has been citrated but has no kaolin or tissue factor added. Table 3 provides the healthy volunteer data sorted by CN MA. Table 4 provides the raw data (CRD) from trauma patients sorted by significance of hemorrhage. Table 5 provides the trauma patient data sorted by significance of hemorrhage, where the errors are eliminated. The data from these patients were taken from the TEG apparatus (commercially available from Haemonetics, Corp., Braintree, Mass.) using the computer software provided with the apparatus and additional software for speedy calculations. Note that the data was taken from native TEG (i.e., citrated or non-citrated whole blood without the addition of clotting factors or enhancers of clot formation such as kaolin). These data were then used to calculate Acrit and dAmax values using the equations described above.


In FIGS. 8 and 9, dAmax values were then plotted as a function of Acrit. The data plotted are healthy volunteers (triangles), patients with no massive hemorrhage (squares), patients with significant hemorrhage (circles), and patients with massive hemorrhage (diamonds). A patient with no massive hemorrhage (or no significant hemorrhage) is a patient who does not need more than 6 units of blood in 6 hours. A patient with significant hemorrhage needs between 6 units and 10 units of blood in 6 hours. And a patient with massive hemorrhage is a patient who either needs more than 10 units of blood in 6 hours or less, or who dies of blood loss in 6 hours.


As shown in FIG. 8, patients with massive hemorrhage (orange diamonds) had slightly lower dAmax and slightly lower Acrit values than patients with no significant hemorrhage (blue squares). The difference between both of these populations is striking when compared to healthy volunteers (green triangles) who had higher Acrit values and lower dAmax values. FIG. 9 shows that patients with significant hemorrhage (yellow circles) overlap the patients with massive hemorrhage, but had very little overlap with patients with no significant hemorrhage.


The data is FIGS. 8 and 9 show that healthy volunteers form a tight cluster of fairly high Acrit, and modest dAmax. Furthermore, patients who are injured but do not have significant hemorrhage (i.e., do not require transfusion of more than 6 units of blood in 6 hours) will increase dAmax dramatically (i.e., by increasing generation of thrombin). By doing so, this increase in dAmax in injured patients will shift Acrit values lower. This may be due to the thermodynamic efficiency of clot formation being lower at higher velocity (a common feature of enzymatic chemistry) or simply that there are consumptive processes at work. However, massive bleeders will fail to up-regulate their dAmax and also have a subnormal (i.e., low) Acrit, either from catalysis failure or exhaustion of resources.


Example III

To even more accurately predict the MA, the discontinuity with the model near MA was addressed by taking the area under the tracing and relating it to MA (i.e., Amax). Since there is no closed form solution to relate the MA in the time domain back to the integrated differential equation in the amplitude domain, the relationship will be modeled. By dimensional analysis the solution to the integral of dA/dT with respect to A from A=0 to A=∞ should have units equivalent to A2. Calling this area product “Q”, this provided a solution that must be in the form Q=c(Amax2)+d where c is a function zero order in Amax and T (note that Amax is used synonymously with the time-dependent variable “MA”). The simplest model for this is thus merely a linear fit to existing healthy volunteer and patient data.


The results described here provide the identification of new parameters that can be obtained very early, and that ae reflective of the maximum amplitude. The maximum amplitude is one of the most important predictors of outcomes for trauma patients, and whether or not such patient will require a blood transfusion. In healthy volunteers, the MA occurs typically between about 15 to about 35 minutes after the start of the viscoelastic assay. A lower MA may reflect a hypocoagulable state, such as platelet dysfunction or thrombocytopenia, and thus identifies a patient that is likely to require a blood transfusion. Since the Acrit is reflective of MA, an Acrit that is lower than an equivalent MA at about 15 to about 35 minutes identifies the patient as likely to require a blood transfusion.


As discussed in more detailed in Example IV below, FIG. 15 shows the data points of MA plotted against the area under the curve (see red shaded area in FIG. 10) fit to the model. The area under the curve is clearly shown in FIG. 10 (red shaded area). This red shaded area stops in FIG. 10 at “crit” (i.e., Acrit), which occurs when dA is at its maximum value.



FIGS. 11 and 12 are two graphs showing the correlation between plotting the % sensitivity versus % specificity for the rate of change of the time-independent TEG area under the curve (TITAUC). The straight diagonal line shows a 50/50 chance of prediction of a patient with significant hemorrhage (FIG. 11) or massive hemorrhage (FIG. 12). Plotting the area under the curve (see FIG. 10), FIG. 11 shows that using the Acrit and dAmax values, a patient with significant hemorrhage could be predicted with an accuracy of 83.65% and FIG. 12 shows that using the Acrit and dAmax values, a patient with massive hemorrhage could be predicted with an accuracy of 88.23%.


Example IV

The MA of a TEG curve is the hypothetical representation of the maximum clot strength which represents a combination of platelet and fibrinogen contributions to the clot's architecture and ultrastructure. However, this MA number is not a simple additive sum, as platelets and fibrinogen are not merely a homogeneous admixture (see FIGS. 5A and 5B). Instead, platelets form nodes in the fibrin network which catalyze the formation of and organize the network as well as actively generating internal stresses by their contraction which enhance the shear and tensile strength of the clot. The complex, non-additive relationship of platelets and fibrinogen to clot strength is exemplified by the fact that an entirely platelet-free clot loses around 80% of its strength, but a fibrinogen free clot loses 100% of its strength.


Thus, simple differential thromboelastography analysis between samples with and without platelet inhibitors is not a fully accurate measure of the individual contributions of platelets and fibrinogen, or more importantly which of these elements is deficient in the setting of a given individual, such as a trauma patient who may or may need a blood transfusion.


To obtain a faster parameter reflective of MA, the TEG tracings of the 161 healthy volunteers were analyzed and more information was extracted from these TEG tracings (also referred to as TEG curves) to obtain novel parameters. These tracing are drawn initially in the time domain (see. e.g., FIG. 4A or 5A), but can be transformed into other coordinate systems that reveal other information encoded in the tracing. For example, the reference frame of the TEG tracings can be arbitrarily shifted to a set of axes which appear to encode the greatest information content.


Another method is to deliberately transform the data into a new set of coordinates may be based on inherent physical properties of the system, for example transforming a complex signal read out in the time domain into the frequency domain to reveal hidden patterns (e.g., a fourier transform).


Similarly, one can transform a signal in the time domain to a signal in the amplitude domain.



FIG. 6A, for example, classic TEG tracing of one typical healthy volunteer. In FIG. 4A, time (in min) is on the X axis and amplitude (in mm) is on the Y axis).


A term of interest, such as the amplitude, can be pulled out of the non-periodic signal (e.g., a TEG tracing) and recast as an independent variable that term (i.e., the amplitude) as the domain, with the rate of change of amplitude as the new dependent variable, dA. This is shown in FIG. 6B. FIG. 6B thus effectively removes the time variable.


Thus, just as MA is an obvious feature of the time-domain TEG curve, a global maximum exists in the time independent TEG curve. This is called the dAmax for the maximum in the rate of change of A, the corresponding amplitude is called the critical amplitude or Acrit. Acrit is shown on FIG. 6A and FIG. 6C. In FIG. 6C, it is clear that Acrit occurs at dAmax (i.e., at the time that dA is at its maximum value. In the healthy volunteer shown in FIG. 6A, Acrit occurs when the dA is 0.68 and the A is 11.64 mm (see FIGS. 6A and 6C). The Amax is 55.62 mm, and occurs at approximately 38 minutes (see FIG. 6A).


The TEG tracing of another healthy volunteer is shown in FIG. 7A. In FIG. 7A, it is evident that the Acrit parameter is obtainable before 5 minutes after the beginning of clotting (i.e., before the A5 time). In the patient shown in FIG. 7A, the A5 parameter (i.e., 5 minutes after clotting) is obtained 18.17 minutes after the start of the TEG assay. However, the Acrit parameter is obtained at approximately 17 minutes after the start of the assay.


Thus, in some embodiments, the invention provides a parameter for detecting whether or not a patient will need a blood transfusion less than 5 minutes after the blood starts clotting in a viscoelastic assay. In some embodiments, the invention provides a parameter for detecting whether or not a patient will need a blood transfusion less than 10 minutes after the blood starts clotting in a viscoelastic assay. In some embodiments, the invention provides a parameter for detecting whether or not a patient will need a blood transfusion less than 15 minutes after the blood starts clotting in a viscoelastic assay.


In some embodiments, the invention provides a parameter for detecting whether or not a patient will need a blood transfusion less than 18 minutes after the start of the viscoelastic assay (i.e., after the blood sample from the patient is placed into the viscoelastic analyzer for analysis). In some embodiments, the invention provides a parameter for detecting whether or not a patient will need a blood transfusion less than 20 minutes after the start of the viscoelastic assay. In some embodiments, the invention provides a parameter for detecting whether or not a patient will need a blood transfusion less than 25 minutes after the start of the viscoelastic assay. In some embodiments, the invention provides a parameter for detecting whether or not a patient will need a blood transfusion less than 30 minutes after the start of the viscoelastic assay.



FIG. 13 shows that the mapping of Acrit and Amax parameters of the tracing of FIG. 7A in a Planck-like fit is stable. (See red line in FIG. 14A, fit up to the maximum at Acrit).


The behavior in the TEG tracings suggests some degree of coupling with some hidden variables. Pulling these hidden variables out requires integrating this differential equation:






dA/dT=f(A)


This equation is an implied function and is clearly a nonlinear differential equation even in the case of the simplest model. So solving in closed form is likely not possible and there is a good chance that its expansion will not converge.


Note that initially the TEG tracings from the healthy volunteers were modeled with the empirically derived equation






dA/dT=aA
2/(ebA−1)


Fitting to this model equation was used to test the robustness of the fit. The same fitting was done, varying only a and b, to only the accelerative phase of the curve, prior to the maximum value of dA (dAmax).


As a first step to deriving this model, a curve fitting was attempted as a methodology for prediction of early from late (notably attempts to do this in the time domain have been notoriously unsuccessful). The goal was to develop the simplest possible model for interpolation and extrapolation in order to avoid the pitfalls of overfitting. Furthermore, the model developed is based on other natural phenomena not simply a polynomial. Thus, a lower order modification of Planck's equation on this basis, as it contains only 2 fitting parameters in its simplest form. These are shown in FIG. 13, and the fit on the two parameters (Acrit and Amax) is stable.


However, as shown in FIG. 14, the fit converges with increasing data. This convergence is an important characteristic of predictive stability. On the x axis in FIG. 14 is the time off-set from Acrit in minutes. As time increases, there is an increasing progression of inclusion of data points in the TEG tracing. 0 on the x-axis in FIG. 14 is Acrit. On the y-axis in FIG. 14 is the normalized difference in area under the curve between the model and the actual Amplitude domain data. Note that this is simply a convenient representation of the aggregate error of the fit. The root mean square deviation (or root mean square error) (RMSE) for each point can also be used to obtain an equivalent result.


As FIG. 14 shows, the more the TEG curve is allowed to progress before attempting the fit, the better the prediction, but this rapidly converges near Acrit. This increasing fit and the rapid convergence near Acrit provides that the model is sound.


Thus, in many individuals' TEG tracings, the accelerative phase fit was nearly superimposable with the full tracing fit all the way to MA. Interestingly, even when the least squares fit is poor, the two model trajectories appear to converge at MA (see FIG. 13). This is suggestive that there is a valid physical basis to the trajectory equation. However, the behavior of the time-independent TEG tracing (TITT) and the model diverge near MA (see FIG. 13). This is because the actual TITT is not smooth in this limit, and is no longer a explicitly definable function as it doubles back on itself as the curve decays based on physical processes distinct from its formation, whereas the model is asymptotic at the X-axis (i.e. in the model the clot grows forever albeit at rate limit 0 at infinity).


To map this back to the MA, since the model is asymptomatic at the x-axis, no explicit coordinate pair defines MA. Therefore, this is analogous to infinite, infinitely slow growth of the clot. The model






dA/dT=aA
2/(ebA−1)


is solved, yielding A(t). Theoretically A(t) could then be evaluated at infinity to yield the MA, but of course this is not possible.


Instead the area under the model curve at infinity is evaluated which should have units of mm-squared per second which obviously yields infinite amplitude when evaluated at T=infinity. This can be done by taking the area under the tracing and relating it to MA. Since there is no closed form solution to relate the MA in the time domain back to the integrated differential equation in the amplitude domain, the relationship will be modeled. By dimensional analysis, the solution to the integral of dA/dT with respect to A from A=0 to A=∞ should have units equivalent to A2. Calling this area product “Q”, this provided a solution that must be in the form Q=c(Amax2)+d where c is a function zero order in Amax and T (note that Amax is used synonymously with the time-dependent variable “MA”). The simplest model for this is thus merely a linear fit to existing healthy volunteer and patient data.


In fact, the area under the curve converges itself and should have an explicit relation (albeit unknown) to the solution to the differential equation which must include this integral. Thus, evaluated the explicit integral, a and b are unitless constants and yield a result in terms of Amplitude squared.








0






aA
2



e
bA

-
1







dA





Therefore, a function of this area was hypothesized to yield MA. This was then tested against the actual data.


As shown in FIG. 15, this relationship is stable even when the fit is run only to Acrit and yields the very simple prediction:






MA is approximately equal to 15(ln Q)+12 mm


The test for fit was on a subset of the actual human data where the original curve fit was good (see FIG. 15). Note that the “goodness” of the curve fit was not being tested. Rather, the test was whether the hypothesis that MA bears an explicit mathematical relation to the integral in question was plausible. Our test revealed that the MA clearly bears an explicit mathematical relation to the integral. This appears to conform to a logarithmic fit but it is actually more likely a fractional power.


Thus, these studies show that Acrit occurs very early—even before the A5 min or A10 min marks which some practitioners advocate as a means of early estimation of MA (see FIG. 7A). Note that FIG. 7A (and FIG. 6A) is a native tracing which accounts for the long R-time.


With these new parameters (e.g., Acrit, and dA), numerous objectives can be achieved in the quest to predict late TEG events in a very rapid fashion.


Example V

Massive hemorrhage is a significant cause of death in trauma patients.


However, all the information needed to determine if a patient (e.g., a trauma patient) will require a large blood transfusion within six hours (or die) is contained within a blood sample taken from that patient. Currently, some of the best indicators of significant or massive hemorrhage in the patient take over 40 minutes to obtain (i.e., the MA value). The methods described herein, and the new parameters (e.g., dAmax and Acrit) allow accurate prediction of the MA in a much fast time (e.g., less than twenty, or less than fifteen, or less than ten, or less than five minutes after the start of the viscolastic assay).


In addition, the methods and parameters described herein are useful for determining what part of the coagulation process is not functioning normally in a patient who might experience significant or massive hemorrhage. As discussed above, hemostasis is a complicated, tightly regulated process involving multiple factors (see FIG. 1). The intrinsic pathway to coagulation is initiated by providing a surface on which the clotting factors can aggregate. To do this using a viscoelastic assay, reagents such as kaolin are added to provide that surface. This surface contact can activate Factor XII to form Factor XIIa which then activates Factor XI to form Factor XIa. In other words, the surface of kaolin is acting like Kininogen and kallikrein in FIG. 1. The extrinsic pathway is the tissue factor pathway, and provides a thrombin burst during traumatic injury. As shown in FIG. 1, trauma acts via Factor VIIa and tissue factor to activate Factor X to form Factor Xa.


Platelets also play a role in clot formation. During injury, platelets immediately form a plug at the injury site. The clotting cascade pictured in FIG. 1 occurs simultaneously, and contributes fibrin to strengthen the clot. Thus, platelets and fibrin (and its precursor, fibrinogen) contribute to clot strength; however, their contributions are not additive (see FIGS. 3A and 3B). It would be useful, however, to determine if problems with clotting are due to the fibrin contribution or the platelet contribution, because identifying the source of the problem could lead to better patient treatments. For example, if the lack of clotting was the result of low platelet activation, the patient could be treated with a platelet activator such as Factor VIIa, desmopressin, and thrombopoietin and thrombopoietin mimetics. Conversely, if the lack of clotting was the result of low fibrinogen activation to produce fibrin, the patient could be treated with thrombin and/or fibrinogen to increase fibrin production.


Surprisingly, the methodologies described herein are able to detect contributions of fibrinogen to clot strength, and are able to detect contributions of platelets to clot strength. In FIG. 16, increasing amounts of fibrinogen are added to a blood sample ranging from the hypo to hypercoagulable range while platelet count is held constant. These spiked samples were subjected to viscoelastic analysis, and the dAmax values plotted against the amount of added fibrinogen. As shown in FIG. 16, fibrinogen activity demonstrated a very tightly correlated sigmoid relationship to dAmax. In other words, in an artificial system (i.e., using spiked blood), dAmax was found to be correlative to functional fibrinogen level, and therefore is a marker of the contribution of fibrinogen (and fibrin) to a blood clot.


Similarly, in order to derive correlates of time-independent TEG parameters to total platelet function, another artificial system was set up in which platelets were depleted from whole blood by differential centrifugation, and then counted. The blood samples containing various amounts of platelets were then subjected to viscoelastic analysis and the dAmax value multiplied by the Acrit value to arrive at a “critical product”. This “critical product” value was plotted against the number of platelets in the sample in FIG. 17, and the resulting graph shows a clear linear relationship between the product of dAmax and Acrit (the “critical product”) and total platelet count.


Thus, using the methods and parameters identified herein allows the dissection of the blood clotting into the contributions of fibrinogen and platelets.


Finally, as shown in FIG. 18, the area under the receiver operating characteristic curve (ROC) of the time-independent TEG (TITAUC) for patients with massive hemorrhage is more accurate at predicting patients who will suffer massive hemorrhage compared to the AUC for maximum amplitude (MA; red line), the AUC for the alpha angle (purple line), the AUC for activated clotting time (ACT; brown line) and the AUC for the International Normalization Ratio (INR) (green line).


The embodiments of the invention described above are intended to be merely exemplary; numerous variations and modifications will be apparent to those skilled in the art. All such variations and modifications are intended to be within the scope of the present invention as defined in any appended claims.


















TABLE 2














CRT
CN
CFF



CRT Amax
CN Amax
CFF Amax
CRT Acrit
CN Arit
CFF Acrit
dAmax
dAmax
dAmax


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





20064
62.4453125
57.59375
22.6015625
1.9296875
16.82421875
3.60546875
1.453125
0.8203125
0.5390625


20066
57.40625
52.2265625
17.3515625
1.25
17.84375
2.29296875
0.984375
0.46875
0.3515625


20067
59.2578125
59.9609375
21.8046875
16.15625
12.78125
2.609375
0.984375
0.890625
0.375


20068
63.359375
55.671875
24.453125
1.37890625
14.97265625
4.49609375
1.0546875
0.5859375
0.6328125


20069
68.65625
64.484375
25.484375
2.85546875
15.828125
5.5390625
2.0390625
0.9375
0.84375


20070
61.7890625
56.046875
18.03125
14.01171875
17.6328125
3.58203125
1.1953125
0.5625
0.3984375


20072B
58.0390625
47.9375
16.1328125
1.71875
14.1875
3.37109375
1.125
0.328125
0.3046875


20073D
68.234375
62.515625
21.6640625
20.4453125
18.2421875
4.33203125
1.3125
0.609375
0.5390625


20074B
63.9921875
59.0234375
22.484375
5.33984375
13.6484375
3.8046875
1.1953125
0.65625
0.65625


20075D
69.59375
62.8203125
24.3828125
16.63671875
16.578125
5.421875
1.4765625
0.703125
0.5625


20076B
59.9140625
51.78125
17.2109375
5.45703125
16.2734375
2.24609375
1.0546875
0.375
0.3515625


20077D
61.34375
57.7578125
16.2265625
15.8515625
14.0234375
2.52734375
1.03125
0.515625
0.3515625


20078B
56.1640625
50.5859375
18.265625
1.21484375
15.83984375
3.62890625
1.1015625
0.4921875
0.3046875


20079D
61.015625
48.078125
18.3359375
6.2421875
17.10546875
3.37109375
1.265625
0.3984375
0.3984375


20080B
64.2265625
61.5078125
25.4140625
18.60546875
18.640625
4.63671875
1.2421875
0.65625
0.4921875


20081D
69.5234375
63.0546875
25.8125
3.23046875
19.96484375
5.59765625
1.6171875
0.4921875
0.6328125


20082B
55.53125
54.6171875
18.3125
0.93359375
14.5859375
3.06640625
0.9140625
0.515625
0.3515625


20083B
67.4375
56.3046875
22.4140625
17.10546875
21.06640625
4.6953125
1.2890625
0.3984375
0.609375


20084D
62.1875
57.6640625
19.578125
14.3984375
19.84765625
3.21875
1.078125
0.4453125
0.328125


20085D
62.5390625
52.625
19.8359375
1.73046875
14.45703125
4.109375
1.3828125
0.4921875
0.28125


20086B
62.2578125
54.125
22.7890625
1.859375
14.87890625
4.70703125
1.171875
0.4921875
0.5390625


20087D
69.4765625
64.953125
23.984375
18.1015625
18.7578125
5.8671875
1.40625
0.796875
0.46875


20088B
61.625
54.8984375
17.609375
19.33203125
19.8359375
2.99609375
0.9140625
0.421875
0.3046875


20090B
60.40625
50.421875
20.7265625
6.03125
18.5703125
4.16796875
1.078125
0.46875
0.4921875


20091D
66.453125
62.9140625
23.46875
2.01171875
18.4765625
4.30859375
1.4765625
0.65625
0.4453125


20092B
69.3125
60.546875
21.6875
14.6328125
18.81640625
4.33203125
1.640625
0.6328125
0.3515625


20093D
71.5625
63.8515625
25.3671875
19.625
17.1875
5.75
2.484375
0.5625
0.65625


20094B
65.28125
61.2265625
20.984375
2.57421875
16.94140625
2.8203125
1.4765625
0.7265625
0.46875


20095D
67.7421875
62.46875
23.890625
17.45703125
17.703125
4.00390625
1.2890625
0.46875
0.3984375


20096B
64.53125
54.6875
19.2734375
5.59765625
13.7421875
3.6875
1.1953125
0.421875
0.1875


20097D
66.640625
69.359375
20.375
14.10546875
16.49609375
3.44140625
1.2421875
1.0078125
0.3984375


20098B
61.953125
57.59375
17.9609375
1.66015625
20.1875
3.39453125
1.1015625
0.515625
0.3984375


20099D
58.578125
59.328125
18.3828125
13.42578125
12.6875
3.546875
0.8203125
0.5625
0.1875


20100B
52.90625
45.2421875
20.8671875
1.49609375
15.91015625
3.1015625
1.3359375
0.5390625
2.203125


20101D
60.3828125
53.09375
18.875
1.4140625
16.44921875
3.76953125
1.359375
0.4921875
0.4453125


20102B
68.9140625
61.0625
25.9765625
6.5
19.8828125
5.99609375
1.5
0.5625
0.6796875


20103D
72.5703125
67.9765625
28.109375
10.2734375
24.265625
6.359375
1.921875
0.796875
0.75


20104B
65.3515625
64.6953125
27.4296875
17.41015625
24.21875
7.68359375
1.0546875
0.703125
0.4921875


20105D
60.734375
55.71875
19.1796875
1.26171875
22.0625
4.1796875
1.3359375
0.375
0.234375


20106B
62.046875
52.4375
23.5859375
1.89453125
14.57421875
5.375
1.7578125
0.6328125
0.375


20108B
54.5234375
46.6484375
16.296875
15.9453125
15.53515625
2.73828125
0.84375
0.4453125
0.2578125


20109D
62.1640625
58.71875
20.3046875
1.70703125
18.78125
4.68359375
1.5234375
0.609375
0.5390625


20110B
56.28125
47.6328125
16.953125
1.09765625
16.859375
2.796875
1.0078125
0.421875
0.328125


20111D
61.53125
55.2265625
18.59375
1.37890625
16.484375
5.3046875
1.2890625
0.515625
0.46875


20112B
62.8203125
57.640625
21.453125
1.71875
21.0078125
4.49609375
1.453125
0.421875
0.4921875


20113D
65.046875
61.6953125
24.3125
16.2734375
18.53515625
3.7578125
1.5
0.6328125
0.515625


20114B
57.8984375
52.34375
20.046875
11.75
17.17578125
3.546875
0.890625
0.4453125
0.46875


20115B
61.8359375
52.90625
18.359375
1.5546875
22.4375
3.40625
1.265625
0.421875
0.375


20116D
58.4375
56.796875
19.6953125
1.70703125
17.08203125
2.9375
1.4765625
0.4453125
0.421875


20117B
56.28125
51.4296875
17.890625
12.125
18.55859375
2.92578125
0.984375
0.3984375
0.3984375


20118D
67.578125
63.8515625
22.34375
3.55859375
16.7890625
3.58203125
1.8984375
0.796875
0.6328125


20119B
67.0390625
63.7109375
22.203125
13.87109375
17.66796875
4.0390625
1.2890625
0.6328125
0.421875


20120D
67.1796875
59.7734375
22.7890625
14.48046875
17.64453125
5.19921875
1.4296875
0.5859375
0.6328125


20121B
58.0859375
59.9375
18.6171875
13.30859375
14.3984375
3.08984375
1.1015625
0.890625
0.5390625


20122D
69.5234375
62.84375
26.140625
11.1171875
15.8984375
4.61328125
2.109375
0.5625
0.6796875


20123B
55.765625
56.5859375
21.7578125
1.578125
17.22265625
5.01171875
1.359375
0.4921875
0.6796875


20124D
61.203125
53.234375
20.890625
2.08203125
18.3828125
9.59375
1.4765625
0.609375
0.375


20125B
61.296875
54.8046875
20
16.75390625
17.90234375
4.33203125
1.1015625
0.4921875
0.3984375


20126D
61.8359375
52.34375
20.75
1.63671875
13.4375
0.6640625
1.4765625
0.703125
0.46875


20127B
57.5703125
52.4140625
19.3671875
1.3203125
13.578125
3.7578125
1.171875
0.609375
0.46875


20128D
64.1796875
65.0234375
24.6875
5.52734375
15.3125
11.26953125
1.5234375
0.75
0.6796875


20129B
60.3359375
52.625
19.203125
10.5078125
14.703125
3.91015625
1.5
0.46875
0.4453125


20130D
69.171875
66.3828125
22.5546875
1.58984375
23.12890625
4.8828125
1.4296875
0.5859375
0.609375


20131B
59.28125
42.2421875
18.5234375
5.48046875
14.4453125
4.07421875
1.3359375
0.328125
0.3984375


20132D
68.4921875
59.1640625
25.859375
6.01953125
21.60546875
4.77734375
1.4765625
0.5390625
0.5859375


20133B
61.765625
59.703125
17.3984375
1.90625
17.6796875
3.34765625
1.03125
0.515625
0.3984375


20134D
62.4921875
61.2734375
21.1953125
1.25
15.44140625
0.79296875
1.265625
0.7734375
0.4921875


20135B
59.4453125
50.84375
20.7265625
14.984375
16.16796875
3.359375
1.21875
0.5390625
0.5625


20136D
67.25
61.90625
23.375
2.26953125
18.5234375
5.10546875
1.9453125
0.515625
0.5390625


20137B
55.2734375
43.0625
15.21875
0.83984375
18.55859375
2.75
0.8203125
0.3046875
0.328125


20138D
56.703125
49.8828125
17.234375
1.33203125
23.1171875
2.8203125
1.1015625
0.28125
0.609375


20139B
64.53125
58.2734375
22.4140625
2.76171875
20.3046875
5.140625
1.7578125
0.609375
0.609375


20140D
67.71875
61.8828125
26.46875
2.3984375
18.8515625
5.5390625
1.640625
0.84375
0.703125


20141B
60.78125
55.0390625
20.0234375
2.50390625
19.25
4.30859375
1.2421875
0.46875
0.4453125


20142D
65.09375
58.5546875
26.328125
6.6875
28.87109375
5.8203125
1.78125
0.4921875
0.75


20144B
55.1796875
50.515625
18.875
1.47265625
16.33203125
2.69140625
0.7734375
0.3984375
0.3046875


20145D
61.625
53.28125
21.7109375
5.85546875
16.5546875
2.71484375
0.8671875
0.46875
0.3515625


20146B
62.7265625
48.8515625
21.2421875
1.484375
17.66796875
4.42578125
1.359375
0.3515625
0.4921875


20147D
63.171875
52.3203125
22.8828125
1.75390625
17.71484375
3.96875
1.5234375
0.3515625
0.46875


20148B
60.1953125
50.3984375
34.1328125
2.10546875
18.30078125
45.8515625
1.1015625
0.4453125
91.453125


20149D
63.125
48.2890625
19.625
1.56640625
14.046875
3.58203125
1.4296875
0.328125
0.3046875


20150B
57.265625
41.796875
17.46875
1.61328125
15.2890625
0.40625
1.1484375
0.234375
0.375


20151D
56.28125
49.34375
20.2109375
1.14453125
16.671875
3.83984375
1.1484375
0.328125
0.3515625


20152B
57.03125
45.21875
20.234375
1.80078125
20.76171875
4.2734375
1.1484375
0.3984375
0.5625


20153D
62.2578125
47.6328125
23.0703125
1.625
19.61328125
3.2890625
1.03125
0.3046875
0.421875


20154B
64.90625
55.1328125
22.671875
24.875
22.0625
3.6875
1.40625
0.421875
0.5625


20155D
64.4140625
52.671875
18.734375
1.9296875
19.90625
5.7265625
1.5
0.375
0.515625


20156A
59.234375
49.109375
21.171875
1.4140625
18.078125
4.82421875
1.3125
0.421875
0.7734375


20157D
60.7578125
54.875
22.0390625
2.421875
13.19140625
3.21875
1.78125
0.4921875
0.46875


20158B
61.1328125
52.3203125
19.90625
15.8984375
18.98046875
3.51171875
0.9375
0.3984375
0.5859375


20159D
62
54.453125
21.6171875
1.89453125
20.31640625
4.484375
1.3359375
0.4453125
0.515625


20160B
62.0703125
55.671875
23.703125
1.90625
17.99609375
4.8828125
1.171875
0.4921875
0.5625


20161D
55.953125
53.8203125
17.65625
1.4609375
18.640625
1.98828125
1.03125
0.375
0.3046875


Donor 20003
63.359375
54.0078125
22.3203125
2.76171875
32.38671875
4.4609375
1.4765625
0.4453125
0.796875


Donor 20004
70.3203125
64.390625
27.78125
7.14453125
24.78125
4.51953125
1.7109375
0.796875
3.8671875


Donor 20005
61.1796875
53.3515625
19.8828125
1.54296875
16.56640625
4.09765625
1.1484375
0.3515625
0.4921875


Donor 20006
66.921875
57.2890625
24.875
7.3671875
18.9921875
4.4609375
1.265625
0.65625
0.703125


Donor 20007
68.2109375
56.9140625
29.9609375
8.22265625
22.9765625
12.875
1.8984375
0.515625
1.3125


Donor 20008
60.921875
52.765625
19.53125
11.71484375
19.1328125
3.86328125
1.0546875
0.328125
0.3984375


Donor 20009
63.7578125
51.3828125
21.21875
2.05859375
19.82421875
3.6640625
1.7109375
0.3984375
0.46875


Donor 2001
63.96875
50.0703125
17.703125
17.83203125
22.05078125
3.04296875
1.7109375
0.4453125
0.2578125


Donor 20010
59.1171875
52.8359375
15.21875
22.6015625
17.046875
3.16315625
1.21875
0.375
0.4453125


Donor 20011
63.734375
55.7421875
21.4765625
3.8515625
16.00390625
4.8125
2.625
0.6796875
0.421875


Donor 20012
56.890625
57.7578125
22.25
3.0078125
17.3984375
4.5078125
1.875
0.515625
0.328125


Donor 20013
74.6328125
67.9765625
26.6328125
2.515625
18.4765625
6.41796875
2.484375
0.984375
0.6796875


Donor 20014
71.46875
63.2890625
26.0234375
1.90625
18.171875
5.703125
1.734375
0.515625
0.5625


Donor 20015
75.1015625
67.015625
32.1171875
5.33984375
23.48046875
7.96484375
2.8828125
0.9140625
1.0546875


Donor 20016
70.34375
59.0234375
25.390625
3.6640625
18.88671875
6.08984375
2.484375
0.9609375
0.7734375


Donor 20017
53.703125
49.5546875
19.71875
1.1796875
13.37890625
3.5703125
1.03125
0.3984375
0.5625


Donor 20018
61.53125
59.421875
20.8671875
2.515625
18.76953125
6.7139375
1.40625
0.4453125
0.421875


Donor 20019
63.7578125
51.921875
22.8828125
18.79296875
17.9375
2.69140625
1.1015625
0.328125
0.4453125


Donor 2002
56.796875
61.90625
20.7734375
1.73046875
13.91796875
4.25
1.4765625
0.9143625
0.609375


Donor 20020
68.046875
62.84375
26.046875
1.9765625
13.4375
2.234375
1.875
0.65625
0.796875


Donor 20021
58.8359375
56.2109375
22.71875
15.21875
16.51953125
4.61328125
1.03125
0.7734375
0.6328125


Donor 20022
63.0078125
66.3359375
23.3984375
13.71875
14.7265625
3.30078125
1.3125
0.703125
0.4921875


Donor 20023
62.9609375
55.3203125
22.6953125
2.375
15.76953125
3.62890625
1.5
0.5859375
0.6796875


Donor 20024
58.296875
47.75
17.515625
18.4765625
17.29296875
3.95703125
0.75
0.3984375
0.5859375


Donor 20025
63.453125
55.7890625
17.639375
2
16.296875
3.74609375
1.359375
0.703125
0.5859375


Donor 20026
70.90625
65
26.1640625
3.72265625
15.13671875
6.4765625
2.1796875
0.8671875
0.75


Donor 20027
59.5625
54.5234375
22.4609375
16.00390625
15.76953125
4.90625
1.0078125
0.7265625
0.65625


Donor 20028
57.5703125
52.3671875
17.2578125
1.0625
14.99609375
2.75
1.078125
0.3984375
0.421875


Donor 20029
62.8203125
57.8984375
25.8828125
16.8359375
19.12109375
4.15625
1.171875
0.7265625
0.703125


Donor 20030
58.0390625
47.8671875
17.2109375
1.54296875
17.57421875
3.40625
1.2421875
0.3515625
0.421875


Donor 20031
57.59375
54.6875
15.8515625
12.734375
17.64453125
0.828125
1.265625
0.3984375
0.375


Donor 20032
68.046875
62.4921875

19.859375
20.84375

1.3125
0.65625



Donor 20033
57.8515625
60.643625
15.453125
13.58984375
15.125
3.4296875
0.9609375
0.65625
0.28125


Donor 20034
65.84375
55.859375
23.2578125
17.29296875
17.41015625
5.1640625
1.7109375
0.7265625
0.65625


Donor 20035
62.375
62.3515625
21.546875
15.48828125
16.80078125
2.84375
1.0078125
0.4453125
0.421875


Donor 20036
64.5546875
52.390625
21.9453125
1.91796875
12.25390625
5.0234375
1.5703125
0.4921875
0.609375


Donor 20037
63.078125
60.21875
23.234375
1.3671875
17.90234375
4.37890625
1.3125
0.4921875
0.3515625


Donor 20038
54.828125
51.96875
15.078125
14.05859375
14.45703125
4.8125
1.0546875
0.4453125
0.375


Donor 20039
59
54.4296875
16.8828125
1.8828125
16.75390625
2.3515625
1.265625
0.4453125
0.28125


Donor 20040
61.9296875
55.8828125
17.9609375
2.3984375
14.97265625
3.1484375
1.21875
0.6328125
0.515625


Donor 20041
69.546875
63.546875
22.0390625
3.5234375
17.36328125
4.44921875
1.78125
0.6328125
0.7265625


Donor 20042
60.7109375
49.6953125
19.53125
2.0703125
15.67578125
0.88671875
1.078125
0.3515625
0.5390625


Donor 20043
60.453125
58.4140625
19.765625
1.16796875
15.546875
4.70703125
1.1484375
0.515625
0.3984375


Donor 20044
54.8046875
43.2265625
18.1015625
12.7109375
15.60546875
70.47265625
0.9375
0.4453125
15.0703125


Donor 20045
57.8515625
55.34375
18.078125
12.6875
19.28515625
5.09375
0.890625
0.3984375
0.5625


Donor 20046
60.6875
55.7421875
21.03125
1.49609375
20.85546875
25.859375
1.1015625
0.4921875
4.640625


Donor 20047
67.9765625
59.84375
21.078125
9.55859375
17.31640625
3.6640625
1.3359375
0.4921875
0.375


Donor 20048
57.125
50.984375
15.921875
3.65234375
15.6758125
2.38671875
0.9140625
0.3984375
0.3515625


Donor 20049
65.984375
62.234375
22.2265265
1.5546875
17.0234375
4.51953125
1.3125
0.515625
0.5859375


Donor 20050
67.4140625
55.859375
27.9453125
3.20703125
18.8984375
5.75
1.7578125
0.46875
0.84375


Donor 20051
67.953125
57.875
23.140625
2.796875
12.7109375
4.390625
2.34375
0.46875
0.5625


Donor 20052
60.9453125
55.109375
17.3984375
1.82421875
21.5703125
2.48046875
1.1484375
0.375
0.3984375


Donor 20053
76.296875
71.3046875
31.3203125
12.93359375
21.21875
6.79296875
1.8984375
0.84375
0.8671875


Donor 20054
60.9921875
54.921875
20.2578125
1.58984375
19.015625
1.05078125
1.3359375
0.46875
0.9140625


Donor 20055
65.84375
58.53125
0.21875
2.45703125
17.22265625
0.171875
1.8515625
0.4453125
0.046875


Donor 20056
61.53125
53.5390625
18.265625
1.5078125
14.703125
3.27734375
1.078125
0.5625
0.3515625


Donor 20057
60.171875
55.8125
15.3125
2.10546875
19.58984375
2.375
1.2421875
0.3984375
0.234375


Donor 20058
59.796875
46.4609375
16.3671875
1.8125
15.5
6.41796875
0.9375
0.28125
0.3046875


Donor 20059
56.09375
49.1328125
13.7890625
1.765625
19.2265625
2.71484375
1.125
0.28125
0.2109375


Donor 20060
66.3359375
57.5703125
27.2421875
7.14453125
17.31640625
5.2578125
1.6171875
0.6796875
0.890625


Donor 20061
65.8671875
54.5234375
21.6640625
2.328125
12.16015625
3.8984375
1.40625
0.3984375
0.46875


Donor 20062
66.734375
60.3125
22.5078125
16.109375
18.37109375
3.96875
1.5
0.6328125
0.703125


Donor 20063
53.3984375
47.1640625
15.453125
1.34375
12.2421875
3.06640625
0.984375
0.28125
0.2578125












CRT dA
CN dA
CFF dA









Integration
Integration
Integration









to Acrit
to Acrit
to Acrit


Patient ID
CRT LY30
CN LY30
CFF LY30
CRT CL30
CN CL30
CFF C130
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)





20064
0.024833187
0.032159975
9.17E-04
0.945202052
0.930819316
0.998963014
22.01000977
123.6604614
13.46868896


20066
0.027227931
0.031155364
3.31533656
0.935930925
0.931338818
0.966231427
9.047241211
79.45422363
7.499816895


20067
0.057821358
0.036387622
−0.003856145
0.875837515
0.912442997
0.998925116
153.9547119
99.68444824
9.722900391


20068
0.028914749
0.022136074
0.014169329
0.942663379
0.943586865
0.969329073
10.61444092
73.97808838
16.71514893


20069
0.010409081
0.021366745
0.006801809
0.976786527
0.951659801
0.989883507
45.56744385
124.6541748
40.34179687


20070
0.02001886
0.01853278
0.021710115
0.954102921
0.954418734
0.959705373
177.7263794
85.78564453
12.21624756


20072B
0.032224503
0.015311278
0.026953188
0.932561583
0.955997392
0.947699758
15.43798828
37.31286621
7.895324707


20073D
0.031841081
0.023220757
0.009871479
0.929929013
0.94563859
0.988099531
289.40625
91.93579102
19.81658936


20074B
0.02866456
0.026303772
0.019107598
0.944695397
0.939642621
0.966643502
48.4118042
70.91455078
22.12207031


20075D
0.039951448
0.042670895
0.00504913
0.91142793
0.900385524
0.982697853
257.40802
91.57983398
22.74169922


20076B
0.043616073
0.01924223
0.02673753
0.917068718
0.951116476
0.950975942
48.6293335
54.76135254
6.827453613


20077D
0.04500375
0.009964381
0.014003905
0.931991849
0.969971595
0.979778527
136.005249
63.19555664
6.870300293


20078B
0.059638955
0.0397574
0.0332274142
0.883989428
0.90965251
0.935842601
8.946716309
65.0725708
9.99810791


20079D
0.066583796
0.051418454
0.01426999
0.872471191
0.883002925
0.969322539
76.22094727
55.92645264
11.32965088


20080B
0.049277595
0.023347729
0.020451634
0.905485951
0.944366823
0.956655395
245.0846558
83.91027832
20.39337158


20081D
0.016452223
−0.001491967
−0.00394093
0.962917182
0.988105563
1.00090799
47.89105225
83.4307251
22.50933838


20082B
0.036992942
0.028016378
0.008201792
0.922341024
0.936918896
0.984641638
5.176208496
68.65686035
9.922302246


20083B
0.014174326
0.007678877
−0.001578657
0.972196478
0.973359234
1.001045661
186.598938
67.07647705
24.83129883


20084D
0.033066897
0.02959325
0.01943336
0.926884422
0.937000406
0.959297686
140.1745605
82.28704834
9.225219727


20085D
0.041087168
0.023255641
−0.007493108
0.919830125
0.944328979
1.007089405
18.01373291
52.26830537
7.194946289


20086B
0.042433701
0.033799237
3.81E−04
0.920943657
0.927684758
0.994857731
17.7088623
62.7522583
22.92791748


20087D
0.022928927
0.017378819
−0.005552389
0.954458563
0.956338706
1.004885993
270.4449463
118.2469482
20.77075195


20088B
0.021815134
0.008897823
0.010444395
0.956643002
0.971822969
0.978704525
140.0905151
79.40148926
8.343566895


20090B
0.059329015
0.044530954
0.013343385
0.883988619
0.898667493
0.970599322
61.87060547
69.78076172
17.21282959


20091D
0.025758288
0.01940219
−0.007108577
0.942158476
0.952688439
1.004993342
23.20477295
110.65979
17.00518799


20092B
0.022125789
0.022683333
0.011923631
0.949278629
0.947741935
0.976224784
216.5800781
97.90631104
13.76202393


20093D
0.024585153
0.016145642
−0.009099425
0.94628821
0.957420776
1.012011087
367.4399414
79.46740723
33.99719238


20094B
0.014574856
0.012071477
0.009293042
0.965892772
0.969758836
0.987714073
31.93560791
106.9568481
10.24035645


20095D
0.027034079
0.008573037
−0.013358404
0.940491293
0.971485743
1.013734467
225.9354858
68.21191406
14.21026611


200961B
0.021996402
0.01234881
0.021483583
0.953874092
0.962285714
0.956222132
64.88140869
38.86523438
6.565429687


20097D
0.023692686
0.018750939
−0.004599629
0.949033517
0.959112413
1.005751534
171.539978
155.7394409
11.30657959


20098B
0.026020912
0.019252464
0.026261418
0.939470366
0.954015193
0.947803393
14.31903076
86.23718262
12.51617432


20099D
0.024551547
0.026462046
−0.013231336
0.941184316
0.943903081
1.002549936
102.4249878
61.70910645
5.507446289


201001B
0.040584392
0.078264405
0.032046362
0.915829888
0.853393196
0.933732684
13.95648193
77.07623291
60.44018555


20101D
0.03119636
0.027867496
0.009337058
0.933238453
0.933343143
0.98013245
12.74194336
72.55755615
14.88262939


201021B
0.03191815
0.032849106
−0.008873434
0.930960209
0.932446264
1.047819549
91.86328125
96.72802734
33.78460693


20103D
0.038131123
0.026895376
−0.007834213
0.922488965
0.93931732
1.020844914
201.2475586
169.8640137
34.12243652


201041B
0.035729727
0.014632895
0.007350707
0.926838016
0.969568893
0.993164341
198.9783325
154.1293945
34.80633545


20105D
0.044985779
0.024768064
−0.015139172
0.91278621
0.944054964
1.02688391
10.42987061
72.78662109
8.246337891


201061B
0.048066538
0.030807178
0.020493357
0.911639166
0.929827175
0.968201391
23.42230225
76.59503174
12.2244873


20108B
0.04610737
0.055939588
0.008846676
0.897693079
0.880924468
0.987056568
137.7454834
62.3303833
6.303405762


20109D
0.032723807
0.02958799
0.00963191
0.929873068
0.934539649
0.983839938
18.49822998
101.1774902
23.00372314


201101B
0.041664932
0.037481321
0.005831413
0.916296502
0.922748893
1.020737327
7.199890137
59.24377441
7.386108398


20111D
0.07380315
0.035058589
0.01398226
0.864779076
0.917244306
1.001260504
11.9262085
72.05822754
18.81628418


20112B
0.037126394
0.019984526
0.014676904
0.923516976
0.952426132
0.95193008
18.40759277
82.00195313
16.73822021


20113D
0.062763232
0.03286058
0.004612521
0.875330291
0.921362543
0.987467866
237.548584
95.33221436
17.81433105


201141B
0.024689651
0.02696704
0.001779683
0.944137094
0.937761194
0.99766173
108.7250977
63.23675537
14.72607422


20115B
0.026801432
0.019098248
0.010429078
0.937839545
0.957028943
0.974468085
14.66674805
84.22009277
12.0135498


20116D
0.041788659
0.012975699
0.012377694
0.909358289
0.957083906
0.970249901
18.28729248
61.83599854
10.85668945


201171B
0.036011244
0.027881581
0.035371179
0.924625208
0.941667933
0.929257642
121.7373047
69.22869873
10.15301514


20118D
0.020317437
0.023174715
0.007876845
0.95283237
0.951180717
0.987412587
61.04168701
121.1506348
17.87860107


20119B
0.02381942
0.007657879
0.021167605
0.952802704
0.974248927
0.955665025
174.1404419
97.82391357
15.67858887


20120D
0.040758131
0.023425042
0.010314535
0.918711478
0.945497321
0.980459376
222.6000366
91.41998291
29.78997803


20121B
0.031288949
0.032133624
0.009660442
0.924949563
0.926094891
0.98111624
136.7023315
108.9755859
13.52471924


20122D
0.035321697
0.027525692
−0.00513424
0.930216878
0.938090502
1.006276151
224.470459
72.49328613
22.86859131


20123B
0.033839427
0.088742387
0.008031119
0.9260297
0.828109899
0.987073609
15.44128418
58.38848877
19.63201904


20124D
0.055306995
0.057727962
0.02311456
0.892009191
0.893894922
0.948391922
25.14276123
102.321167
27.14172363


20125B
0.048024825
0.026111309
0.041437174
0.907468774
0.939272986
0.914453125
185.3300171
70.58001709
9.764099121


20126D
0.033167509
0.109710199
0.005837412
0.930638029
0.806567164
0.980798193
16.9821167
76.05615234
2.073120117


20127B
0.04030228
0.053709983
0.020658532
0.917356493
0.890892831
0.957644211
10.63256836
71.53088379
12.26733398


20128D
0.044331507
0.023482618
0.011477672
0.908703591
0.94196804
0.979113924
77.29376221
87.25891113
62.69952393


20129B
0 .034457501
0.028807898
0.023877814
0.930078985
0.933194774
0.95362083
142.3498535
57.01574707
13.45880127


20130D
0.023212202
0.007788533
6.96E−04
0.946803705
0.973520066
0.991686872
15.94061279
121.3665161
26.18920898


20131B
0.043807474
0.03083657
−0.006430128
0.91341592
0.92454226
1.003795867
55.03985596
35.0255127
11.60980225


20132D
0.042476997
0.025035029
0.005946626
0.915478499
0.94810511
0.985498489
82.80780029
70.1350708
23.00372314


20133B
0.012985918
−7.23E−04
−0.008082622
0.969643309
0.989008113
1.01077683
16.52893066
82.35131836
12.51617432


20134D
0.039836577
0.026127863
0.014341442
0.926115764
0.938416422
0.969037965
9.996459961
67.71917725
2.796569824


20135B
0.035194616
0.059814843
0.020118734
0.925877251
0.887523049
0.959291368
182.315918
75.27008057
17.15844727


20136D
0.022431653
0.022472166
0.01052529
0.951208178
0.953054013
0.979946524
33.27044678
85.70654297
25.14935303


20137B
0.037332155
0.030097212
0.024850274
0.921978799
0.931966618
0.947638604
4.075378418
52.4196167
6.858764648


20138D
0.047406693
0.023399896
0.005910018
0.901625792
0.938919342
0.985040798
10.56170654
57.3684082
9.422973633


20139B
0.041498688
0.031996581
0.017536114
0.912106538
0.922375654
0.968630185
39.67437744
95.60412598
27.92944336


20140D
0.527082853
1
1
0.951892017
1
1
31.40002441
142.3432617
32.80407715


20141B
0.047614967
0.032637805
0.027701912
0.904755784
0.925904897
0.939133828
28.31011963
79.32568359
17.22271729


20142D
0.022763142
0.033247165
−0.006142433
0.940590494
0.923549033
1.008902077
105.5742188
104.3069458
30.98803711


20144B
0.016424796
0.024664914
0.00211955
0.96092312
0.939220538
0.988824503
9.5 0314941
59.581604
8.468811035


20145D
0.029375317
0.029634449
−0.016528727
0.93724645
0.93797654
1.0215905
43.99200439
69.5994873
5.809020996


20146B
0.027744219
0.029046058
0.002625046
0.924523602
0.932832241
0.994483266
13.85925293
54.21258545
19.41119385


20147D
0.047133935
0.033383522
0.021421797
0.902052931
0.92160669
0.961078867
19.40130615
37.47930908
16.64099121


20148B
0.032600404
0.044176398
−0.343559739
0.9330305
0.904200899
0.003662165
20.50213623
66.52935791
105.208374


20149D
0.025634798
0.029747074
−0.008754644
0.946534653
0.929623038
1.00955414
15.53192139
31.12646484
9.361999512


20150B
0.037720365
0.054626687
0.027442979
0.922646658
0.894579439
0.939624329
14.42779541
21.01464844
0.685546875


20151D
0.04069884
0.036162788
0.015357235
0.922543032
0.919252692
0.964051024
8.215026855
44.57702637
12.90838623


20152B
0.043437785
0.035774447
0.033006757
0.909178082
0.914996545
0.929343629
16.7744751
76.15338135
22.21435547


20153D
0.029718283
0.03837133
0.001880856
0.936002008
0.924225029
0.990856756
13.03857422
54.78277588
10.1282959


20154B
0.041638581
0.039198078
0.019272149
0.914058739
0.915403146
0.964851826
318.8287354
86.66235352
18.76025391


20155D
0.029455731
0.023614407
0.016167408
0.938508187
0.944378523
0.974979149
21.53210449
61.49816895
22.1385498


20156A
0.031059307
0.040872574
−0.014663284
0.927195991
0.906458797
1.047601476
12.55407715
60.21936035
24.66815186


20157D
0.029935851
0.021280609
−0.009133877
0.934807766
0.943621868
1.012761432
35.09802246
53.40179443
10.31945801


20158B
0.038318779
0.033309691
0.023378903
0.922172524
0.926534269
0.952904239
154.956665
63.73443604
14.00262451


20159D
0.039985334
0.020185119
0.022336164
0.920236895
0.953084648
0.955547524
19.22662354
81.96734619
15.30944824


20160B
0.032691245
0.026974577
0.001812788
0.933920705
0.935587988
0.990112063
17.83410645
78.66485596
24.4720459


20161D
0.064456894
0.030047298
0.040432645
0.871404636
0.922920598
0.92300885
11.79602051
62.04528809
4.207214355


Donor 20003
0.028680127
0.027663862
0.002012601
0.938224414
0.944018516
1.002100105
36.47076416
130.2588501
31.66699219


Donor 20004
0.022439636
0.027468387
0.004736127
0.949672259
0.941397719
0.993250844
121.7158813
173.2653809
69.75274658


Donor 20005
0.029513579
0.045045639
−0.009513752
0.935257311
0.925318495
1.017681729
13.49505615
52.74261475
16.94586182


Donor 20006
0.030370554
0.042962748
0.006588498
0.933808078
0.904677485
0.996231156
93.28710938
104.8656006
26.24194336


Donor 20007
0.062782995
0.031328071
−0.007090395
0.88592372
0.927522306
1.017209909
136.1321411
100.861084
127.6237793


Donor 20008
0.03659895
0.02103815
0.00228
0.926134906
0.944477347
1
69.38360596
50.48657227
12.7633667


Donor 20009
0.038635312
0.026344331
0.012003968
0.931993628
0.939790178
0.986745214
26.43475342
68.25970459
12.85400391


Donor 2001
0.022351307
0.030189967
−0.010354148
0.949804592
0.93025433
1.014563107
198.2400513
54.50921631
6.537414551


Donor 20010
0.03470864
0.018110799
−0.006091718
0.931412713
0.952979447
1.009240246
205.680542
57.43432617
6.77142334


Donor 20011
0.024335519
0.019395001
−0.015828483
0.959181172
0.955430974
1.036013096
85.6307373
90.99481201
17.77807617


Donor 20012
0.027107937
0.026588214
0.026460089
0.939851689
0.939131611
0.947331461
46.95666504
66.31347656
14.10644531


Donor 20013
0.015684863
0.022569085
0.017489244
0.959803203
0.953108838
0.965679085
43.54870605
145.6160889
37.48260498


Donor 20014
0.041661201
0.025575032
0.007622836
0.912439878
0.940748056
0.985589913
23.54919434
83.30383301
20.16101074


Donor 20015
0.041298242
0.045100839
−0.002598719
0.920108187
0.915364887
1.011675991
137.0714722
186.5791626
61.12738037


Donor 20016
0.024066927
0.022948379
0.009179487
0.951688139
0.944407677
0.981538462
72.82287598
161.2765503
35.73248291


Donor 20017
0.061507734
0.03284789
.009612168
0.876927553
0.922907142
0.983359746
8.26940918
47.06707764
18.23291016


Donor 20018
0.018540503
0.013432926
6.21E−04
0.948958862
0.961740731
0.991014601
31.47253418
74.39666748
26.77258301


Donor 20019
0.016830896
0.001863276
0.010319222
0.963607401
0.980138429
0.981563674
203.8925171
49.21105957
9.816833496


Donor 2002
0.019869899
0.022142472
−0.001980694
0.954195323
0.952675416
1
18.73553467
102.4777222
24.4720459


Donor 20020
0.034770379
0.022890249
0.005045241
0.923536165
0.945176529
0.982903419
25.84313965
71.97912598
9.452636719


Donor 20021
0.040136879
0.03418404
0.004191025
0.911963883
0.918276581
0.992778542
146.1335449
111.3305054
27.13677979


Donor 20022
0.02218158
0.012441605
−0.00942404
0.956106634
0.968201625
1.012020033
169.1784668
89.15075684
14.34869385


Donor 20023
0.029469641
0.026219814
0.004001721
0.93634446
0.935602316
0.991738382
29.16210937
83.44390869
20.65704346


Donor 20024
0.052116278
0.047406741
0.024062717
0.890645939
0.892015707
0.961195361
133.9 23535
61.14385986
19.03216553


Donor 20025
0.018108054
0.024227855
9.74E−04
0.963432652
0.9453858
1.00931677
21.20251465
101.0687256
17.54901123


Donor 20026
0.029490629
0.033851162
3.04E−04
0.933891582
0.922115385
0.99820842
71.36773682
106.2877808
40.62194824


Donor 20027
0.040186145
0.061528036
0.030110145
0.917759706
0.895543774
0.937391304
156.7545776
100.9484253
31.09680176


Donor 20028
0.04236228
0.023107812
−0.008904859
0.928755598
0.942264658
1.014938886
7.016967773
48.56341553
8.37487793


Donor 20029
0.044844132
0.040235236
0.018316732
0.905981843
0.908514371
0.95834591
201.1849365
127.664978
23.58874512


Donor 20030
0.043891431
0.030500925
0.001550915
0.910755149
0.92704423
1.019064911
14.37835693
54.49603271
11.3939209


Donor 20031
0.014741025
−0.006701786
−0.01510391
0.962154097
0.995285714
1.019221291
110.5444336
62.43585205
1.911621094


Donor 20032
0.049918197
0.035924629

0.890815155
0.919364921

277.6662598
120.2178955



Donor 20033
0.031890427
0.096808526
0.049121587
0.93923025
0.819118784
0.925682508
117.9585571
65.63781738
9.043945313


Donor 20034
0.047260619
0.089839161
0.014281715
0.905671571
0.817062937
0.973799127
255.2492065
116.1359253
32.17785645


Donor 20035
0.019283358
−0.005776741
−0.009875816
0.955661323
0.996616965
1.011965192
144.1444702
61.64154053
9.44934082


Donor 20036
0.047403418
0.038066657
0.011970452
0.904877163
0.909633164
0.974368103
22.27532959
49.19952393
27.2109375


Donor 20037
0.058277943
0.028034546
0.018986307
0.889645777
0.942786715
0.96267653
11.84216309
80.40838623
14.2366333


Donor 20038
0.042141636
0.0278638
0.036417674
0.910230835
0.935057126
0.928497409
121.1358032
55.23760986
14.70629883


Donor 20039
0.041930762
0.023091598
−0.008177156
0.916181144
0.947036027
1.006941231
19.96325684
64.29473877
5.260253906


Donor 20040
0.027842956
0.110195606
0.0128806
0.942475085
0.823850133
0.972596781
25.91564941
84.21844482
11.01489258


Donor 20041
0.023519527
0.046152809
0.005627437
0.949786565
0.920334399
0.987238568
50.97766113
94.82794189
24.20013428


Donor 20042
0.031860264
0.006529372
0.022183333
0.935529533
0.97264581
0.9568
19.70288086
50.45526123
3.640319824


Donor 20043
0.028967433
0.025334916
−0.011353755
0.930214526
0.939414204
1.018972332
8.505065918
65.78942871
11.39227295


Donor 20044
0.114197553
0.158564522
0.025780463
0.788310763
0.718055305
0.948208891
36.30432129
52.46905518
297.8486938


Donor 20045
0.064360605
0.026431042
0.009035581
0.875219446
0.93393563
0.979256698
109.1832275
68.46405029
18.89208984


Donor 20046
0.032919778
0.024525812
0.003056897
0.929325438
0.938612474
0.989970282
12.31842041
83.62518311
52.18725586


Donor 20047
0.024480903
0.020561902
−0.009360329
0.945523503
0.946344648
1.010007413
105.4539185
64.4331665
10.7578125


Donor 20048
0.031785649
0.03008713
0.025537019
0.931892779
0.937480846
0.955839058
25.76898193
46.86273193
4.401672363


Donor 20049
0.020950088
0.005545443
0.003060926
0.958797064
0.977403967
0.989455185
14.84802246
76.41870117
25.08013916


Donor 20050
0.028353356
0.025734848
0.00905787
0.9426353
0.938741259
0.978194017
48.99188232
78.01721191
42.89941406


Donor 20051
0.04621832
0.0282808
−7.22E−04
0.908254771
0.933180346
0.994935854
50.53601074
44.65283203
23.11743164


Donor 20052
0.023606482
0.018178811
0.007644814
0.946545315
0.95151687
0.981140548
16.95574951
74.86303711
7.892028809


Donor 20053
0.028782681
0.025034087
0.008367285
0.943170182
0.947737482
0.989523572
252.0686646
150.3588867
48.98529053


Donor 20054
0.019195202
0.021942864
0.003445173
0.958883054
0.946230441
0.995372156
15.55169678
77.12072754
6.395690918


Donor 20055
0.016911387
0.006258898
0.355654762
0.959776934
0.975173518
0.571428571
35.99285889
65.85040283
0.009887695


Donor 20056
0.033615837
0.032245002
0.038925126
0.927628238
0.928206625
0.926860565
12.4354248
69.6159668
9.968444824


Donor 20057
0.023619226
−0.001850037
0.007844388
0.953648403
0.98656215
0.975510204
21.93255615
69.59454346
4.726318359


Donor 20058
0.037410178
0.021196962
0.009401352
0.919649856
0.942492013
0.978520286
14.59753418
35.77038574
8.762145996


Donor 20059
0.035590761
0.012877644
0.026754013
0.924791086
0.959453013
0.947308782
16.30810547
50.58544922
5.380554199


Donor 20060
0.039458937
0.027774951
0.004994742
0.916617595
0.937712037
0.989675939
84.71942139
89.47869873
40.0715332


Donor 20061
0.026452477
0.005382218
0.00186621
0.941999763
0.975497922
0.991345114
27.33288574
38.02313232
16.60803223


Donor 20062
0.037482927
0.023038104
0.01319565
0.922383517
0.944430052
0.975008678
244.914917
101.2318726
24.81811523


Donor 20063
0.037364667
0.016231848
0.011351955
0.918800293
0.948318701
0.975733064
9.897583008
26.38366699
6.593444824


























TABLE 3







Patient ID
CRT Amax (mm)
CN Amax (mm)
CFF Amax (mm)
CRT Acrit (mm)
CN Arit (mm)
CFF Acrit (mm)
CRT dAmax (mm)
CN dAmax (mm)
CFF dAmax (mm)
CRT LY30





20150B
57.265625
41.796875
17.46875
1.61328125
15.2890625
0.40625
1.1484375
0.234375
0.375
0.037720365


20131B
59.28125
42.2421875
18.5234375
5.48046875
14.4453125
4.07421875
1.3359375
0.328125
0.3984375
0.043807474


20137B
55.2734375
43.0625
15.21875
0.83984375
18.55859375
2.75
0.8203125
0.3046875
0.328125
0.037332155


Donor 20044
54.8046875
43.2265625
18.1015625
12.7109375
15.60546875
70.47265625
0.9375
0.4453125
15.0703125
0.114197553


20152B
57.03125
45.21875
20.234375
1.80078125
20.76171875
4.2734375
1.1484375
0.3984375
0.5625
0.043437785


20100B
52.90625
45.2421875
20.8671875
1.49609375
15.91015625
3.1015625
1.3359375
0.5390625
2.203125
0.040584392


Donor 20058
59.796875
46.4609375
16.3671875
1.8125
15.5
6.41796875
0.9375
0.28125
0.3046875
0.037410178


20108B
54.5234375
46.6484375
16.296875
15.9453125
15.53515625
2.73828125
0.84375
0.4453125
0.2578125
0.04610737


Donor 20063
53.3984375
47.1640625
15.453125
1.34375
12.2421875
3.06640625
0.984375
0.28125
0.2578125
0.037364667


20110B
56.28125
47.6328125
16.953125
1.09765625
16.859375
2.796875
1.0078125
0.421875
0.328125
0.041664932


20153D
62.2578125
47.6328125
23.0703125
1.625
19.61328125
3.2890625
1.03125
0.3046875
0.421875
0.029718283


Donor 20024
58.296875
47.75
17.515625
18.4765625
17.29296875
3.95703125
0.75
0.3984375
0.5859375
0.052116278


Donor 20030
58.0390625
47.8671875
17.2109375
1.54296875
17.57421875
3.40625
1.2421875
0.3515625
0.421875
0.043891431


20072B
58.0390625
47.9375
16.1328125
1.71875
14.1875
3.37109375
1.125
0.328125
0.3046875
0.032224503


20079D
61.015625
48.078125
18.3359375
6.2421875
17.10546875
3.37109375
1.265625
0.3984375
0.3984375
0.066583796


20149D
63.125
48.2890625
19.625
1.56640625
14.046875
3.58203125
1.4296875
0.328125
0.3046875
0.25634798


20146B
62.7265625
48.8515625
21.2421875
1.484375
17.66796875
4.42578125
1.359375
0.3515625
0.4921875
0.027744219


20156A
59.234375
49.109375
21.171875
1.4140625
18.078125
4.82421875
1.3125
0.421875
0.7734375
0.031059307


Donor 20059
56.09375
49.1328125
13.7890625
1.765625
19.2265625
2.71484375
1.125
0.28125
0.2109375
0.35590761


20151D
56.28125
49.34375
20.2109375
1.14453125
16.671875
3.83984375
1.1484375
0.328125
0.3515625
0.04069884


Donor 20017
53.703125
49.5546875
19.71875
1.1796875
13.37890625
3.5703125
1.03125
0.3984375
0.5625
0.061507734


Donor 20042
60.7109375
49.6953125
19.53125
2.0703125
15.67578125
0.88671875
1.078125
0.3515625
0.5390625
0.031860264


20138D
56.703125
49.8828125
17.234375
1.33203125
23.1171875
2.8203125
1.1015625
0.28125
0.609375
0.047406693


Donor 2001
63.96875
50.0703125
17.703125
17.83203125
22.05078125
3.04296875
1.7109375
0.4453125
0.2578125
0.02235107


20148B
60.1953125
50.3984375
34.1328125
2.10546875
18.30078125
45.8515625
1.1015625
0.4453125
91.453125
0.032600404


20090B
60.40625
50.421875
20.7265625
6.03125
18.5703125
4.16796875
1.078125
0.46875
0.4921875
0.059329015


20144B
55.1796875
50.515625
18.875
1.47265625
16.33203125
2.69140625
0.7734375
0.3984375
0.3046875
0.016424796


20078B
56.1640625
50.5859375
18.265625
1.21484375
15.83984375
3.62890625
1.1015625
0.4921875
0.3046875
0.059638995


20135B
59.4453125
50.84375
20.7265625
14.984375
16.16796875
3.359375
1.21875
0.5390625
0.5625
0.035194616


Donor 20048
57.125
50.984375
15.921875
3.65234375
15.67578125
2.38671875
0.9140625
0.3984375
0.3515625
0.031785649


Donor 20009
63.7578125
51.3828125
21.21875
2.05859375
19.82421875
3.6640625
1.7109375
0.3984375
0.46875
0.038635312


20117B
56.28125
51.4296875
17.890625
12.125
18.55859375
2.92578125
0.984375
0.3984375
0.3984375
0.036011244


20076B
59.9140625
51.78125
17.2109375
5.45703125
16.2734375
2.24609375
1.0546875
0.375
0.3515625
0.04316073


Donor 20019
63.7578125
51.921875
22.8828125
18.79296875
17.9375
2.69140625
1.1015625
0.328125
0.4453125
0.016830896


Donor 20038
54.828125
51.96875
15.078125
14.05859375
14.45703125
4.8125
1.0546875
0.4453125
0.375
0.042141636


20066
57.40625
52.2265625
17.3515625
1.25
17.84375
2.29296875
0.984375
0.46875
0.3515625
0.027227931


20147D
63.171875
52.3203125
22.8828125
1.75390625
17.71484375
3.96875
1.5234375
0.3515625
0.46875
0.047133935


20158B
61.1328125
52.3203125
19.90625
15.8984375
18.98046875
3.51171875
0.9375
0.3984375
0.5859375
0.038318779


20114B
57.8984375
52.34375
20.046875
11.75
17.17578125
3.546875
0.890625
0.4453125
0.46875
0.024689651


20126D
61.8359375
52.34375
20.75
1.63671875
13.4375
0.6640625
1.4765625
0.703125
0.46875
0.033167509


Donor 20028
57.5703125
52.3671875
17.2578125
1.0625
14.99609375
2.75
1.078125
0.3984375
0.421875
0.04206228


Donor 20036
64.5546875
52.390625
21.9453125
1.91796875
12.25390625
5.0234375
1.5703125
0.4921875
0.609375
0.047403418


20127B
57.5703125
52.4140625
19.3671875
1.3203125
13.578125
3.7578125
1.171875
0.609375
0.46875
0.0403228


20106B
62.046875
52.4375
23.5859375
1.89453125
14.57421875
5.375
1.7578125
0.6328125
0.375
0.048066538


20085D
62.5390625
52.625
19.8359375
1.73046875
14.45703125
4.109375
1.3828125
0.4921875
0.28125
0.041087168


20129B
60.3359375
52.625
19.203125
10.5078125
14.703125
3.91015625
1.5
0.46875
0.4453125
0.034457501


20155D
64.4140625
52.671875
18.734375
1.9296875
19.90625
5.7265625
1.5
0.375
0.515625
0.029455731


Donor 20008
60.921875
52.765625
19.53125
11.7148375
19.1328125
3.86328125
1.0546875
0.328125
0.3984375
0.03659895


Donor 20010
59.1171875
52.8359375
15.21875
22.6015625
17.046875
3.16015625
1.21875
0.375
0.4453125
0.03470864


20115B
61.8359375
52.90625
18.359375
1.5546875
22.4375
3.40625
1.265625
0.421875
0.375
0.026801432


20101D
60.3828125
53.09375
18.875
1.4140625
16.44921875
3.76953125
1.359375
0.4921875
0.4453125
0.03119636


20124D
61.203125
53.234375
20.890625
2.08203125
18.3828125
9.59375
1.4765625
0.609375
0.375
0.055306995


20145D
61.625
53.28125
21.7109375
5.85546875
16.5546875
2.71484375
0.8671875
0.46875
0.3515625
0.029375317


Donor 20005
61.1796875
53.3515625
19.8828125
1.54296875
16.56640625
4.09765625
1.1484375
0.3515625
0.4921875
0.029513579


Donor 20056
61.53125
53.5390625
18.265625
1.5078125
14.703125
3.27734375
1.078125
0.5625
0.3515625
0.033615837


20161D
55.953125
53.8203125
17.65625
1.4609375
18.640625
1.98828125
1.03125
0.375
0.3046875
0.064456894


Donor 20003
63.359375
54.0078125
22.3203125
2.76171875
32.38671875
4.4609375
1.4765625
0.4453125
0.796875
0.028680127


20086B
62.2578125
54.125
22.7890625
1.859375
14.87890625
4.70703125
1.171875
0.4921875
0.5390625
0.042433701


Donor 20039
59
54.4296875
16.8828125
1.8828125
16.75390625
2.3515625
1.265625
0.4453125
0.28125
0.041930762


20159D
62
54.453125
21.6171875
1.89453125
20.31640625
4.484375
1.3359375
0.4453125
0.515625
0.039985334


Donor 20027
59.5625
54.5234375
22.4609375
16.00390625
15.76953125
4.90625
1.0078125
0.7265625
0.65625
0.040186145


Donor 20061
65.8671875
54.5234375
21.6640625
2.328125
12.16015625
3.8984375
1.40625
0.3984375
0.46875
0.026452477


20082B
55.53125
54.6171875
18.3125
0.93359375
14.5859375
3.06640625
0.9140625
0.515625
0.3515625
0.036992942


20096B
64.53125
54.6875
19.2734375
5.59765625
13.7421875
3.6875
1.1953125
0.421875
0.1875
0.021996402


Donor 20031
57.59375
54.6875
15.8515625
12.734375
17.64453125
0.828125
1.265625
0.3984375
0.375
0.014741025


20125B
61.296875
54.8046875
20
16.75390625
17.90234375
4.33203125
1.1015625
0.4921875
0.3984375
0.048024825


20157D
60.7578125
54.875
22.0390625
2.421875
13.19140625
3.21875
1.78125
0.4921875
0.46875
0.029935851


20088B
61.625
54.8984375
17.609375
19.33203125
19.8359375
2.99609375
0.9140625
0.421875
0.3046875
0.021815134


Donor 20054
60.9921875
54.921875
20.2578125
1.58984375
19.015625
1.05078125
1.3359375
0.46875
0.9140625
0.019195202


20141B
60.78125
55.0390625
20.0234375
2.50390625
19.25
4.30859375
1.2421875
0.46875
0.4453125
0.047614967


Donor 20052
60.9453125
55.109375
17.3984375
1.82421875
21.5703125
2.48046875
1.1484375
0.375
0.3984375
0.023606482


20154B
64.90625
55.1328125
22.671875
24.875
22.0625
3.6875
1.40625
0.421875
0.5625
0.041638581


20111D
61.53125
55.2265625
18.59375
1.37890625
16.484375
5.3046875
1.2890625
0.5 5625
0.46875
0.07380315


Donor 20023
62.9609375
55.3203125
22.6953125
2.375
15.76953125
3.62890625
1.5
0.5859375
0.6796875
0.029469641


Donor 20045
57.8515625
55.34375
18.078125
12.6875
19.28515625
5.09375
0.890625
0.3984375
0.5625
0.064360605


20068
63.359375
55.671875
24.453125
1.37890625
14.97265625
4.49609375
1.0546875
0.5859375
0.6328125
0.028914749


20160B
62.0703125
55.671875
23.703125
1.90625
17.99609375
4.8828125
1.171875
0.4921875
0.5625
0.032691245


20105D
60.734375
55.71875
19.1796875
1.26171875
22.0625
4.1796875
1.3359375
0.375
0.234375
0.044985779


Donor 20011
63.734375
55.7421875
21.4765625
3.8515625
16.00390625
4.8125
2.625
0.6796875
0.421875
0.024335519


Donor 20046
60.6875
55.7421875
21.03125
1.49609375
20.85546875
25.859375
1.1015625
0.4921875
4.640625
0.032919778


Donor 20025
63.453125
55.7890625
17.609375
2
16.296875
3.74609375
1.359375
0.703125
0.5859375
0.018108054


Donor 20057
60.171875
55.8125
15.3125
2.10546875
19.58984375
2.375
1.2421875
0.3984375
0.234375
0.023619226


Donor 20034
65.84375
55.859375
23.2578125
17.29296875
17.41015625
5.1640625
1.7109375
0.7265625
0.65625
0.047260619


Donor 20050
67.4140625
55.859375
27.9453125
3.20703125
18.8984375
5.75
1.7578125
0.46875
0.84375
0.028353356


Donor 20040
61.9296875
55.8828125
17.9609375
2.3984375
14.97265625
3.1484375
1.21875
0.6328125
0.515625
0.027842956


20070
61.7890625
56.046875
18.03125
14.01171875
17.6328125
3.58203125
1.1953125
0.5625
0.3984375
0.02001886


Donor 20021
58.8359375
56.2109375
22.71875
15.21875
16.51953125
4.61328125
1.03125
0.7734375
0.6328125
0.040136879


20083B
67.4375
56.3046875
22.4140625
17.10546875
21.06640625
4.6953125
1.2890625
0.3984375
0.609375
0.014174326


20123B
55.765625
56.5859375
21.7578125
1.578125
17.22265625
5.01171875
1.359375
0.4921875
0.6796875
0.033839427


20116D
58.4375
56.796875
19.6953125
1.70703125
17.08203125
2.9375
1.4765625
0.4453125
0.421875
0.041788659


Donor 20007
68.2109375
56.9140625
29.9609375
8.22265625
22.9765625
12.875
1.8984375
0.515625
1.3125
0.062782995


Donor 20006
66.921875
57.2890625
24.875
7.3671875
18.9921875
4.46093765
1.265625
0.65625
0.703125
0.030370554


Donor 20060
66.3359375
57.5703125
27.241875
7.14453125
17.31640625
5.2578125
1.6171875
0.6796875
0.890625
0.039458937


20064
62.4453125
57.59375
22.6015625
1.9296875
16.82421875
3.60546875
1.453125
0.8203125
0.5390625
0.024833187


20098B
61.953125
57.59375
17.9609375
1.66015625
20.1875
3.39453125
1.1015625
0.515625
0.3984375
0.026020912


20112B
62.8203125
57.640625
21.453125
1.71875
21.0078125
4.49609375
1.453125
0.421875
0.4921875
0.037126394


20084D
62.1875
57.6640625
19.578125
14.3984375
19.84765625
3.21875
1.078125
0.4453125
0.328125
0.033066897


20077D
61.34375
57.7578125
16.2265625
15.8515625
14.0234375
2.52734375
1.03125
0.515625
0.3515625
0.04530375


Donor 20012
56.890625
57.7578125
22.25
3.0078125
17.3984375
4.5078125
1.875
0.515625
0.328125
0.027107937


Donor 20051
67.953125
57.875
23.140625
2.796875
12.7109375
4.393625
2.34375
0.46875
0.5625
0.04621832


Donor 20029
62.8203125
57.8984375
25.8828125
16.8359375
19.12109375
4.15625
1.171875
0.7265625
0.703125
0.044844132


20139B
64.53125
58.2734375
22.4140625
2.76171875
20.3046875
5.140625
1.7578125
0.609375
0.609375
0.041498688


Donor 20043
60.453125
58.4140625
19.765625
1.16796875
15.546875
4.70703125
1.1484375
0.515625
0.3984375
0.028967433


Donor 20055
65.84375
58.53125
0.21875
2.45703125
17.22265625
0.171875
1.8515625
0.4453125
0.046875
0.016911387


20142D
65.09375
58.5546875
26.328125
6.6875
28.87109375
5.8203125
1.78125
0.4921875
0.75
0.022763142


20109D
62.1640625
58.71875
20.3346875
1.70703125
18.78125
4.68359375
1.5234375
0.609375
0.5390625
0.032723807


20074B
63.9921875
59.0234375
22.484375
5.33984375
13.6484375
3.8046875
1.1953125
0.65625
0.65625
0.028666456


Donor 20016
70.34375
59.0234375
25.390625
3.6640625
18.88671875
6.08984375
2.484375
0.9609375
0.7734375
0.024066927


20132D
68.4921875
59.1640625
25.859375
6.01953125
21.60546875
4.77734375
1.4765625
0.5393625
0.5859375
0.042476997


20099D
58.578125
59.328125
18.3828125
13.42578125
12.6875
3.546875
0.8203125
0.5625
0.1875
0.024551547


Donor 20018
61.53125
59.421875
20.8671875
2.515625
18.76953125
6.7109375
1.40625
0.4453125
0.421875
0.018540503


20133B
61.765625
59.703125
17.3984375
1.90625
17.6796875
3.34765625
1.03125
0.515625
0.3984375
0.012985918


20120D
67.1796875
59.7734375
22.7890625
14.48046875
17.64453125
5.19921875
1.4296875
0.5859375
0.6328125
0.040758131


Donor 20047
67.9765625
59.84375
21.078125
9.55859375
17.31640625
3.6640625
1.3359375
0.4921875
0.375
0.024480903


20121B
58.0859375
59.9375
18.6171875
13.30859375
14.3984375
3.08984375
1.1015625
0.890625
0.5390625
0.031288949


20067
59.2578125
59.9639375
21.8046875
16.15625
12.78125
2.609375
0.984375
0.890625
0.375
0.057821358


Donor 20037
63.078125
60.21875
23.234375
1.3671875
17.90234375
4.37890625
1.3125
0.4921875
0.3515625
0.058277943


Donor 20062
66.734375
60.3125
22.5078125
16.109375
18.37109375
3.96875
1.5
0.6328125
0.703125
0.037482927


20092B
69.3125
60.546875
21.6875
14.6328125
18.81640625
4.33203125
1.640625
0.6328125
0.3515625
0.022125789


Donor 20033
57.8515625
60.640625
15.453125
13.58984375
15.125
3.4296875
0.9609375
0.65625
0.28125
0.031890427


20102B
68.9140625
61.0625
25.9765625
6.5
19.8828125
5.99609375
1.5
0.5625
0.6796875
0.03191815


20094B
65.28125
61.2265625
20.984375
2.57421875
16.94140625
2.8203125
1.4765625
0.7265625
0.46875
0.014574856


20134D
62.4921875
61.2734375
21.1953125
1.25
15.44140625
0.79296875
1.265625
0.7734375
0.4921875
0.039836577


20080B
64.2265625
61.5078125
25.4140625
18.60546875
18.640625
4.63671875
1.2421875
0.65625
0.4921875
0.049277595


20113D
65.046875
61.6953125
24.3125
16.2734375
18.53515625
3.7578125
1.5
0.6328125
0.515625
0.062763232


20140D
67.71875
61.8828125
26.46875
2.3984375
18.8515625
5.5390625
1.640625
0.84375
0.703125
0.527082853


20136D
67.25
61.90625
23.375
2.26953125
18.5234375
5.10546875
1.9453125
0.515625
0.5390625
0.022431653


Donor 2002
56.796875
61.90625
20.7734375
1.73046875
13.91796875
4.25
1.4765625
0.9140625
0.609375
0.019869899


Donor 20049
65.984375
62.234375
22.2265625
1.5546875
17.0234375
4.51953125
1.3125
0.515625
0.5859375
0.020950088


Donor 20035
62.375
62.3515625
21.546875
15.48828125
16.80078125
2.84375
1.0078125
0.4453125
0.421875
0.019283358


20095D
67.7421875
62.46875
23.890625
17.45703125
17.703125
4.00390625
1.2890625
0.46875
0.3984375
0.027034079


Donor 20032
68.046875
62.4921875

19.859375
20.84375

1.3125
0.65625

0.049918197


20073D
68.234375
62.515625
21.6640625
20.4453125
18.2421875
4.33203125
1.3125
0.609375
0.5390625
0.031841081


20075D
69.59375
62.8233125
24.3828125
16.63671875
16.578125
5.421875
1.4765625
0.703125
0.5625
0.039951448


20122D
69.5234375
62.84375
26.140625
11.1171875
15.8984375
4.61328125
2.109375
0.5625
0.6796875
0.035321697


Donor 20020
68.046875
62.84375
26.046875
1.9765625
13.4375
2.234375
1.875
0.65625
0.796875
0.034770379


20091D
66.453125
62.9140625
23.46875
2.01171875
18.4765625
4.30859375
1.4765625
0.65625
0.4453125
0.025758288


20081D
69.5234375
63.0546875
25.8125
3.23046875
19.96484375
5.59765625
1.6171875
0.4921875
0.6328125
0.016452223


Donor 20014
71.46875
63.2890625
26.0234375
1.90625
18.171875
5.703125
1.734375
0.515625
0.5625
0.041661201


Donor 20041
69.546875
63.546875
22.0390625
3.5234375
17.36328125
4.44921875
1.78125
0.6328125
0.7265625
0.023519527


20119B
67.0390625
63.7109375
22.203125
13.87109375
17.66796875
4.0390625
1.2890625
0.6328125
0.421875
0.02381942


20093D
71.5625
63.8515625
25.3671875
19.625
17.1875
5.75
2.484375
0.5625
0.65625
0.024585153


20118D
67.578125
63.8515625
22.34375
3.55859375
16.7890625
3.58203125
1.8984375
0.796875
0.6328125
0.020317437


Donor 20004
70.3203125
64.390625
27.78125
7.14453125
24.78125
4.51953125
1.7109375
0.796875
3.8671875
0.022439636


20069
68.65625
64.484375
25.484375
2.85546875
15.828125
5.5390625
2.0390625
0.9375
0.84375
0.010409081


20104B
65.3515625
64.6953125
27.4296875
17.41015625
24.21875
7.68359375
1.0546875
0.703125
0.4921875
0.035729727


20087D
69.4765625
64.953125
23.984375
18.1015625
18.7578125
5.8671875
1.40625
0.796875
0.46875
0.022928927


Donor 20026
70.90625
65
26.1640625
3.72265625
15.13671875
6.4765625
2.1796875
0.8671875
0.75
0.029490629


20128D
64.1796875
65.0234375
24.6875
5.52734375
15.3125
11.26953125
1.5234375
0.75
0.6796875
0.044331507


Donor 20022
63.0078125
66.3359375
23.3984375
13.71875
14.7265625
3.30378125
1.3125
0.703125
0.4921875
0.02218158


20130D
69.171875
66.3828125
22.5546875
1.58984375
23.12890625
4.8828125
1.4296875
0.5859375
0.609375
0.023212202


Donor 20015
75.1015625
67.015625
32.1171875
5.33984375
23.48046875
7.96484375
2.8828125
0.9140625
1.0546875
0.041298242


20103D
72.5703125
67.9765625
28.109375
10.2734375
24.265625
6.359375
1.921875
0.796875
0.75
0.038131123


Donor 20013
74.6328125
67.9765625
26.6328125
2.515625
18.4765625
6.41796875
2.484375
0.984375
0.6796875
0.015684863


20097D
66.640625
69.359375
20.375
14.10546875
16.49609375
3.44140625
1.2421875
1.0078125
0.3984375
0.023692686


Donor 20053
76.296875
71.3046875
31.3203125
12.93359375
21.21875
6.79296875
1.8984375
0.84375
0.8671875
0.028782681

























CRT dA Integration
CN dA Integration
CFF dA Integration



Patient ID
CN LY30
CFF LY30
CRT CL30
CN CL30
CFF CL30
to Acrit (mm{circumflex over ( )}2)
to Acrit (mm{circumflex over ( )}2)
to Acrit (mm{circumflex over ( )}2)
CN Crit Prod





20150B
0.054626687
0.027442979
0.922646658
0.894579439
0.939624329
14.42779541
21.01464844
0.685546875
3.583374023


20131B
0.03083657
−0.006430128
0.91341592
0.92454226
1.003795867
55.03985596
35.0255127
11.60980225
4.739868164


20137B
0.030097212
0.024850274
0.921978799
0.931966618
0.947638604
4.075378418
52.4196167
6.858764648
5.654571533


Donor 20044
0.158564522
0.025780463
0.78810773
0.718055305
0.948208891
36.30432129
52.46905518
297.8486938
6.949310303


20152B
0.035774447
0.03306757
0.909178082
0.914996545
0.929343629
16.7744751
76.15338135
22.21435547
8.272247314


20100B
0.078264405
0.032046362
0.915829888
0.853393196
0.933732684
13.95648193
77.07623291
60.44018555
8.576568604


Donor 20058
0.021196962
0.009401352
0.919649856
0.942492013
0.978520286
14.59753418
35.77038574
8.762145996
4.359375


20108B
0.055939588
0.008846676
0.897693079
0.880924468
0.987056568
137.7454834
62.3303833
6.303405762
6.917999268


Donor 20063
0.016231848
0.011351955
0.918800293
0.948318701
0.975733064
9.897583008
26.38366699
6.593444824
3.443115234


20110B
0.037481321
−0.005831413
0.916296502
0.922748893
1.020737327
7.199890137
59.24377441
7.386108398
7.112548828


20153D
0.03837133
0.001880856
0.936002008
0.924225029
0.990856756
13.03857422
54.78277588
10.1282959
5.975921631


Donor 20024
0.047406741
0.024062717
0.890645939
0.892015707
0.961195361
133.9123535
61.14385986
19.03216553
6.890167236


Donor 20030
0.030500925
0.001550915
0.910755149
0.92704423
1.019064911
14.37835693
54.49603271
11.3939209
6.178436279


20072B
0.015311278
0.026953188
0.932561583
0.955997392
0.947699758
15.43798828
37.31286621
7.895324707
4.655273438


20079D
0.051418454
0.01426999
0.872471191
0.883002925
0.969322539
76.22094727
55.92645264
11.32965088
6.815460205


20149D
0.029747074
−0.008754644
0.946532653
0.0929623038
1.00955414
15.53192139
31.12646484
9.361999512
4.609130859


20146B
0.029046058
0.002625046
0.924523602
0.932832241
0.994483266
13.85925293
54.21258545
19.41119385
6.211395264


20156A
0.040872574
−0.014663284
0.927105991
0.906458797
1.047601476
12.55407715
60.21936035
24.66815186
7.626708984


Donor 20059
0.012877644
0.026754013
0.924791086
0.959453013
0.947308782
16.30810547
50.58544922
5.380554199
5.407470703


20151D
0.036162788
0.015357235
0.922543032
0.919252692
0.964051024
8.215026855
44.57702637
12.90838623
5.470458984


Donor 20017
0.03284789
0.009612168
0.876927553
0.922907142
0.983359746
8.26940918
47.06707764
18.23291016
5.330657959


Donor 20042
0.006529372
0.022183333
0.935529533
0.97264581
0.9568
19.70288086
50.45526123
3.640319824
5.511016846


20138D
0.023399896
0.005910018
0.901625792
0.938919342
0.985040798
10.56170654
57.3684082
9.422973633
6.501708984


Donor 2001
0.030189967
−0.010354148
0.949804592
0.93025433
1.014563107
198.2400513
54.50921631
6.537414551
9.819488525


20148B
0.044176398
−0.343559739
0.9330305
0.904200899
0.003662165
20.50213623
66.52935791
105.208374
8.14956665


20090B
0.044530954
0.013343385
0.883988619
0.898667493
0.970599322
61.87060547
69.78076172
17.21282959
8.704833984


20144B
0.024664914
0.00211955
0.96092312
0.939220538
0.988824503
9.510314941
59.581604
8.468811035
6.507293701


20078B
0.0397574
0.032274142
0.8883989428
0.90965251
0.935842601
8.946716309
65.0725708
9.99810791
7.796173096


20135B
0.059814843
0.020118734
0.925877251
0.887523049
0.959291368
182.315918
75.27008057
17.15844727
8.715545654


Donor 20048
0.03008713
0.025537019
0.931892779
0.937480846
0.955839058
25.76898193
46.86273193
4.401672363
6.245819092


Donor 20009
0.026344331
0.012003968
0.931993628
0.939790178
0.986745214
26.43475342
68.25970459
12.85400391
7.898712158


20117B
0.027881581
0.035371179
0.924625208
0.941667933
0.929257642
121.7373047
69.22869873
10.15301514
7.394439697


20076B
0.01924223
0.02673753
0.917068718
0.951116476
0.950975942
48.6293335
54.76135254
6.827453613
6.102539063


Donor 20019
0.001863276
0.010319222
0.963607401
0.980138429
0.981563674
203.8925171
49.21105957
9.816833496
5.885742188


Donor 20038
0.278638
0.036417674
0.910230835
0.935057126
0.928497409
121.1358032
55.23760986
14.70629883
6.437896729


20066
0.031155364
0.01533656
0.939500925
0.931338818
0.966231427
9.047241211
79.45422363
7.499816895
8.364257813


20147D
0.033383522
0.021421797
0.902052931
0.92160669
0.961078867
19.40130615
37.47930908
16.64099121
6.227874756


20158B
0.033309691
0.023378903
0.922172524
0.926534269
0.952904239
154.956665
63.73443604
14.00262451
7.562530518


20114B
0.02696704
0.001779683
0.944137094
0.937761194
0.99766173
108.7250977
63.23675537
14.72607422
7.648590088


20126D
0.109710199
0.005837412
0.930638029
0.806567164
0.980798193
16.9821167
76.05615234
2.073120117
9.448242188


Donor 20028
0.023107812
−0.008904859
0.928755598
0.942264658
1.014938886
7.016967773
48.56341553
8.37487793
5.975006104


Donor 20036
0.038066657
0.011970452
0.904877163
0.909633164
0.974368103
22.27532959
49.19952393
27.2109375
6.031219482


20127B
0.053709983
0.020658532
0.917356493
0.890892831
0.957644211
10.63256836
71.53088379
12.26733398
8.274169922


20106B
0.030807178
0.020493357
0.911609166
0.929827175
0.968201391
23.42230225
76.59503174
12.2244873
9.222747803


20085D
0.023255641
−0.007493108
0.919800125
0.944328979
1.007089405
18.01373291
52.26800537
7.194946289
7.115570068


20129B
0.028807898
023877814
0.930078985
0.933194774
0.95362083
142.3498535
57.01574707
13.45880127
6.892089844


20155D
0.023614407
0.016167408
0.938508187
0.944378523
0.974979149
21.53210449
61.49816895
22.1385498
7.46484375


Donor 20008
0.02103815
0.00228
0.926134906
0.944477347
1
69.38360596
50.48657227
12.7633667
6.277954102


Donor 20010
0.018110799
−0.006091718
0.931412713
0.952979447
1.009240246
205.680542
57.43432617
6.77142334
6.392578125


2011513
0.019098248
0.010429078
0.937839545
0.957028943
0.974468085
14.66674805
84.22009277
12.0135498
9.465820313


201010
0.027867496
0.009337058
0.933238453
0.933343143
0.98013245
12.74194336
72.55755615
14.88262939
8.096399854


20124D
0.057727962
0.02311456
0.892039191
0.893894922
0.948391922
25.14276123
102.321167
27.14172363
11.20202637


20145D
0.029634449
−0.016528727
0.93724645
0.93797654
1.0215905
43.99200439
69.5994873
5.809020996
7.760009766


Donor 20005
0.045045639
−0.009513752
0.935257311
0.925318495
1.017681729
13.49505615
52.74261475
16.94586182
5.824127197


Donor 20056
0.032245002
0.038925126
0.927628238
0.928206625
0.926860565
12.4354248
69.6159668
9.968444824
8.270507813


201610
0.030047298
0.040432645
0.871404636
0.922920598
0.92300885
11.79602051
62.04528809
4.207214355
6.990234375


Donor 20003
0.027663862
0.002012601
0.938224414
0.944018516
1.002100105
36.47076416
130.2588501
31.66699219
14.42221069


2008613
0.033799237
3.81E−04
0.920943657
0.927684758
0.994857731
17.7088623
62.7522583
22.92791748
7.32321167


Donor 20039
0.023091598
−0.008177156
0.916181144
0.947036027
1.006941231
19.96325684
64.29473877
5.260253906
7.460723877


20159D
0.020185119
0.022336164
0.920236895
0.953084648
0.955547524
19.22662354
81.96734619
15.30944824
9.047149658


Donor 20027
0.061528036
0.030110145
0.917759706
0.895543774
0.937391304
156.7545776
100.9484253
31.09680176
11.45755005


Donor 20061
0.005382218
0.00186621
0.941999763
0.975497922
0.991345114
27.33288574
38.02313232
16.60803223
4.845062256


20082B
0.028016378
0.008201792
0.922341024
0.936918896
0.984641638
5.176208496
68.65686035
9.922302246
7.520874023


20096B
0.01234881
0.021483583
0.953874092
0.962285714
0.956222132
64.88140869
38.86523438
6.565429687
5.797485352


Donor 20031
−0.006701786
−0.01510391
0.962154097
0.995285714
1.019221291
110.5444336
62.43585205
1.911621094
7.03024292


2012513
0.026111309
0.041437174
0.907468774
0.939272986
0.914453125
185.3300171
70.58001709
9.764099121
8.811309814


201570
0.021280609
−0.009133877
0.934807766
0.943621868
1.012761432
35.09802246
53.40179443
10.31945801
6.492645264


200888
0.008897823
0.010444395
0.956643002
0.971822969
0.978704525
140.0905151
79.40148926
8.343566895
8.368286133


Donor 20054
0.021942864
0.003445173
0.958883054
0.946230441
0.995372156
15.55169678
77.12072754
6.395690918
8.913574219


20141B
0.032637805
0.027701912
0.904755784
0.925904897
0.939133828
28.31011963
79.32568359
17.22271729
9.0234375


Donor 20052
0.018178811
0.007644814
0.946545315
0.95151687
0.981140548
16.95574951
74.86303711
7.892028809
8.088867188


20154B
0.039198078
0.019272149
0.914058739
0.915403146
0.964851826
318.8287354
86.66235352
18.76025391
9.307617188


20111D
0.035058589
0.01398226
0.864779076
0.917244306
1.001260504
11.9262085
72.05822754
18.81628418
8.499755859


Donor 20023
0.026219814
0.004001721
0.93634446
0.935602316
0.991738382
29.16210937
83.44390869
20.65704346
9.239959717


Donor 20045
0.026431042
0.009035581
0.875219446
0.93393563
0.979256698
109.1832275
68.46405029
18.89208984
7.683929443


20068
0.022136074
0.014169329
0.942663379
0.943586865
0.969329073
10.61444092
73.97808838
16.71514893
8.773040771


20160B
0.026974577
0.001812788
0.933920705
0.935587988
0.990112063
17.83410645
78.66485596
24.4720459
8.857452393


20105D
0.024768064
−0.015139172
0.91278621
0.944054964
1.02688391
10.42987061
72.78662109
8.246337891
8.2734375


Donor 20011
0.019395001
−0.015828483
0.959181172
0.955430974
1.036013096
85.6307373
90.99481201
17.77807617
10.87765503


Donor 20046
0.024525812
0.003056897
0.929325438
0.938612474
0.989970282
12.31842041
83.62518311
52.18725586
10.26480103


Donor 20025
0.024227855
9.74E−04
0.963432652
0.9453858
1.00931677
21.20251465
101.0687256
17.54901123
11.45874023


Donor 20057
−0.001850037
0.007844388
0.953648403
0.98656215
0.975510204
21.93255615
69.59454346
4.726318359
7.805328369


Donor 20034
0.089839161
0.014281715
0.905671571
0.817062937
0.973799127
255.2492065
116.1359253
32.17785645
12.64956665


Donor 20050
0.025734848
0.009057087
0.9426353
0.938741259
0.978194017
48.99188232
78.01721191
42.89941406
8.858642578


Donor 20040
0.110195606
0.0128806
0.942475085
0.823850133
0.972596781
25.91564941
84.21844482
11.01489258
9.474884033


20070
0.01853278
0.021710115
0.954102921
0.954418734
0.959705373
177.7263794
85.78564453
12.21624756
9.918457031


Donor 20021
0.03418404
0.004191025
0.911963883
0.918276581
0.992778542
146.1335449
111.3305054
27.13677979
12.77682495


20083B
0.007678877
−0.001578657
0.972196478
0.973359234
1.001045661
186.598938
67.07647705
24.83129883
8.39364624


20123B
0.088742387
0.008031119
0.9260297
0.828109899
0.987073609
15.44128418
58.38848877
19.63201904
8.476776123


20116D
0.012975699
0.012377694
0.909358289
0.957083906
0.970249901
18.28729248
61.83599854
10.85668945
7.606842041


Donor 20007
0.031328071
−0.007090395
0.88592372
0.927522306
1.017209909
136.1321411
100.861084
127.6237793
11.84729004


Donor 20006
0.042962748
0.006588498
0.933838078
0.904677485
0.996231156
93.28710938
104.8656006
26.24194336
12.46362305


Donor 20060
0.027774951
0.004994742
0.916617595
0.937712037
0.989675939
84.71942139
89.47869873
40.0715332
11.76974487


20064
0.032159975
9.17E−04
0.945202052
0.930819316
0.998963014
22.01000977
123.6604614
13.46868896
13.80111694


20098B
0.019252464
0.026261418
0.939470366
0.954015193
0.947803393
14.31903076
86.23718262
12.51617432
10.40917969


20112B
0.019984526
0.014676904
0.923516976
0.952426132
0.95193008
18.40759277
82.00195313
16.73822021
8.862670898


20084D
0.02959325
0.01943336
0.926884422
0.937000406
0.959297686
140.1745605
82.28704834
9.225219727
8.838409424


20077D
0.009964381
0.014003905
0.931991849
0.969971595
0.979778527
136.005249
63.19555664
6.870300293
7.230834961


Donor 20012
0.026588214
0.026460089
0.939851689
0.939131611
0.947331461
46.95666504
66.31347656
14.10644531
8.971369336


Donor 20051
0.0282808
−7.22E−04
0.908254771
0.933180346
0.994935854
5153601074
44.65283203
23.11743164
5.958251953


Donor 20029
0.040235236
0.0118316732
0.905981843
0.908514371
0.95834591
201.1849365
127.664978
23.58874512
13.89266968


20139B
0.031996581
0.017536114
0.912106538
0.922375654
0.968630185
39.67437744
95.60412598
27.92944336
12.37316895


Donor 20043
0.025334916
−0.011353755
0.930214526
0.939414204
1.018972332
8.505065918
65.78942871
11.39227295
8.016357422


Donor 20055
0.006258898
0.355654762
0.959776934
0.975173518
0.571428571
35.99285889
65.85040283
0.009887695
7.669464111


20142D
0.033247165
−0.006142433
0.940590494
0.923549033
1.008902077
105.5742188
104.3069458
30.98803711
14.20999146


20109D
0.02958799
0.00963191
0.929873068
0.934539649
0.983839938
18.49822998
101.1774902
23.00372314
11.44482422


20074B
0.026303772
0.019107598
0.944695397
0.939642621
0.966643502
48.4118042
70.91455078
22.12207031
8.956787109


Donor 20016
0.022948379
0.009179487
0.951688139
0.944407677
0.981538462
72.82287598
161.2765503
35.73248291
18.1489563


20132D
0.025035029
0.005946626
0.915478499
0.94810511
0.985498489
82.80786029
70.1350708
23.00372314
11.646698


20099D
0.026462046
−0.013231336
0.941184316
0.943903081
1.002549936
102.4249878
61.70910645
5.507446289
7.13671875


Donor 20018
0.013432926
6.21E0−4
0.948958862
0.961740731
0.991014601
31.47253418
74.39666748
26.77258301
8.358306885


20133B
−7.23E−34
−0.008082622
0.969643309
0.989008113
1.01077683
16.52893066
82.35131836
12.51617432
9.116088867


20120D
0.023425042
0.010314535
0.918711478
0.945497321
0.980459376
222.6000366
91.41998291
29.78997803
10.33859253


Donor 20047
0.020561902
−0.009360329
0.945523503
0.946344648
1.010007413
105.4539185
64.4331665
10.7578125
8.522918701


20121B
0.032133624
0.009660442
0.924949563
0.926094891
0.98111624
136.7023315
108.9755859
13.52471924
12.8236084


20067
0.036387622
−0.003856145
0.875807515
0.912442997
0.998925116
153.9547119
99.68444824
9.722900391
11.38330078


Donor 20037
0.028034546
0.018986307
0.889645777
0.942786715
0.96267653
11.84216309
80.40838623
14.2366333
8.811309814


Donor 20062
0.023038104
0.01319565
0.922383517
0.944430052
0.975008678
244.914917
101.2318726
24.81811523
11.62545776


20092B
0.022683333
0.011923631
0.949278629
0.947741935
0.976224784
216.5800781
97.90631104
13.76202393
11.90725708


Donor 20033
0.096808526
0.049121587
0.93923025
0.819118784
0.925682508
117.9585571
65.63781738
9.043945313
9.92578125


20102B
0.032849106
−0.008873434
0.930960209
0.932446264
1.047819549
91.86328125
96.72802734
33.78460693
11.18408203


20094B
0.012071477
0.009293042
0.965892772
0.969758836
0.987714073
31.93560791
106.9568481
10.24035645
12.30899048


20134D
0.026127863
0.014341442
0.926115764
0.938416422
0.969037965
9.996459961
67.71917725
2.796569824
11.94296265


20080B
0.023347729
0.020451634
0.905485951
0.944366823
0.956655395
245.0846558
83.91027832
20.39337158
12.23291016


20113D
0.03286058
0.004612521
0.875330291
0.921362543
0.987467866
237.548584
95.33221436
17.81433105
11.72927856


20140D
1
1
0.951892017
1
1
31.40002441
142.3432617
32.80407715
15.90600586


20136D
0.022472166
0.01052529
0.951208178
0.953054013
0.979946524
33.27044678
85.70654297
25.14935303
9.551147461


Donor 2002
0.022142472
−0.001980694
0.954195323
0.952675416
1
18.73553467
102.4777222
24.4720459
12.72189331


Donor 20049
0.005545443
0.003060926
0.958797064
0.977403967
0.989455185
14.84802246
76.41870117
25.08013916
8.777709961


Donor 20035
−0.005776741
−0.009875816
0.955661323
0.996616965
1.011965192
144.1444702
61.64154053
9.44934082
7.4815979


20095D
0.008573037
−0.013358404
0.940491293
0.971485743
1.013734467
225.9354858
68.21191406
14.21026611
8.298339844


Donor 20032
0.035924629

0.890815155
0.919364921

277.6662598
120.2178995

13.67871094


20073D
0.023220757
0.009871479
0.929929013
0.94563859
0.988099531
289.40625
91.93579102
19.81658936
11.11633301


20075D
0.042670895
0.00504913
0.91142793
0.900385524
0.982697853
257.40802
91.57983398
22.74169922
11.65649414


20122D
0.027525692
−0.00513424
0.930216878
0.938090502
1.006276151
224.470459
72.49328613
22.86859131
8.942871094


Donor 20020
0.022890249
0.005045241
0.923536165
0.945176529
0.982903419
25.84313965
71.97912598
9.452636719
8.818359375


20091D
0.01940219
−0.007108577
0.942158476
0.952688439
1.004993342
23.20477295
110.65979
17.00518799
12.12524414


20081D
-0.001491967
−0.00394093
0.962917182
0.988105563
1.00090799
47.89105225
83.4307251
22.50933838
9.826446533


Donor 20014
0.025575032
0.007622836
0.912439878
0.940748056
0.985589913
23.54919434
83.30383301
20.16101074
9.369873047


Donor 20041
0.046152809
0.005627437
0.949786565
0.920334399
0.987238568
50.97766113
94.82794189
24.20013428
10.98770142


20119B
0.007657879
0.021167605
0.952802704
0.974248927
0.955665025
174.1404419
97.82391357
15.67858887
11.18051147


20093D
0.016145642
−0.009099425
0.94628821
0.957420776
1.012011087
367.4399414
79.46740723
33.99719238
9.66796875


20118D
0.023174715
0.007876845
0.95283237
0.951180717
0.987412587
61.04168701
121.1506348
17.87860107
13.37878418


Donor 20004
0.027468387
0.004736127
0.949672259
0.941397719
0.993250844
121.7158813
173.2653809
69.75274658
19.74755859


20069
0.021366745
0.006801809
0.976786527
0.951659801
0.989883507
45.56744385
124.6541748
40.34179687
14.83886719


20104B
0.014632895
0.007350707
0.926838016
0.969568893
0.993164341
198.9783325
154.1293945
34.80633545
17.02880859


20087D
0.017378819
−0.005552389
0.954458563
0.956338706
1.004885993
270.4449463
118.2469482
20.77075195
14.94763184


Donor 20026
0.033851162
3.04E−04
0.933891582
0.922115385
0.99820842
71.36773682
106.2877808
40.62194824
13.12637329


20128D
0.023482618
0.011477672
0.908733591
0.94196804
0.979113924
77.29376221
87.25891113
62.69952393
11.484375


Donor 20022
0.012441605
−0.00942404
0.956106634
0.968201625
1.012020033
169.1784668
89.15075684
14.34869385
10.35461426


20130D
0.007788533
6.96E−04
0.946833705
0.973520066
0.991686872
15.94061279
121.3665161
26.18920898
13.55209351


Donor 20015
0.0451000839
−0.002598719
0.920108187
0.915364887
1.011675991
137.0714722
186.5791626
61.12738037
21.46261597


20103D
0.026895376
−0.007834213
0.922488965
0.93931732
1.020844914
201.2475586
169.8640137
34.12243652
19.33666992


Donor 20013
0.022569085
0.017489244
0.959833203
0.953108838
0.965679085
43.54870605
145.6160889
37.48260498
18.18786621


20097D
0.018750939
−0.004599629
0.949003517
0.959112413
1.005751534
171.539978
155.7394409
11.30657959
16.62496948


Donor 20053
0.025034087
0.008367285
0.943170182
0.947737482
0.989523572
252.0686646
150.3588867
48.98529053
17.90332031























TABLE 4








CRT Amax
CN Amax
CN + 75tPA Amax
CN + 150tPA Amax
CFF Amax
CFF + TXA Amax
CRT Acrit


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10027
55.7421875
58.625
43.1328125
19.3203125
19.015625
16.859375
0.86328125


10036
44.75
28.953125
5.703125
4.578125
11.703125
13.578125
1.25


10013
40.671875
42.9453125
18.0546875
13.203125
18.21875
17.9140625
1.73046875


10099
31.0859375
10.7421875
3.2421875
0.921875
9.96875
5.9609375
0.76953125


10107
52.3203125
42.734375
30.9453125
22.6484375
16.0390625
16.5546875
1.625


10093
51.125
54.8984375
40.5546875
26.3046875
12.3828125
13.6484375
1.53125


10044
21.6171875
20.984375
14.0703125
2.1171875
4.5546875
9.453125
0.59375


10068
47.84375
48.3359375
33.03125
15.9296875
7.4140625
10.8359375
12.48828125


10030
61.2265625
64.5078125
47.2578125
33.59375
22.015625
23.421875
1.8359375


10077
52.6015625
55.484375
51.0546875
40.765625
16.2265625
15.8046875
1.82421875


10016
28.1796875
28.5546875
14.0703125
6.5234375
16.8828125
12.265625
1.49609375


10075
46.203125
53.421875
44.8671875
27.6640625
21.0078125
19.7421875
3.04296875


10090
46.671875
45.6171875
31.859375
19.15625
9.0546875
10.203125
5.05859375


10059
60.6875
55.5546875
41.4453125
30.265625
15.1953125
18.03125
1.16796875


10061
52.8359375
58.7421875
55.15625
33.9921875
23.3046875
22.2734375
15.78125


10097
50.5859375
56.7265625
52.6953125
32.1171875
19.1328125
16.8828125
1.16796875


10025
62.234375
70.203125
64.4375
51.8984375
22.765625
23.1640625
1.9296875


10050
53.4453125
59.8671875
53.9375
32.9609375
19.9765625
18.921875
12.03125


10060
61.7890625
46.2734375
54.5
38.1171875
23
15.1484375
1.7890625


10032
59.7734375
61.6953125
52.6015625
45.9921875
20.9140625
19.4140625
12.76953125


10106
33.5
36.5
30.40625
12.453125
6.875
6.546875
0.9921875


10063
48.59375
64.7890625
63.3828125
53.375
23.0234375
21.640625
1.35546875


10088
63.5
59.984375
60.8046875
49.9296875
20.6796875
20.5625
13.51953125


10102
55.25
61.34375
48.4765625
22.6953125
10.71875
11.0703125
14.0703125


10115
72.5703125
70.5546875
68.7734375
51.5
27.8046875
27.640625
12.91015625


10014
62.515625
65.0234375
62.3046875
49.578125
18.640625
22.3671875
1.7421875


10085
64.0390625
69.453125
65.9609375
58.3671875
21.8984375
21.7109375
1.68359375


10047
62.703125
69.171875
61.015625
42.3828125
23.8203125
24.59375
10.44921875


10051
66.078125
68.65625
66.1015625
38.2109375
25.15625
24.078125
2.0703125


10056
61.859375
70.6015625
58.90625
52.4609375
25.578125
28.4609375
2.9609375


10057
67.5078125
68.1640625
64.15625
57.03125
25.6015625
26.46875
3.2421875


10039
65.09375
67.1796875
62.84375
56.2109375
21.96875
22.0859375
2.38671875


10067
58.484375
61.1328125
52.7890625
44.609375
22.203125
21.8046875
16.5546875


10071
55.2265625
56.703125
0.125
19.9765625
14.234375
13.390625
0.79296875


10104
64.4609375
68
64.0859375
65.6796875
27.171875
26.234375
2.890625


10001
56.84375
55.625
52.2265625
41.75
21.1953125
20.28125
1.73046875


10002
63.03125
64.2734375
63.921875
58.203125
26.28125
25.578125
17.9375


10003
66.6875
67.53125
60.8046875
44.6796875
26.2578125
25.0859375
6.0546875


10004
46.203125
34.203125
22.7890625
16.6015625
14.9609375
20.984375
0.828125


10005
56.5625
60.359375
58.7890625
47.796875
27.5234375
26.2578125
1.3203125


10006
63.8515625
62.2109375
59.0234375
39.4765625
23.7265625
23.4921875
1.8828125


10007
61.953125
65.5625
59.3515625
52.296875
35.75
25.0625
2.140625


10008
70.1796875
60.734375
48.5703125
35.703125
32.46875
27.640625
6.11328125


10009
71.5390625
70.4375
65.9609375
48.828125
29.5859375
29.2109375
8.55078125


10010
59.046875
61.5078125
57.7109375
48.7578125
21.875
21.2890625
34.51953125


10011
68.4453125
66.03125
59.1640625
54.3828125
25.296875
24.5703125
8.71484375


10012
52.015625
46.7890625
32.4453125
26.5625
17.7734375
19.53125
1.7421875


10015
68.6796875
69.359375
64.5078125
54.8984375
27.5
25.6953125
1.77734375


















CN Arit
CN + 75tPA Acrit
CN + 150tPA Acrit
CFF Acrit
CFF + TXA Acrit
CRT dAmax
CN dAmax


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10027
9.69921875
11.890625
7.44921875
1.49609375
1.53125
0.7734375
1.0078125


10036
10.75390625
2.7265625
3.67578125
1.61328125
1.56640625
1.078125
0.4921875


10013
8.515625
7.578125
6.21875
4.1328125
4.390625
1.1484375
0.5625


10099
6.6640625
2.0703125
0.2421875
0.6875
0.23046875
0.5390625
0.140625


10107
7.07421875
9.37109375
7.61328125
1.37890625
2.234375
0.796875
0.4453125


10093
10.0390625
9.04296875
8.515625
1.26171875
1.0859375
0.84375
0.84375


10044
6.16015625
2.80859375
1.54296875
0.359375
1.484375
0.421875
0.3046875


10068
13.0859375
6.58203125
8.66796875
0.3125
32.9140625
0.4921875
0.515625


10030
12.7578125
12.41796875
13.7890625
5.4453125
4.37890625
1.171875
1.40625


10077
8.0703125
5.50390625
6.18359375
1.015625
1.0390625
1.5703125
0.9375


10016
27.1953125
0.69921875
1.0390625
1.58984375
3.58203125
1.0078125
7.453125


10075
5.3515625
7.015625
6.60546875
3.8984375
3.23046875
1.7578125
1.03125


10090
9.83984375
9.3359375
6.51171875
1.15625
0.359375
0.5390625
0.4921875


10059
15.3359375
13.63671875
13.63671875
2.38671875
2.01171875
1.0078125
0.703125


10061
14.140625
11.84375
12.1015625
4.671875
5.1875
1.546875
1.078125


10097
9.4296875
7.77734375
8.140625
3.3828125
1.015625
0.9140625
0.9375


10025
10.26171875
12.81640625
9.58203125
4.4140625
3.41796875
1.734375
1.6640625


10050
9.98046875
9.8984375
8.76171875
2.3984375
2.515625
0.75
1.0546875


10060
5.66796875
14.796875
10.4609375
4.16796875
3.69921875
1.734375
0.3046875


10032
13.14453125
12.6640625
13.625
3.3828125
2.64453125
1.0546875
1.0546875


10106
4.84765625
5.234375
3.7578125
0.40625
0.4296875
0.5625
0.3984375


10063
9.46484375
7.7890625
8.48046875
2.41015625
2.22265625
1.0078125
1.1953125


10088
16.61328125
16.015625
14.8671875
39.0546875
3.34765625
0.8671875
0.6328125


10102
12.6875
12.18359375
8.62109375
26.78515625
0.37109375
0.515625
0.65625


10115
17.87890625
17.328125
16.8125
4.16796875
4.23828125
0.8671875
0.7734375


10014
10.37890625
9.7578125
13.47265625
3.4765625
3.9921875
0.9375
1.1953125


10085
13.16796875
12.27734375
13.4609375
4.07421875
4.40234375
1.6171875
1.4296875


10047
13.296875
13.19140625
13.6484375
5.421875
4.37890625
7.3828125
1.265625


10051
14.26953125
15.1484375
14.57421875
5.55078125
4.25
1.359375
1.4765625


10056
10.66015625
10.25
12.67578125
3.95703125
6.2890625
1.6875
1.4296875


10057
11.65625
10.91796875
11.52734375
4.44921875
5.7265625
1.875
1.921875


10039
12.875
9.6171875
10.28515625
1.6015625
2.99609375
1.2890625
1.03125


10067
12.3359375
11.5859375
12.62890625
43.54296875
3.5703125
0.75
0.75


10071
9.3125
0.125
9.265625
2.3046875
2.046875
0.7265625
0.515625


10104
11.73828125
9.81640625
10.91796875
5.421875
4.91796875
1.546875
1.3359375


10001
13.00390625
13.96484375
9.8046875
3.3828125
2.984375
1.4296875
0.6796875


10002
14.3984375
12.34765625
12.95703125
3.93359375
4.47265625
0.75
0.984375


10003
16.015625
15.16015625
14.0703125
6.3828125
6.1015625
1.40625
1.078125


10004
16.25
10.51953125
5.234375
2.9609375
1.16796875
0.703125
0.515625


10005
11.84375
11.83203125
11.15234375
2.41015625
1.625
1.03125
0.984375


10006
14.97265625
13.80078125
10.390625
4.42578125
4.859375
1.546875
0.9609375


10007
11.84375
8.94921875
12.65234375
14.17578125
4.390625
1.453125
1.171875


10008
14.10546875
18.55859375
15.34765625
8.9609375
6.8046875
1.3828125
0.6796875


10009
19.51953125
21.13671875
15.55859375
5.03515625
6.453125
1.5703125
1.1015625


10010
10.42578125
12.91015625
10.3671875
4.82421875
3.13671875
2.2734375
1.0546875


10011
13.05078125
13.40234375
13.70703125
5.31640625
5.22265625
1.4296875
0.8671875


10012
12.03125
9.58203125
11.15234375
2.0234375
1.96484375
0.9375
1.03125


10015
14.97265625
16.00390625
14.22265625
6.265625
5.36328125
1.2890625
1.0546875

















CN + 75tPA dAmax
CN + 150tPA dAmax
CFF dAmax
CFF + TXA dAmax




Patient ID
(mm)
(mm)
(mm)
(mm)
CRT LY30
CN LY30





10027
0.9375
0.8203125
0.8203125
0.28125
0.032181149
0.036531072


10036
0.1875
0.1640625
1.1015625
0.2578125
0.620687849
0.570174492


10013
0.515625
0.609375
0.5625
0.421875
0.122440453
0.17333015


10099
0.09375
0.046875
0.515625
0.1171875
0.700512063
0.676866667


10107
0.5859375
0.7265625
0.7265625
0.46875
0.206567617
0.301307892


10093
0.8203125
0.84375
0.3515625
0.234375
0.157658839
0.205500806


10044
0.3515625
0.0703125
0.1875
0.28125
0.795071377
0.8215557


10068
0.5859375
0.4921875
0.140625
0.140625
0.413549604
0.333138705


10030
1.4765625
1.3125
0.796875
0.8671875
0.049018013
0.048666115


10077
1.0546875
1.2421875
0.703125
0.65625
0.104187707
0.107589411


10016
1.1484375
1.828125
1.0546875
0.2109375
−3.82E−04
0.10379731


10075
1.078125
1.0546875
0.75
0.6328125
0.013590398
0.005073974


10090
0.46875
0.4921875
0.140625
0.234375
0.273513001
0.251932409


10059
0.7265625
0.6796875
0.2578125
0.2109375
0.403412504
0.205224691


10061
1.125
0.984375
0.796875
0.65625
0.01238212 
0.016334176


10097
1.1953125
0.890625
1.03125
0.703125
0.013837838
0.020287418


10025
1.6171875
1.6640625
0.9375
0.9609375
0.020103147
0.020015858


10050
1.078125
1.0078125
0.515625
0.421875
0.017763607
0.016338611


10060
0.890625
0.984375
0.7734375
0.3046875
0.033260983
−0.087673758


10032
1.078125
1.078125
0.703125
0.5859375
0.079844138
0.07552534


10106
0.375
0.421875
0.140625
0.234375
0.037628265
0.009302761


10063
1.125
1.1953125
0.4453125
0.3515625
0.036809352
0.00174796


10088
0.65625
0.703125
0.5625
0.3515625
0.033335384
0.038860489


10102
0.5859375
0.5859375
0.1640625
0.2109375
0.013800905
0.004507344


10115
0.890625
0.65625
0.6796875
0.7265625
−9.07E−04
0.00166233


10014
1.40625
0.5859375
0.609375
0.609375
0.036194424
0.0174196


10085
1.4296875
1.265625
1.0546875
0.7265625
0.012515249
0.014965317


10047
1.4296875
1.171875
0.609375
0.7265625
0.015036548
0.023598091


10051
1.78125
0.9609375
0.8203125
0.609375
0.051359495
0.036818989


10056
1.3125
1.2890625
0.7265625
1.125
0.040883465
0.030727841


10057
1.8984375
1.8984375
0.9609375
1.078125
0.02123211 
0.019522923


10039
1.265625
1.2421875
0.796875
0.7734375
0.030087314
0.021265554


10067
0.5625
0.8203125
39.2578125
0.5625
0.024026887
0.023099042


10071
0
0.515625
0.234375
0.1875
0.029964163
0.015405989


10104
1.7109375
1.6171875
0.984375
0.9140625
0.02263059 
0.016736079


10001
0.7265625
0.65625
0.46875
0.515625
0.044339839
0.035448853


10002
1.1484375
1.0078125
0.5390625
0.4921875
0.020561684
0.01556089


10003
1.3359375
1.3125
0.984375
0.84375
0.023201246
0.02049543


10004
0.5390625
0.46875
0.75
0.5859375
0.673048416
0.667148241


10005
1.0546875
1.0078125
1.8515625
1.3125
0.06026761 
0.049426


10006
1.1484375
1.21875
0.7734375
0.5625
0.034280048
0.006880259


10007
1.2890625
1.1953125
2.0859375
0.84375
0.014223939
0.015482503


10008
0.4453125
0.5390625
0.9375
0.609375
0.040747338
0.03000636


10009
1.0078125
0.8671875
0.7265625
0.75
0.026999381
0.014878642


10010
1.1015625
1.078125
0.8203125
1.5703125
0.034516958
0.035916


10011
0.8671875
1.1484375
0.5390625
0.4921875
0.023568783
0.021000454


10012
1.0078125
0.9140625
1.5
1.2890625
0.490499524
0.474602744


10015
1.0546875
0.9140625
0.5625
0.5859375
0.021365601
0.017188087



















CN + 75tPA
CN + 150tPA

CFF + TXA


CN + 75tPA
CN + 150tPA


Patient ID
LY30
LY30
CFF LY30
LY30
CRT CL30
CN CL30
CL30
CL30





10027
0.610296293
0.877309947
0.001396878
−0.018850402
0.912123336
0.934834755
0.003984785
0.006469875


10036
0.883573059
0.90988339
0.723025145
−0.033342923
0.003840782
0.007555316
0.021917808
0.027303754


10013
0.764863695
0.920766765
0.18963098
−0.028770534
0.593161736
0.525195561
0.008221549
0.011242604


10099
0.862426372
0.803248588
0.741447884
−0.040334207
0.005529027
0.022545455
0.038554217
0.13559322


10107
0.721292673
0.869580028
0.486720653
−0.010193487
0.418545617
0.257952468
0.004039384
0.007588824


10093
0.659639012
0.875379913
0.443278128
−0.036288399
0.524144254
0.459086381
0.003660181
0.004752005


10044
0.874518786
0.844049815
0.814686964
−0.038434343
0.005782436
0.007073716
0.010549695
0.05904059


10068
0.684876616
0.863611367
0.646364594
−0.02922074
0.111365121
0.201390011
0.005203406
0.007383479


10030
0.5668166
0.87458624
0.190315235
−0.015613187
0.874441751
0.840135642
0.003636965
0.004418605


10077
0.630032517
0.814858822
0.300028085
0.030363322
0.632407545
0.656153196
0.002448355
0.003066309


10016
0.824400796
0.90074684
0.133519718
−0.037340764
0.95092875
0.708618331
0.008883953
0.019161677


10075
0.66195731
0.882000141
−0.01578034
−0.017857143
0.97717281
0.983767183
0.002786
0.004518498


10090
0.654669364
0.873151169
0.479155882
−0.01954441
0.329092735
0.370097619
0.00980873
0.006525285


10059
0.634131061
0.750124763
0.628603256
−0.01975195
0.048403708
0.434256785
0.003016023
0.004130098


10061
0.341356822
0.715671685
0.025839479
0.022295783
0.976489723
0.968080862
0.085127479
0.003677316


10097
0.295816654
0.749214506
−0.006116442
−0.006813975
0.967567568
0.959096543
0.217642698
0.003891997


10025
0.301405728
0.60935634
0.018522173
0.001226813
0.951041928
0.950255954
0.20271581
0.00240855


10050
0.239333478
0.692515011
−0.002336723
−0.001073493
0.960532086
0.967506199
0.334733488
0.003792368


10060
0.297550929
0.694521589
0.009783552
−0.057673629
0.937792388
1.141820024
0.236238532
0.003279361


10032
0.051217676
0.417378452
−0.010187088
−0.006750503
0.859234087
0.875775611
0.882370414
0.040428062


10106
0.455055955
0.935377457
0.003082386
−0.075740851
0.907649254
0.969820205
0.063463515
0.010037641


10063
0.006560459
0.550600117
−0.008719319
−0.015025572
0.932958199
0.987338719
0.974855171
0.00234192


10088
0.074793888
0.391418053
0.013625488
−0.012183384
0.926181102
0.90974212
0.789926763
0.08699734


10102
0.562845152
0.848988812
5.16E−04
0.005384027
0.972002262
0.984717269
0.002578566
0.005507745


10115
0.072674562
0.491382863
−0.014777091
−0.013430375
0.99515556
0.991030894
0.776780643
0.017445388


10014
0.016686346
0.239035744
−0.001005868
9.21E−04
0.930642339
0.961792623
0.966520376
0.34714781


10085
0.019434574
0.426500617
−0.00628196
0.00456849
0.971818958
0.965579303
0.957005804
0.040289118


10047
0.31609724
0.653241935
0.028920684
0.002780866
0.961126339
0.940027106
0.18950064
0.002949309


10051
0.129969698
0.588880654
0.003277692
0.00937838
0.900685741
0.916021848
0.617421109
0.013085259


10056
0.049351606
0.304203276
0.009619986
6.10E−04
0.918161152
0.934270222
0.842838196
0.175725987


10057
0.097372578
0.54744863
0.002834147
0.001678309
0.952088879
0.952893983
0.667924988
0.003013699


10039
0.065426612
0.356663192
−8.83E−04 
0.001954369
0.937710034
0.951157111
0.806439582
0.131063238


10067
0.127341193
0.52226187
−0.089839901
−0.023327959
0.949104996
0.947476038
0.636821074
0.004378284


10071
1
0.823419372
0.074108123
0.010054454
0.913000424
0.946266189
1
0.009777083


10104
0.473321752
0.343410253
0.015296147
0.009525346
0.954550964
0.960018382
0.007070584
0.101463066


10001
0.125558464
0.574256955
0.003027092
0.014933231
0.905992303
0.920365169
0.639192221
0.003555389


10002
0.025736373
0.048507271
−0.026026803
−0.025764865
0.952032722
0.970827762
0.939868003
0.883221477


10003
0.285959784
0.639335257
3.64E−04
−0.006207827
0.950445173
0.953840814
0.20441989
0.003322259


10004
0.766353845
0.823688235
0.835254569
−0.004840428
0.004734528
0.005025126
0.005485087
0.007529412


10005
0.075513843
0.383931977
−0.028563488
−0.02444461
0.87859116
0.892052809
0.809435216
0.128636809


10006
0.121344584
0.527154661
0.009525573
0.010931438
0.93723235
0.979279166
0.615618795
0.003166436


10007
0.175179896
0.483857435
−0.017598157
−0.017704437
0.970870113
0.968898951
0.515861524
0.023453839


10008
0.186974559
0.347914843
−0.022982836
−0.014046307
0.914505176
0.936712117
0.529515844
0.214223195


10009
0.07481
0.452688
0.003454802
4.71E−04
0.941683958
0.963065661
0.794978088
0.02848


10010
0.153788562
0.578757411
−0.007364583
7.22E−04
0.926964806
0.919979677
0.568701773
0.005447845


10011
0.034518465
0.19155214
−0.013607937
−0.027164812
0.945896587
0.949952674
0.914828998
0.496624048


10012
0.691469018
0.849708333
0.680998168
−0.020095
0.024932412
0.07380197
0.003852637
0.004705882


10015
0.094819042
0.270578957
−0.007755682
−0.005489257
0.950176317
0.959788241
0.737313794
0.369005265


















CFTX dV @ CFF max
CN dV @ CN + tPA75 max
CRT dA Integration to Acrit


Patient ID
CFF CL30
CFF + TXA CL30
(mm/min)
(mm/min)
(mm{circumflex over ( )}2)





10027
0.98767461
1.029193698
0
0.84375
4.167663574


10036
0.010680908
1.058688147
0.421875
3.65625
3.351928711


10013
0.428816467
1.064108155
0.28125
2.953125
0.851989746


10099
0.202978056
1.086500655
0.28125
1.6875
0.16973877


10107
0.054554311
1.022652194
0.421875
1.546875
0.385620117


10093
0.14637224
1.077275329
0.140625
1.265625
0.853637695


10044
0.027444254
1.084297521
0.28125
1.96875
0.402099609


10068
0.035827187
1.080028839
0.5625
1.96875
55.67266846


10030
0.444286728
1.030020013
0.140625
1.96875
0.866821289


10077
0.254694271
0.922886802
0.28125
0.84375
0.374084473


10016
0.601573346
1.072611465
0.28125
1.96875
11.56695557


10075
1.033469691
1.035615354
0
0.84375
45.57073975


10090
0.119930975
1.036753446
0.28125
1.40625
13.43243408


10059
0.028277635
1.035095321
0.28125
1.546875
1.507873535


10061
0.954743547
0.967379867
0.140625
0.140625
158.5063477


10097
1.013474888
1.011105969
0
0.28125
7.57232666


10025
0.963967056
0.998988196
0.140625
0.421875
24.0534668


10050
1.0023465
1.002477291
0
0.28125
71.05297852


10060
0.991847826
1.103661681
0.140625
0.84375
21.12670898


10032
1.016809862
1.014486922
0
0.5625
144.5267944


10106
0.928409091
1.132458234
0
0.5625
4.676879883


10063
1.00916186
1.022743682
0
0.140625
10.36724854


10088
0.984132981
1.036474164
0.140625
0.140625
108.4498901


10102
1.008746356
0.993648553
0
0.984375
60.84887695


10115
1.048890138
1.028829847
0.140625
0.28125
85.81365967


10014
1.015088013
0.996856444
0
0
13.54943848


10085
1.019265073
0.994602375
0
0.140625
18.49822998


10047
0.914398163
0.999047014
0.140625
0.5625
685.0376587


10051
0.999068323
0.985399091
0
0.28125
22.11547852


10056
0.978924863
1.000823497
0.140625
0.421875
44.68249512


10057
0.995422643
1.001770956
0
0.140625
50.58215332


10039
0.997866287
0.997877609
0
0.28125
27.48944092


10067
1.329345531
1.064493013
−0.140625
0.421875
130.4022217


10071
0.761251372
0.982497083
0.140625
1.125
3.468933105


10104
0.9706728
0.991066111
0.140625
0.703125
40.84606934


10001
0.990047917
0.969953775
0
0.28125
18.53118896


10002
1.070451843
1.076053757
0
0.421875
33.03479004


10003
0.998214817
1.026160075
0.140625
0.84375
88.00708008


10004
0.008355091
1.048026806
0.84375
3.65625
0.405395508


10005
1.04513199
1.037488843
0.140625
0.28125
10.16784668


10006
0.981231478
0.983039574
0.140625
0.28125
22.12866211


10007
1.029501748
1.04021197
0.421875
0.421875
25.69812012


10008
1.054860443
1.038157151
0
0.421875
79.16253662


10009
0.995246897
1.005616475
0.140625
0.28125
126.6432495


10010
1.0225
1.008807339
0
0.421875
342.4257202


10011
1.03428042
1.072496025
0
0.140625
120.1107788


10012
0.007032967
1.0348
0.5625
2.671875
1.974243164


10015
1.025568182
1.020979021
0
0.140625
16.7744751














CN dA Integration to Acrit
CN + 75tPA dA Integration to Acrit
CN + 150tPA dA Integration to Acrit


Patient ID
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)





10027
85.9520874
101.4642334
45.04669189


10036
35.29083252
3.318969727
5.532165527


10013
30.48376465
26.18261719
28.65124512


10099
7.577270508
1.272216797
0.019775391


10107
19.28265381
41.2300415
48.57000732


10093
56.30053711
62.28094482
61.1685791


10044
18.49493408
7.592102051
0.552062988


10068
57.52990723
26.35565186
37.64080811


10030
124.614624
154.8099976
178.7167969


10077
54.78771973
52.32073975
70.82391357


10016
47.28295898
0.248840332
0.771240234


10075
46.79187012
69.48083496
39.81280518


10090
25.65362549
35.08813477
22.11383057


10059
84.42773438
79.0010376
80.16778564


10061
129.7397461
115.2773438
100.2183838


10097
77.203125
74.16265869
68.04382324


10025
150.218811
161.7544556
138.9138794


10050
81.03790283
91.74462891
71.90496826


10060
14.2399292
119.973999
86.43164063


10032
95.99468994
120.9364014
131.7700195


10106
18.36639404
10.99182129
13.90209961


10063
70.71185303
78.4588623
91.31121826


10088
94.48846436
91.61279297
64.3458252


10102
56.65649414
65.57684326
44.1897583


10115
121.9993286
85.35388184
97.12023926


10014
111.3931274
118.4084473
66.15362549


10085
173.6295776
155.6900024
159.0864258


10047
147.9067383
162.7630005
143.6055908


10051
186.1671753
231.9521484
107.1282349


10056
126.6663208
54.03625488
143.7094116


10057
200.618042
164.661438
188.5501099


10039
123.7412109
88.77832031
101.6867065


10067
79.40478516
48.34094238
90.79046631


10071
37.39196777
0
39.15856934


10104
138.3964233
144.7278442
159.5033569


10001
75.84356689
60.63299561
53.13317871


10002
134.4034424
122.3388062
120.6018677


10003
157.7351074
175.6664429
143.7802734


10004
75.09375
51.08477783
17.79125977


10005
105.791748
104.5079956
97.47784424


10006
92.40875244
124.972229
106.2235107


10007
125.6231689
73.32220459
135.4202271


10008
75.42169189
47.03411865
63.8102417


10009
176.0454712
181.0288696
114.6494751


10010
90.99481201
116.6401978
93.13879395


10011
102.0822144
104.9727173
72.57733154


10012
84.82324219
82.31671143
86.3838501


10015
146.3724976
146.1582642
81.92449951






















CFF dA
CFF + TXA dA












Integration to Acrit
Integration to Acrit


Patient ID
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)
ID
SBP
HR
OR?
ICU?
Death?
pRBC
FFP
PLT





10027
10.11346436
4.268188477
10027
150
Unk
Yes
Yes
Yes
61
12
2


10036
5.04107666
3.314025879
10036
0
0
Yes
Yes
No
32
8
3


10013
2.231323242
16.37072754
10013
96
100
Yes
Yes
Yes
29
16
5


10099
0.260375977
0.087341309
10099
80
120
Yes
Yes
Yes
27
12
4


10107
0.393859863
9.271362305
10107
0
130
Yes
Yes
Yes
24
13
2


10093
0.271911621
0.557006836
10093
70
140
Yes
Yes
No
23
12
2


10044
0.052734375
3.348632813
10044
140
93
Yes
Yes
No
21
12
1


10068
0.046142578
18.60534668
10068
160
70
No
Yes
Yes
14
12
2


10030
18.28894043
30.75897217
10030
180
40
Yes
Yes
Yes
12
8
2


10077
0.283447266
5.164672852
10077
0
110
Yes
Yes
No
11
4
1


10016
14.26629639
7.041687012
10016
0
130
Yes
0
Yes
6
2
0


10075
29.9630127
18.2477417
10075
100
100
Yes
Yes
No
9
4
2


10090
0.177978516
0.411987305
10090
Unk
Unk
Yes
Yes
No
9
4
2


10059
2.480163574
3.093200684
10059
180
150
Yes
Yes
Yes
8
6
1


10061
35.8560791
32.24707031
10061
108
112
Yes
Yes
No
7
6
2


10097
30.8001709
5.164672852
10097
104
130
Yes
Yes
No
7
4
1


10025
38.51916504
28.14532471
10025
204
102
Yes
Yes
Yes
6
4
1


10050
11.390625
10.31945801
10050
107
89
Yes
Yes
No
6
4
1


10060
25.09991455
8.211730957
10060
70
112
Yes
Yes
No
6
3
0


10032
20.671875
13.52142334
10032
0
0
Yes
Yes
No
5
6
1


10106
0.385620117
0.639404297
10106
0
122
Yes
Yes
No
5
3
0


10063
10.2288208
6.98236084
10063
80
100
Yes
Yes
No
4
2
1


10088
49.21435547
11.0725708
10088
102
110
Yes
Yes
No
4
4
1


10102
19.89239502
0.430114746
10102
122
90
Yes
Yes
Yes
4
5
2


10115
19.7210083
26.19085693
10115
102
130
Yes
Yes
<28 d
4
4
2


10014
15.51049805
20.10827637
10014
80
110
Yes
Yes
No
3
1
0


10085
35.84454346
24.3583374
10085
132
108
Yes
Yes
No
3
0
0


10047
25.88598633
27.24554443
10047
0
120
Yes
Yes
No
2
1
0


10051
40.11602783
22.52087402
10051
110
124
Yes
Yes
No
2
0
0


10056
25.6206665
60.17321777
10056
108
100
Yes
Yes
No
2
0
0


10057
38.38238525
52.54980469
10057
90
130
Yes
Yes
No
2
2
0


10039
10.98852539
21.26019287
10039
140
120
Yes
Yes
No
1
0
0


10067
103.7993774
16.0378418
10067
100
120
Yes
Yes
No
1
0
0


10071
4.624145508
2.059936523
10071
90
80
Yes
Yes
No
1
2
0


10104
47.8861084
30.43267822
10104
100
72
Yes
Yes
No
1
0
0


10001
13.2989502
13.25280762
10001
132
90
No
0
No
0
0
0


10002
17.91815186
20.62738037
10002
110
110
Yes
0
No
0
0
0


10003
55.2557373
47.34228516
10003
118
120
Yes
Yes
No
0
0
0


10004
7.280639648
5.517858887
10004
0
0
No
Yes
No
0
0
0


10005
35.14910889
15.49072266
10005
124
120
Yes
0
No
0
0
0


10006
32.91778564
21.35083008
10006
60
86
No
0
No
0
0
0


10007
273.8776245
30.1673584
10007
98
66
Yes
Yes
No
0
2
0


10008
73.72595215
37.30297852
10008
84
90
Yes
0
No
0
0
0


10009
28.65618896
37.08874512
10009
72
112
Yes
Yes
No
0
0
0


10010
35.91375732
45.75531006
10010
Walk-in
Walk-in
No
0
No
0
0
0


10011
25.35040283
20.23187256
10011
124
72
Yes
0
No
0
0
0


10012
19.26452637
20.21868896
10012
0
0
No
Yes
Yes
0
0
0


10015
29.44885254
28.83416748
10015
122
112
Yes
Yes
No
0
0
0













Patient ID
CRYO
CN Crit Prod





10027
6
9.774993896


10036
4
5.292938232


10013
0
4.790039063


10099
6
0.937133789


10107
2
3.150238037


10093
2
8.470458984


10044
1
1.876922607


10068
1
6.747436523


10030
1
17.94067383


10077
0
7.565917969


10016
0
202.6900635
Artefact- Spike at end


10075
0
5.518798828


10090
2
4.843048096


10059
2
10.78308105


10061
0
15.24536133


10097
0
8.840332031


10025
1
17.07614136


10050
0
10.52627563


10060
0
1.726959229


10032
0
13.8633728


10106
0
1.931488037


10063
0
11.31344604


10088
0
10.51309204


10102
2
8.326171875


10115
0
13.82821655


10014
0
12.40603638


10085
0
18.82608032


10047
0
16.82885742


10051
0
21.06985474


10056
0
15.24069214


10057
0
22.40185547


10039
0
13.27734375


10067
0
9.251953125


10071
1
4.801757813


10104
0
15.68161011


10001
0
8.838592529


10002
0
14.17346191


10003
0
17.2668457


10004
0
8.37890625


10005
0
11.65869141


10006
0
14.38778687


10007
0
13.87939453


10008
0
9.587310791


10009
0
21.50198364


10010
0
10.99594116


10011
0
11.31747437


10012
0
12.40722656


10015
0
15.79147339


















CRT Amax
CN Amax
CN + 75tPA Amax
CN + 150tPA Amax
CFF Amax
CFF + TXA Amax
CRT Acrit


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10017
59.5625
62.84375
58.6953125
45.59375
21.171875
19.71875
1.96484375


10019
67.765625
68.9609375
62
52.015625
27.8046875
25.765625
2.36328125


10020
68.9609375
66.2890625
62.890625
51.828125
23.8671875
23.328125
2.2109375


10021
10.6953125
15.546875
15.3125
11.6796875
16.6484375
9.5703125
0.62890625


10022
59.890625
64.4140625
59.84375
61.0859375
22.296875
19.7421875
1.1796875


10023
63.1015625
68.4453125
55.6015625
35.3046875
32.234375
32.5390625
11.01171875


10024
62.46875
66.8984375
57.8515625
38.6796875
22.203125
20.46875
1.1796875


10026
51.6875
50.515625
52.7421875
25.5859375
13.90625
13.7890525
11.41015625


10028
64.0390625
69.59375
66.6171875
57.8984375
27.640625
26.84375
1.484375


10029
65.6796875
65.140625
47.84375
29.421875
25.1328125
26.375
7.09765625


10031
61.8359375
61.1796875
49.0625
33.6640625
23.8203125
24.0078125
14


10033
62.0234375
66.59375
57.9453125
42.1484375
24.5234375
24.2421875
1.75390625


10034
60.640625
57.6875
43.0625
31.1796875
20.609375
17.8203125
14.33984375


10035
56.65625
60.5
52.6015625
47.0234375
20.046875
19.671875
1.89453125


10037
66.40625
70.53125
66.875
62.46875
25.25
24.6640625
1.859375


10038
60.8046875
58.625
51.7578125
51.0546875
23.0234375
24.8046875
4.28515625


10040
65.5859375
61.2265625
49.296875
46.6484375
25.8125
23.65625
6.55859375


10041
59.140625
63.546875
55.203125
35.3515625
21.1953125
21.0546875
1.14453125


10042
62.75
63.78125
56.5859375
44.28125
22.9296875
21.4765625
2.1875


10043
62.8671875
64.015625
54.6640625
36.640625
19.765625
19.6953125
4.77734375


10045
62.65625
63.171875
48.171875
25.6484375
27.9921875
23.703125
12.1015625


10046
49.6953125
55.7890625
51.40625
31.578125
19.15625
17.65625
0.8984375


10048
74.703125
73.8828125
65.890625
56.1171875
31.6953125
34.484375
7.84765625


10049
58.7421875
62.609375
55.4140625
49.859375
19.6484375
17.984375
14.66796875


10052
71.796875
70.2734375
67.0390625
35.234375
31.34375
29.3984375
7.578125


10053
65.5625
66.359375
62.0703125
57.6171875
24.2421875
23.5859375
1.6953125


10054
59.4453125
59.9375
50.4921875
41.65625
21.4765625
21.1484375
12.96875


10055
66.40625
66.21875
48.2890625
50.7734375
28.671875
26.84375
6.16015625


10058
57.8984375
58.7890625
50.84375
32.609375
21.6171875
20.84375
2.09375


10062
62.5859375
64.7421875
63.40625
58.9765625
25.4375
24.4765625
1.28515625


10064
72.78125
71.8671875
72.6640625
66.1953125
36.40625
34.9296875
5.73828125


10065
57.0546875
58.25
49.203125
35.3984375
21.2421875
22.15625
4.15625


10069
65.5625
69.9921875
70.8125
69.9453125
28.8125
28.4375
2.7265625


10070
48.546875
58.34375
52.9296875
46.1328125
17.2578125
15.6875
1.56640625


10072
67.9765625
64.25
63.8515625
54.921875
21.078125
22.203125
13.26171875


10073
72.078125
73.8828125
71.984375
28.5078125
31.9296875
93.78125
7.0859375


10074
64.7890625
67.7890625
62.328125
51.265625
20.140625
20.515625
1.58984375


10076
63.8984375
66.125
59.84375
49.765625
23.09375
23.375
2.66796875


10078
68.2578125
65.4921875
61.2734375
52.3203125
27.734375
26.28125
7.765625


10079
70.1328125
71.6328125
67.8828125
41.4921875
40.0390625
31.0625
2.48046875


10080
56.0234375
55.859375
56.75
36.8515625
18.2421875
16.4609375
11.69140625


10081
69.3359375
68.46875
67.296875
62.984375
27.4765625
25.4375
17.10546875


10082
53.703125
51.40625
54.9921875
53.3515625
20.1171875
18.8515625
2.1171875


10083
58.6015625
62.328125
61.6484375
55.15625
25.15625
22.390625
2.43359375


10084
63.640625
65.2578125
63.4765625
57.4765625
27.265625
26.1875
6.23046875


10086
65.65625
64.6953125
62.75
46.3671875
26.234375
24.5703125
17.796875


10087
70.34375
66.59375
66.6875
59.046875
31.625
33.9453125
14.03515625


10089
63.40625
72.1953125
68.2578125
60.0078125
27.171875
28.4609375
3.2421875


















CN Arit
CN + 75tPA Acrit
CN + 150tPA Acrit
CFF Acrit
CFF + TXA Acrit
CRT dAmax
CN dAmax


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10017
13.77734375
15.2421875
13.02734375
3.78125
3.65234375
1.3359375
0.7734375


10019
16.12109375
13.66015625
9.0078125
1.484375
4.4140625
1.6640625
1.1953125


10020
16.37890625
14.1171875
13.44921875
4.80078125
5.31640625
1.359375
0.8671875


10021
2.41015625
3.6171875
2.1640625
2.984375
1.2734375
0.5390625
0.5390625


10022
11.046875
10.49609375
12.39453125
1.3203125
1.1796875
0.984375
0.9375


10023
16.51953125
13.0625
13.0625
4.4140625
6.58203125
1.5234375
1.1953125


10024
6.78125
18.69921875
10.484375
3.921875
3.265625
0.9375
1.171875


10026
10.56640625
8.7734375
7.89453125
0.32421875
1.671875
0.7265625
0.8203125


10028
14.65625
15.8046875
14
3.4765625
3.67578125
1.40625
1.40625


10029
16.47265625
10.625
13.8125
4.14453125
4.21484375
1.2421875
0.7265625


10031
12.46484375
12.65234375
11.84375
2.10546875
3.875
1.21875
1.1015625


10033
13.87109375
15.93359375
13.21484375
5.84375
5.09375
1.1015625
0.8671875


10034
12.69921875
13.84765625
9.16015625
0.8515625
2.609375
0.8203125
0.8203125


10035
10.390625
8.46875
7.84765625
4.35546875
2.85546875
1.3828125
1.03125


10037
14.46875
15.5234375
13.015625
4.19140625
4.58984375
1.546875
1.5


10038
12.265625
16.4375
14.4921875
3.79296875
5.69140625
1.1484375
0.65625


10040
11.59765625
10.98828125
17.03515625
6.37109375
5.75
1.1484375
0.6796875


10041
14.046875
8.1640625
9.98046875
3.25390625
3.21875
0.8671875
0.9375


10042
14.234375
14.69140625
10.3203125
4.16796875
3.3125
1.125
1.03125


10043
13.30859375
15.3359375
12.44140625
5.31640625
4.56640625
0.9609375
1.0546875


10045
13.2734375
12.0546875
9.40625
7.109375
5.7265625
0.984375
1.03125


10046
7.77734375
6.67578125
7.671875
2.3046875
1.90625
0.796875
1.1015625


10048
14.984375
21.37109375
14.97265625
8.57421875
8.64453125
1.9453125
1.640625


10049
11.4453125
11.328125
11.71484375
3.83984375
2.9140625
0.8671875
0.9375


10052
15.1953125
18.3359375
11.69140625
6.21875
4.49609375
1.359375
1.21875


10053
15.39453125
13.05078125
11.1171875
4.1328125
4.82421875
1.6875
1.1015625


10054
12.11328125
12.0078125
14.3515625
3.9453125
3.6875
0.890625
0.7734375


10055
13.28515625
9.04296875
12.76953125
7.54296875
6.734375
1.3359375
1.0546875


10058
11.69140625
9.5234375
11.1171875
4.42578125
3.04296875
1.734375
1.0546875


10062
14.4921875
12.30078125
12.0546875
4.109375
4.90625
1.1953125
0.796875


10064
12.9921875
14.45703125
14.80859375
5.73828125
5.421875
1.5234375
1.359375


10065
12.453125
6.51171875
9.1015625
4.12109375
5.48046875
1.03125
0.75


10069
15.76953125
14.50390625
14.8203125
5.90234375
6.18359375
2.296875
1.4296875


10070
9.8984375
8.99609375
10.77734375
2.45703125
15.96875
0.8203125
0.984375


10072
15.55859375
15.125
14.87890625
5.140625
3.60546875
1.3359375
0.9140625


10073
15.37109375
16.859375
20.57421875
7.5078125
46.75390625
4.03125
1.8984375


10074
11.1875
8.94921875
9.0078125
3.13671875
2.90234375
1.1015625
1.21875


10076
14.3515625
17.6328125
13.75390625
4.49609375
4.484375
2.0390625
1.171875


10078
19.21484375
14.7734375
15.2421875
6.078125
6.40625
1.875
1.1484375


10079
10.98828125
12.11328125
14.2109375
11.046875
5.22265625
2.2265625
1.9921875


10080
12.58203125
10.58984375
12.32421875
4.15625
19.30859375
0.8671875
0.4921875


10081
15.95703125
15.828125
18.55859375
7.4140625
5.24609375
1.4765625
1.0546875


10082
15.2890625
14.85546875
13.8359375
4.87109375
3.875
1.734375
0.515625


10083
10.89453125
10.6953125
10.33203125
4.15625
3.46484375
1.7109375
1.0546875


10084
14.65625
12.546875
12.20703125
4.8125
4.70703125
1.8046875
1.265625


10086
17.703125
17.234375
14.2578125
5.796875
4.28515625
0.84375
0.703125


10087
19.0625
26.41015625
19.47265625
7.23828125
7.40234375
1.2890625
0.796875


10089
12.5703125
11.64453125
10.6484375
5.03515625
8.2578125
1.96875
2.15625

















CN + 75tPA dAmax
CN + 150tPA dAmax
CFF dAmax
CFF + TXA dAmax




Patient ID
(mm)
(mm)
(mm)
(mm)
CRT LY30
CN LY30





10017
0.890625
0.8671875
0.375
0.2578125
0.06030463
0.016644911


10019
1.1953125
1.125
1.5
0.703125
0.018560257
0.022788509


10020
0.890625
0.8203125
0.5390625
0.5390625
0.030007206
0.014039481


10021
0.703125
0.375
2.484375
1.03125
−0.069673728
−0.032943886


10022
0.8203125
1.0546875
0.9375
0.796875
0.015688864
0.01108298


10023
0.9375
0.46875
1.03125
1.1953125
0.050798564
0.02016465


10024
0.9140625
1.078125
0.515625
0.421875
0.051351544
0.03619448


10026
0.9375
0.8203125
0.1640625
0.140625
0.0408322
0.045881663


10028
1.40625
1.40625
0.84375
0.8671875
0.036332229
0.01844581


10029
0.609375
0.421875
0.8671875
0.8671875
0.04213007
0.013138143


10031
1.0078125
0.890625
1.1953125
0.46875
0.075543799
0.097434874


10033
0.8671875
0.8203125
0.796875
0.75
0.026377517
0.018340861


10034
0.6328125
0.6796875
0.5625
0.375
0.033425663
0.02512734


10035
0.9375
1.0546875
0.8203125
0.6328125
0.020279463
0.02175914


10037
1.5
1.5
0.8671875
0.7734375
0.030046405
0.021488548


10038
0.515625
0.609375
0.9140625
1.0546875
0.026372114
−0.001829025


10040
0.4453125
0.6796875
0.9609375
0.890625
0.04965042
0.028593531


10041
1.03125
0.8203125
0.6328125
0.5625
0.041559335
0.021645254


10042
1.1953125
1.265625
0.8671875
0.703125
0.028059636
0.027165333


10043
0.984375
1.0078125
0.5859375
0.6796875
0.019282548
0.021101822


10045
0.75
0.703125
1.171875
0.75
0.010444722
0.012927694


10046
1.1484375
1.125
0.421875
0.328125
0.020347299
0.019610932


10048
1.1015625
1.2421875
0.9609375
1.1484375
0.020143973
0.015210808


10049
0.9375
0.8671875
0.5390625
0.375
0.040608237
0.031604588


10052
1.3125
0.7265625
0.796875
0.5859375
0.017503627
0.013801031


10053
1.1953125
1.125
0.65625
0.6796875
0.011311864
0.015675281


10054
0.703125
0.75
0.421875
0.421875
0.054953929
0.027473823


10055
1.0546875
1.1953125
1.1484375
0.9375
0.015969118
0.017118432


10058
1.125
1.03125
0.6796875
0.4921875
0.029763752
0.026953488


10062
0.8671875
0.890625
0.703125
0.65625
0.021739726
0.016778287


10064
1.5234375
1.4765625
1.1015625
1.078125
0.026595224
0.023099733


10065
0.9609375
1.03125
0.9140625
0.8203125
0.018600233
0.025373115


10069
1.6171875
1.453125
0.9140625
0.8671875
0.013138008
0.011164596


10070
0.9609375
1.0078125
0.4453125
1.078125
0.022669018
0.016251562


10072
1.171875
1.1015625
0.46875
0.4921875
0.026998812
0.019600661


10073
2.203125
5.0859375
1.171875
3.1640625
0.032281957
0.033183973


10074
1.5703125
1.3125
0.5859375
0.5390625
0.024875899
0.031321629


10076
1.078125
0.9609375
0.6796875
0.609375
0.045710899
0.028091361


10078
1.171875
1.078125
1.171875
0.984375
0.03587902
0.036731083


10079
2.1796875
2.296875
2.953125
1.2421875
0.012896383
0.004602465


10080
0.8203125
0.7734375
0.515625
3.1171875
0.028764003
0.019558275


10081
1.171875
1.0078125
0.9375
0.5859375
0.03960892
0.020360281


10082
0.6796875
0.5625
0.4453125
0.46875
0.03400434
0.026273852


10083
1.40625
1.5703125
1.03125
0.6328125
0.02385182
0.019988301


10084
1.3125
1.3828125
0.9375
0.9140625
0.009423337
0.021685821


10086
0.75
0.609375
0.75
0.5859375
0.036625251
0.023212273


10087
0.9609375
0.6328125
0.5390625
0.8671875
0.024173361
0.017043544


10089
2.2265625
1.453125
1.1015625
2.15625
0.020497577
0.025572178



















CN + 75tPA
CN + 150tPA

CFF + TXA


CN + 75tPA
CN + 150tPA


Patient ID
LY30
LY30
CFF LY30
LY30
CRT CL30
CN CL30
CL30
CL30





10017
0.081614091
0.569954211
−0.001500615
−0.048368991
0.883525708
0.958975634
0.768401438
0.002741604


10019
0.100859305
0.454886769
0.003487637
−0.009435011
0.957804934
0.950039651
0.691532258
0.013667768


10020
0.060452899
0.432118003
−0.003161484
−0.006205347
0.947320721
0.965350619
0.849068323
0.102351522


10021
−0.032157738
0.127611483
−0.006157125
−0.030527211
1.118334551
1.051256281
1.075
0.672909699


10022
0.011277198
0.026278403
0.04736335
0.043820077
0.962822854
0.970527592
0.967101828
0.933623225


10023
0.106925905
0.536037656
0.001784416
0.006433573
0.900829516
0.94966328
0.72179289
0.028103563


10024
0.432249981
0.633892143
0.02721235
0.135655746
0.900575288
0.918019386
0.019986496
0.003837609


10026
0.128821656
0.681686502
−0.007343165
−0.002573182
0.912031439
0.903495206
0.658717227
0.004701734


10028
0.070189301
0.48095455
−0.011132702
−0.006824796
0.936318165
0.970026942
0.773777413
0.004587775


10029
0.265292973
0.589190565
0.0284828
−0.018540186
0.911145474
0.962221156
0.398922273
0.00424854


10031
0.609129512
0.6387822
0.367293922
−0.005472394
0.79949463
0.741412336
0.002547771
0.003713159


10033
0.095054717
0.423588199
−4.86E−04 
−0.002458642
0.949741781
0.956710465
0.732236753
0.125857275


10034
0.18634948
0.60229057
0.013688821
0.013426129
0.931203298
0.947183099
0.460087083
0.007767477


10035
0.0364523
0.300278285
−0.013139777
−0.010031109
0.953667954
0.953899793
0.904203178
0.145705267


10037
0.062978323
0.313275214
0.001045534
0.001356773
0.942470588
0.956468764
0.834579439
0.129564782


10038
0.002257233
0.024505653
−0.004964088
−0.005459318
0.934087113
0.988006397
0.985962264
0.952716144


10040
0.079753038
0.362801457
−0.003030418
−0.015363551
0.906372841
0.931478882
0.806022187
0.176519846


10041
0.072059274
0.468926949
0.01875384
0.003831169
0.914002642
0.943570199
0.799179168
0.114254144


10042
0.159310139
0.555088509
6.02E−04
0.007616406
0.939492032
0.943042626
0.521192876
0.002822865


10043
0.340209296
0.615954158
−0.004230896
−0.006153312
0.954517211
0.947644618
0.184936401
0.004690832


10045
0.233396854
0.717038532
−0.026521072
−0.031434025
0.975311721
0.969577047
0.378203049
0.004873591


10046
0.229340172
0.645899307
−0.015154296
−0.010567847
0.953309228
0.952947766
0.37218845
0.003958436


10048
0.060154171
0.495028192
0.013921412
0.010570533
0.950428781
0.969546368
0.82712829
0.027286649


10049
0.075264933
0.473617858
7.89E−04
0.004389299
0.911823381
0.92887447
0.805864937
0.016139141


10052
0.157126695
0.32081578
−0.006094217
−0.007797413
0.956909684
0.972984992
0.563337606
0.26097561


10053
0.046222991
0.305119209
−0.011028306
−0.012549685
0.972473785
0.96362138
0.874260541
0.198237288


10054
0.167679483
0.604487059
0.017146639
0.007753048
0.889998686
0.934306569
0.543710351
0.00300075


10055
0.101571797
0.302263169
−0.002832652
−0.012365396
0.960823529
0.956111373
0.729655396
0.224957686


10058
0.492045474
0.728459911
0.010215637
0.009807596
0.934421805
0.93461794
0.015826675
0.003833253


10062
0.018351097
0.420841429
5.95E−04
−0.006456804
0.955436275
0.960178593
0.957121735
0.065704067


10064
0.078911616
0.501083179
5.00E−04
0.003245918
0.945577501
0.952060007
0.756800344
0.004366812


10065
0.662967521
0.860495292
−0.003749847
−0.016334626
0.956045461
0.947290773
0.002540489
0.003531229


10069
0.068198674
0.405900722
−0.021435512
−0.05345696
0.968898951
0.978569037
0.781553398
0.068803753


10070
0.166666052
0.620378916
0.027281701
0.026450448
0.955101384
0.963042314
0.493874539
0.003725656


10072
0.100680595
0.428920697
−0.005763529
0.001426519
0.937938168
0.952942607
0.690566499
0.006970128


10073
0.030185044
0.277177537
0.0096862
0.963302857
0.928463039
0.927038173
0.920555676
0.259249109


10074
0.480037116
0.733005689
0.043781786
0.007443196
0.937417099
0.921170912
0.017798947
0.002438281


10076
0.164391319
0.455341226
0.015017479
0.009141971
0.910869299
0.940808129
0.53002611
0.096232339


10078
0.051553756
0.569544199
0.005193271
0.007651688
0.927206135
0.920553501
0.851969909
0.002389129


10079
0.445629052
0.813086048
−0.057418699
−0.009947183
0.970925699
0.996073727
0.007710899
0.035209942


10080
0.224187202
0.704488199
0.030031525
−0.024219533
0.934737136
0.95048951
0.304102423
0.003391986


10081
0.024098689
0.183163642
0.006851246
0.018016738
0.918197183
0.949680511
0.948804272
0.434383528


10082
0.028358471
0.054769895
−0.160043689
−0.015227126
0.924934536
0.945744681
0.941184827
0.858544443


10083
0.277498451
0.702136449
0.020317892
0.010942952
0.945607252
0.953371772
0.251805855
0.002266289


10084
0.224975897
0.606549884
0.018206383
0.00716612
0.970905966
0.946845445
0.3472
0.0021748


10086
0.025188655
0.276866049
−0.109540649
−0.524623741
0.932175155
0.947470112
0.945094622
0.358550969


10087
0.044756847
0.265357348
−0.111567441
−0.048439778
0.95302088
0.964453308
0.880506092
0.307356444


10089
0.048802507
0.569068155
−0.004630295
0.004302772
0.950468211
0.941240126
0.836213803
0.002083062


















CFTX dV @ CFF max
CN dV @ CN + tPA75 max
CRT dA Integration to Acrit


Patient ID
CFF CL30
CFF + TXA CL30
(mm/min)
(mm/min)
(mm{circumflex over ( )}2)





10017
1
1.199683043
0
0.28125
21.30633545


10019
0.983984265
1.018192844
0.28125
0.5625
31.7411499


10020
1.00589198
1.015070328
0
0.140625
24.37976074


10021
1.015485687
1.071020408
0.140625
−0.140625
1.959411621


10022
0.90119131
0.909774436
0.28125
0.140625
8.127685547


10023
0.993456132
0.987755102
0
0.140625
146.5043335


10024
0.933497537
0.966793893
0.28125
0.421875
7.781616211


10026
1.001685393
0.996600567
0
0.421875
83.27911377


10028
1.014414924
1.010477299
0
0.140625
14.05371094


10029
0.917003419
1.042654028
0.140625
0.84375
87.20123291


10031
0.128238767
1.015619915
0.421875
0.984375
161.4298096


10033
1
1.012568482
0.140625
0.421875
15.75604248


10034
0.977255497
0.978956598
0.140625
0.84375
88.0713501


10035
1.018706157
1.016679905
0.140625
0.421875
20.97674561


10037
0.993502475
0.994298385
0
0.28125
20.60925293


10038
1.007125891
1.011338583
0.140625
0
46.12445068


10040
1.006355932
1.052509908
0
0.28125
73.39471436


10041
0.950239587
0.99109462
0.140625
0.421875
6.969177246


10042
1
0.99454347
0
0.421875
22.359375


10043
1.008300395
1.020230067
−0.140625
0.5625
31.41156006


10045
1.060284678
1.070204351
−0.140625
0.5625
110.9465332


10046
1.024469821
1.015929204
0
0.28125
4.541748047


10048
0.96672418
0.980969642
0.140625
0.28125
105.1243286


10049
0.992842942
0.990877498
0
0.28125
130.3511353


10052
1.011964108
1.014350252
0
0.28125
80.39025879


10053
1.016435707
1.02285525
0
0.140625
19.06677246


10054
0.973808658
0.992242335
0.140625
0.421875
106.6256104


10055
1.004087193
1.023573923
0
0.28125
76.30169678


10058
0.976147452
0.982008996
0.140625
0.703125
27.76794434


10062
1.011977887
1.016278327
0
0.140625
10.21893311


10064
1.018669528
0.999329009
−6.00E−15
0.140625
78.70770264


10065
1.005516734
1.029619182
0
1.265625
41.66015625


10069
1.087039046
1.212637363
−0.140625
0.140625
47.99816895


10070
0.95382526
0.947709163
0.140625
0.421875
11.39886475


10072
1.015567087
1.001055595
−0.140625
0.28125
169.7272339


10073
0.983117201
0.001582806
2.109375
0
266.918335


10074
0.867339022
0.99428789
0.140625
0.703125
13.6137085


10076
0.967523681
0.987967914
0.28125
0.5625
42.14959717


10078
0.998309859
0.991973841
0.140625
0.28125
104.5129395


10079
1.164487805
1.018108652
0.140625
0.5625
40.72576904


10080
0.944753747
1.316089226
0.140625
0.984375
80.52703857


10081
0.981234006
0.962223587
0.140625
0.140625
273.0470581


10082
1.481165049
1.103191048
0
0.140625
28.32495117


10083
0.961801242
0.988485694
0.140625
0.28125
34.64154053


10084
0.976790831
0.99552506
0.140625
0.140625
100.7177124


10086
1.363609291
2.398410175
0.28125
0.140625
128.4246826


10087
1.343873518
1.18296893
−0.140625
0.28125
138.6172485


10089
1.024151811
0.996706012
0.140625
0.140625
53.89782715














CN dA Integration to Acrit
CN + 75tPA dA Integration to Acrit
CN + 150tPA dA Integration to Acrit


Patient ID
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)





10017
94.42584229
128.0390625
101.446106


10019
176.0718384
131.9265747
77.90844727


10020
108.4432983
107.7000732
88.54925537


10021
10.69354248
22.64941406
6.423706055


10022
89.33532715
71.53582764
119.2175903


10023
175.1193237
96.00292969
48.77600098


10024
66.48486328
171.0027466
99.48999023


10026
72.15545654
69.8104248
50.5178833


10028
177.543457
192.3255615
163.6281738


10029
108.4235229
49.97900391
52.5201416


10031
104.6365356
95.62884521
86.88647461


10033
107.480896
101.4098511
85.96856689


10034
91.47601318
77.46844482
49.8883667


10035
93.51123047
68.41296387
68.36846924


10037
194.5535889
209.1115723
169.8145752


10038
64.14477539
73.65673828
75.53210449


10040
60.17816162
37.54193115
100.8495483


10041
111.1772461
30.91552734
69.57476807


10042
139.6043701
149.2036743
113.6920166


10043
120.5161743
126.173584
105.0518188


10045
121.7636719
73.59741211
55.30517578


10046
76.05780029
48.24041748
76.40222168


10048
179.8571777
184.911438
147.2590942


10049
96.63244629
91.41833496
94.50164795


10052
158.8392334
190.2095947
46.33209229


10053
161.8994751
101.8580933
103.1022949


10054
81.1038208
66.59692383
82.92810059


10055
120.0481567
55.00360107
129.8139038


10058
110.1373901
89.20019531
79.67834473


10062
93.27392578
81.41363525
100.6468506


10064
116.4210205
205.6195679
207.8245239


10065
77.69421387
48.6260376
74.17749023


10069
197.9401245
188.4710083
182.1873779


10070
91.3392334
58.20062256
104.883728


10072
128.9833374
158.1075439
152.0348511


10073
257.6453247
311.8577979
98.69732666


10074
120.9594727
96.13311768
108.487793


10076
142.8343506
103.7120361
111.0997925


10078
177.0441284
124.2784424
139.541748


10079
186.0320435
230.6552124
201.6463623


10080
36.67181396
79.13616943
87.91644287


10081
143.079895
147.1552734
149.0718384


10082
68.89086914
87.04962158
64.06237793


10083
100.2694702
137.142334
149.5794067


10084
178.5157471
151.3707275
155.8811646


10086
100.1524658
110.9432373
68.44262695


10087
140.5206299
191.46698
111.8084106


10089
196.9431152
151.2372437
114.6115723






















CFF dA
CFF + TXA dA












Integration to Acrit
Integration to Acrit


Patient ID
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)
ID
SBP
HR
OR?
ICU?
Death?
pRBC
FFP
PLT





10017
12.61669922
9.226867676
10017
80
116
Yes
Yes
No
0
0
0


10019
14.46240234
28.41064453
10019
86
90
Yes
Yes
No
0
0
0


10020
21.8897D947
22.59503174
10020
136
100
Yes
0
No
0
0
0


10021
57.74084473
9.508666992
10021
80
103
Yes
0
No
0
0
0


10022
8.803344727
6.862060547
10022
138
88
No
Yes
No
0
0
0


10023
45.24279785
76.33795166
10023
106
120
Yes
0
No
0
0
0


10024
17.62646484
8.737426758
10024
150
108
Yes
Yes
No
0
0
0


10026
0.278503418
1.496337891
10026
116
100
Yes
Yes
No
0
0
1


10028
24.4588623
26.37213135
10028
102
100
No
Yes
No
0
0
0


10029
30.09979248
31.25994873
10029
62
120
Yes
Yes
No
0
0
0


10031
1.105773926
15.78076172
10031
Uto
Uto
Yes
Yes
No
0
0
0


10033
42.42150879
34.27734375
10033
110
94
Yes
Yes
No
0
0
0


10034
3.371704102
7.218017578
10034
140
100
Yes
Yes
No
0
0
0


10035
34.21307373
14.93206787
10035
80
70
Yes
Yes
No
0
0
0


10037
34.14385986
33.68243408
10037
180
120
No
Yes
No
0
0
0


10038
30.17559814
40.28082275
10038
128
120
Yes
Yes
No
0
0
0


10040
53.66217041
27.57348633
10040
162
108
No
0
No
0
0
0


10041
18.02032471
15.65222168
10041
88
70
Yes
Yes
No
0
2
1


10042
24.84283447
19.11621094
10042
100
90
Yes
Yes
No
0
0
0


10043
29.10772705
26.66546631
10043
90
60
Yes
Yes
No
0
0
0


10045
70.72998047
37.99841309
10045
100
58
No
Yes
Yes
0
0
0


10046
7.864013672
5.115234375
10046
130
90
No
0
No
0
0
0


10048
56.56915283
80.21722412
10048
88
112
No
0
No
0
0
0


10049
16.1416626
9.149414062
10049
Walk-in
Walk-in
No
0
No
0
0
0


10052
34.28393555
21.70184326
10052
100
100
Yes
Yes
No
0
0
0


10053
20.61584473
28.09588623
10053
116
110
Yes
Yes
No
0
0
0


10054
15.07543945
13.2989502
10054
108
124
Yes
Yes
No
0
0
0


10055
59.88153076
55.71386719
10055
136
78
No
Yes
No
0
0
0


10058
26.85992432
11.59661865
10058
118
110
Yes
Yes
No
0
0
0


10062
23.73046875
25.08178711
10062
86
60
No
0
No
0
0
0


10064
56.35821533
51.12597656
10064
118
72
No
0
No
0
0
0


10065
31.25335693
38.93609619
10065
140
120
No
Yes
No
0
0
0


10069
48.08880615
39.92816162
10069
90
140
Yes
Yes
No
0
0
0


10070
8.679748535
20.0291748
10070
160
92
Yes
0
No
0
0
0


10072
17.0859375
14.16412354
10072
Unk
Unk
No
0
No
0
0
0


10073
62.96813965
963.953064
10073
156
114
Yes
Yes
No
0
0
0


10074
11.56365967
13.36651611
10074
81
100
Yes
Yes
No
0
0
0


10076
26.94232178
20.18408203
10076
170
60
Yes
Yes
No
0
0
1


10078
59.2701416
55.34472656
10078
96
60
Yes
Yes
No
0
0
0


10079
238.847168
49.64117432
10079
82
112
No
Yes
No
0
0
0


10080
15.51708984
96.45941162
10080
98
112
No
0
No
0
0
0


10081
61.43225098
24.95159912
10081
Walk-in
Walk-in
Yes
Yes
No
0
0
0


10082
18.13897705
11.51916504
10082
138
120
No
0
No
0
0
0


10083
38.19287109
19.47052002
10083
142
70
Yes
Yes
No
0
0
0


10084
42.3951416
29.05499268
10084
170
104
No
Yes
No
0
0
0


10086
35.31884766
18.47186279
10086
100
120
Yes
0
No
0
0
0


10087
32.47283936
53.8895874
10087
162
120
No
0
No
0
0
0


10089
50.00042725
125.1551514
10089
120
80
Yes
Yes
No
0
0
0













Patient ID
CRYO
CN Crit Prod





10017
0
10.65591431


10019
0
19.26974487


10020
0
14.20358276


10021
0
1.299224854
All tubes clotted


10022
0
10.35644531


10023
0
19.7460022


10024
0
7.946777344


10026
0
8.667755127


10028
0
20.61035156


10029
0
11.96841431


10031
0
13.73080444


10033
0
12.02883911


10034
0
10.41732788


10035
0
10.71533203


10037
0
21.703125


10038
0
8.049316406


10040
0
7.882781982


10041
0
13.16894531


10042
0
14.67919922


10043
0
14.03640747


10045
0
13.68823242


10046
0
8.567230225


10048
0
24.58374023


10049
0
10.72998047


10052
0
18.51928711


10053
0
16.95803833


10054
0
9.368865967


10055
0
14.01168823


10058
0
12.33078003


10062
0
11.54846191


10064
0
17.66125488


10065
0
9.33984375


10069
0
22.54550171


10070
0
9.743774414


10072
0
14.2215271


10073
0
29.18106079


10074
0
13.63476563


10076
0
16.8182373


10078
0
22.06704712


10079
0
21.89071655


10080
0
6.192718506


10081
0
16.8296814


10082
0
7.883422852


10083
0
11.49032593


10084
0
18.54931641


10086
0
12.44750977


10087
0
15.19042969


10089
0
27.10473633


















CRT Amax
CN Amax
CN + 75tPA Amax
CN + 150tPA Amax
CFF Amax
CFF + TXA Amax
CRT Acrit


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10092
67.90625
69.7578125
68.9140625
61.765625
21.40625
21.2890625
17.76171875


10094
64.671875
65.0703125
63.03125
58.7421875
26.1640625
24.8046875
2.48046875


10096
63.640625
65.1875
64.7421875
65.1875
24.6171875
24.8984375
18.40625


10098
59.703125
66.171875
62.5625
61.625
19.296875
19.953125
1.84765625


10100
66.734375
71.65625
67.6015625
54.125
26.0703125
26.65625
2.29296875


10101
63.0546875
66.6640625
64.1328125
55.25
24.3359375
24.3359375
2.1640525


10103
66.4296875
68.46875
63.7109375
45.484375
28.390625
26.65625
10.51953125


10105
56.7734375
60.4296875
62.140625
52.203125
26.5625
24.5
1.84765625


10108
52.2265625
65.375
58.765625
59
20.2578125
18.734375
1.35546875


10109
62.8671875
66.3828125
63.546875
58.8359375
24.359375
24.0546875
2.66796875


10110
65.84375
64.15625
66.78125
65.5625
22.7890625
21.9921875
1.6953125


10111
67.6015625
73.5078125
71.1875
68.6796875
26.6328125
26.65625
15.5703125


10112
82.1328125
62.5625
60.03125
54.4765625
29.2578125
0.125
11.8203125


10113
50.3046875
48.125
28.6015625
23.5625
15.9921875
14.65625
11.375


















CN Arit
CN + 75tPA Acrit
CN + 150tPA Acrit
CFF Acrit
CFF + TXA Acrit
CRT dAmax
CN dAmax


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10092
16.859375
16.70703125
14.65625
3.76953125
3.72265625
0.9609375
0.9375


10094
12.828125
14.29296875
15.53515625
6.25390625
6.21875
2.2734375
1.125


10096
16.15625
13.9765625
13.75390625
3.67578125
4.71875
0.984375
1.03125


10098
6.41796875
7.09765625
8.19921875
1.56640625
2.19921875
1.1953125
1.4296875


10100
13.15625
16.82421875
16.765625
4.390625
5.7734375
1.7578125
1.265625


10101
10.1796875
10.4609375
8.78515625
4.109375
3.91015625
1.40625
1.453125


10103
11.26953125
9.9453125
8.38671875
4.4375
27.875
1.3828125
1.4296875


10105
14.328125
15.18359375
12.8515625
5.609375
4.96484375
1.6640625
0.9375


10108
9.640625
10.15625
8.3515625
1.390625
2.0703125
0.9140625
1.3125


10109
14.10546875
9.7578125
10.49609375
2.92578125
3.72265625
1.8515625
1.1953125


10110
11.41015625
9.41796875
10.2734375
3.546875
3.359375
1.828125
1.0546875


10111
13.90625
11.8203125
14.84375
4.578125
4.89453125
1.78125
1.734375


10112
19.7890625
17.75
16.6953125
5.65625
0.16015625
3.84375
0.75


10113
14.57421875
12.0546875
0.359375
11.22265625
1.7890625
0.703125
0.3515625

















CN + 75tPA dAmax
CN + 150tPA dAmax
CFF dAmax
CFF + TXA dAmax




Patient ID
(mm)
(mm)
(mm)
(mm)
CRT LY30
CN LY30





10092
1.0546875
1.125
0.5390625
0.6328125
0.02308093
0.009447213


10094
1.0546875
1.1015625
1.0078125
0.890625
0.029986443
0.02516742


10096
1.03125
1.1015625
0.5390625
0.609375
0.02673739
0.023091276


10098
1.3359375
1.2421875
0.5390625
0.3984375
0.028060208
0.025009675


10100
1.0078125
0.984375
0.65625
0.703125
0.032283943
0.019990945


10101
1.359375
1.3828125
0.9375
0.8203125
0.023396867
0.017267276


10103
1.3125
0.7265625
1.125
1.921875
0.019735192
0.020560912


10105
1.2421875
1.453125
0.75
0.6796875
0.0298312
0.028208719


10108
1.359375
1.5
0.65625
0.375
0.021454126
0.024958008


10109
1.640625
1.3828125
0.8203125
0.7265625
0.022353396
0.012313169


10110
1.3359375
1.40625
0.84375
0.75
0.022358013
0.020903184


10111
1.734375
1.96875
1.078125
0.8203125
0.022739705
0.01260451


10112
0.5625
0.84375
0.890625
0.0703125
0.879012492
0.027216533


10113
0.234375
0.46875
4.1015625
0.28125
0.046618911
0.009909361



















CN + 75tPA
CN + 150tPA

CFF + TXA


CN + 75tPA
CN + 150tPA


Patient ID
LY30
LY30
CFF LY30
LY30
CRT CL30
CN CL30
CL30
CL30





10092
0.061420505
0.423262923
−1.74E−04
−0.029998471
0.95478601
0.973457274
0.8234894
0.033898305


10094
0.093868782
0.476873587
−0.017023738
−0.002700787
0.938390916
0.947052467
0.704015865
0.025269318


10096
0.022254736
0.04494031
0.002878275
−8.86E−04
0.94254849
0.94822627
0.946060094
0.883149569


10098
0.019210477
0.024390248
−0.011732456
−0.002473245
0.940722324
0.950413223
0.95467033
0.951698783


10100
0.064302843
0.563915151
−0.011968085
−0.023366468
0.93889019
0.960423027
0.812434994
0.002742494


10101
0.079153977
0.54122007
−0.005733012
−0.005837346
0.953537356
0.957810852
0.764648556
0.003959276


10103
0.068618434
0.441085434
0.011639684
−9.79E−04
0.955545102
0.951049749
0.800613121
0.050084034


10105
0.241447525
0.672740198
0.004960784
−0.00922619
0.934773634
0.940271493
0.317701785
0.002394493


10108
0.562259963
0.618193856
0.022240969
0.017528496
0.949289454
0.946223709
0.002127094
0.002118644


10109
0.035683892
0.524804696
−0.006783194
−2.86E−04
0.955635641
0.967517948
0.890828621
0.002124552


10110
0.021046184
0.180870505
0.016776178
0.009773535
0.940199336
0.954335119
0.955077211
0.406577693


10111
0.021232989
0.247648005
−0.016114207
−0.018321366
0.955622328
0.96779679
0.955553117
0.240700717


10112
0.072425928
0.479522205
0.002217401
0
0.001807286
0.932567433
0.805960437
0.014771261


10113
0.266667805
0.752061229
0.024084025
0.009252843
0.902624631
0.960064935
0.328871893
0.00530504


















CFTX dV @ CFF max
CN dV @ CN + tPA75 max
CRT dA Integration to Acrit


Patient ID
CFF CL30
CFF + TXA CL30
(mm/min)
(mm/min)
(mm{circumflex over ( )}2)





10092
1.048175182
1.153027523
0.140625
0.28125
155.1560669


10094
1.058226336
1.009448819
0
0.703125
41.04217529


10096
1.012377023
1.001882648
0.140625
0.28125
137.9168701


10098
1.025506073
1.002349256
−0.140625
0.140625
18.10931396


10100
1.042253521
1.110785463
0
0.28125
30.77545166


10101
1.013483146
1.009630819
0.140625
0.28125
24.70935059


10103
0.987616951
1.175849941
0.140625
0.140625
148.2346802


10105
0.990294118
1.015306122
0.140625
0.28125
21.95892334


10108
0.952564597
0.962468724
0.140625
0.703125
9.876159668


10109
1.011545863
1.000974342
−0.140625
0.140625
41.13446045


10110
0.977374014
0.988277087
0.28125
0.140625
19.80834961


10111
1.036960986
1.055392732
0
0.140625
248.6063232


10112
0.999198932
1
0
0.140625
332.9483643


10113
0.935515388
0.984008529
−0.140625
0.5625
74.6619873














CN dA Integration to Acrit
CN + 75tPA dA Integration to Acrit
CN + 150tPA dA Integration to Acrit


Patient ID
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)





10092
153.1142578
148.8806763
155.2236328


10094
112.9405518
119.8833618
155.0736694


10096
152.5968018
114.3511963
138.5315552


10098
85.04241943
88.23614502
99.55096436


10100
142.5476074
103.4598999
133.3125


10101
126.7272949
113.6920166
106.6964722


10103
139.7114868
101.5993652
47.87127686


10105
119.911377
157.7796021
169.5179443


10108
112.7658691
135.2076416
114.6643066


10109
152.0645142
124.2454834
133.0438843


10110
116.5907593
93.62493896
127.8973389


10111
218.4060059
173.4334717
267.8873291


10112
130.4747314
66.29699707
118.8896484


10113
36.29608154
14.78869529
0.046142578






















CFF dA
CFF + TXA dA












Integration to Acrit
Integration to Acrit


Patient ID
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)
ID
SBP
HR
OR?
ICU?
Death?
pRBC
FFP
PLT





10092
14.43109131
20.99981689
10092
210
128
No
0
No
0
0
0


10094
54.3147583
50.6184082
10094
128
100
Yes
Yes
No
0
0
0


10096
17.31170654
22.05615234
10096
100
96
Yes
Yes
No
0
0
0


10098
6.07598877
8.37322998
10098
108
112
No
Yes
No
0
0
0


10100
24.56433105
35.33862305
10100
Unk
Unk
Yes
0
No
0
0
0


10101
35.62536621
27.97064209
10101
110
110
Yes
0
No
0
0
0


10103
44.81103516
134.5023193
10103
123
92
No
0
No
0
0
0


10105
29.953125
20.06707764
10105
0
0
Yes
Yes
No
0
0
0


10108
8.041992187
7.827758789
10108
150
90
No
Yes
No
0
0
0


10109
18.23126221
18.26751709
10109
92
110
Yes
Yes
No
0
2
0


10110
25.58605957
21.515625
10110
100
92
Yes
Yes
No
0
0
0


10111
41.30090332
29.56256104
10111
115
70
No
Yes
No
0
0
0


10112
39.0135498
0.014831543
10112
210
142
No
Yes
No
0
0
0


10113
11.96575928
3.978149414
10113
110
110
No
Yes
No
0
0
0












Patient ID
CRYO
CN Crit Prod





10092
0
15.80566406


10094
0
14.43164063


10096
0
16.66113281


10098
0
9.175689697


10100
0
16.65087891


10101
0
14.7923584


10103
0
16.11190795


10105
0
13.43261719


10108
0
12.65332031


10109
0
16.86044312


10110
0
12.03414917


10111
0
24.11865234


10112
0
14.84179688


10113
0
5.123748779






















TABLE 5








CRT Amax
CN Amax
CN + 75tPA Amax
CN + 150tPA Amax
CFF Amax
CFF + TXA Amax


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10027
55.7421875
58.625
43.1328125
19.3203125
19.015625
16.859375


10036
44.75
28.953125
5.703125
4.578125
11.703125
13.578125


10013
40.671875
42.9453125
18.0546875
13.203125
18.21875
17.9140625


10099
31.0859375
10.7421875
3.2421875
0.921875
9.96875
5.9609375


10107
52.3203125
42.734375
30.9453125
22.6484375
16.0390625
16.5546875


10093
51.125
54.8984375
40.5546875
26.3046875
12.3828125
13.6484375


10044
21.6171875
20.984375
14.0703125
2.1171875
4.5546875
9.453125


10068
47.84375
48.3359375
33.03125
16.9296875
7.4140625
10.8359375


10030
61.2265625
64.5078125
47.2578125
33.59375
22.015625
23.421875


10077
52.6015625
55.484375
51.0546875
40.765625
16.2265625
15.8046875


10075
46.203125
53.421875
44.8671875
27.6640625
21.0078125
19.7421875


10090
46.671875
45.6171875
31.859375
19.15625
9.0546875
10.203125


10059
60.6875
55.5546875
41.4453125
30.265625
15.1953125
18.03125


10061
52.8359375
58.7421875
55.15625
33.9921875
23.3046875
22.2734375


10097
50.5859375
56.7265625
52.6953125
32.1171875
19.1328125
16.8828125


10025
62.234375
70.203125
64.4375
51.8984375
22.765625
23.1640625


10050
53.4453125
59.8671875
53.9375
32.9609375
19.9765625
18.921875


10060
61.7890625
46.2734375
54.5
38.1171875
23
15.1484375


10032
59.7734375
61.6953125
52.6015625
45.9921875
20.9140625
19.4140625


10106
33.5
36.5
30.40625
12.453125
6.875
6.546875


10063
48.59375
64.7890625
63.3828125
53.375
23.0234375
21.640625


10088
63.5
59.984375
60.8046875
49.9296875
20.6796875
20.5625


10102
55.25
61.34375
48.4765625
22.6953125
10.71875
11.0703125


10115
72.5703125
70.5546875
68.7734375
51.5
27.8046875
27.640625


10014
62.515625
65.0234375
62.3046875
49.578125
18.640625
22.3671875


10085
64.0390625
69.453125
65.9609375
58.3671875
21.8984375
21.7109375


10047
62.703125
69.171875
61.015625
42.3828125
23.8203125
24.59375


10051
66.078125
68.65625
66.1015625
38.2109375
25.15625
24.078125


10056
61.859375
70.6015625
58.90625
52.4609375
25.578125
28.4609375


10057
67.5078125
68.1640625
64.15625
57.03125
25.6015625
26.46875


10039
65.09375
67.1796875
62.84375
56.2109375
21.96875
22.0859375


10067
58.484375
61.1328125
52.7890625
44.609375
22.203125
21.8046875


10071
55.2265625
56.703125
0.125
19.9765625
14.234375
13.390625


10104
64.4609375
68
64.0859375
65.6796875
27.171875
26.234375


10001
56.84375
55.625
52.2265625
41.75
21.1953125
20.28125


10002
63.03125
64.2734375
63.921875
58.203125
26.28125
25.578125


10003
66.6875
67.53125
60.8046875
44.6796875
26.2578125
25.0859375


10004
46.203125
34.203125
22.7890625
16.6015625
14.9609375
20.984375


10005
56.5625
60.359375
58.7890625
47.796875
27.5234375
26.2578125


10006
63.8515625
62.2109375
59.0234375
39.4765625
23.7265625
23.4921875


10007
61.953125
65.5625
59.3515625
52.296875
35.75
25.0625


10008
70.1796875
60.734375
48.5703125
35.703125
32.46875
27.640625


10009
71.5390625
70.4375
65.9609375
48.828125
29.5859375
29.2109375


10010
59.046875
61.5078125
57.7109375
48.7578125
21.875
21.2890625


10011
68.4453125
66.03125
59.1640625
54.3828125
25.296875
24.5703125


10012
52.015625
46.7890625
32.4453125
26.5625
17.7734375
19.53125


10015
68.6796875
69.359375
64.5078125
54.8984375
27.5
25.6953125


10017
59.5625
62.84375
58.6953125
45.59375
21.171875
19.71875

















CRT Acrit
CN Arit
CN + 75tPA Acrit
CN + 150tPA Acrit
CFF Acrit
CFF + TXA Acrit


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10027
0.86328125
9.69921875
11.890625
7.44921875
1.49609375
1.53125


10036
1.25
10.75390625
2.7265625
3.67578125
1.61328125
1.56640625


10013
1.73046875
8.515625
7.578125
6.21875
4.1328125
4.390625


10099
0.76953125
6.6640625
2.0703125
0.2421875
0.6875
0.23046875


10107
1.625
7.07421875
9.37109375
7.61328125
1.37890625
2.234375


10093
1.53125
10.0390625
9.04296875
8.515625
1.26171875
1.0859375


10044
0.59375
6.16015625
2.80859375
1.54296875
0.359375
1.484375


10068
12.48828125
13.0859375
6.58203125
8.66796875
0.3125
32.9140625


10030
1.8359375
12.7578125
12.41796875
13.7890625
5.4453125
4.37890625


10077
1.82421875
8.0703125
5.50390625
6.18359375
1.015625
1.0390625


10075
3.04296875
5.3515625
7.015625
6.60546875
3.8984375
3.23046875


10090
5.05859375
9.83984375
9.3359375
6.51171875
1.15625
0.359375


10059
1.16796875
15.3359375
13.63671875
13.63671875
2.38671875
2.01171875


10061
15.78125
14.140625
11.84375
12.1015625
4.671875
5.1875


10097
1.16796875
9.4296875
7.77734375
8.140625
3.3828125
1.015625


10025
1.9296875
10.26171875
12.81640625
9.58203125
4.4140625
3.41796875


10050
12.03125
9.98046875
9.8984375
8.76171875
2.3984375
2.515625


10060
1.7890625
5.66796875
14.796875
10.4609375
4.16796875
3.69921875


10032
12.76953125
13.14453125
12.6640625
13.625
3.3828125
2.64453125


10106
0.9921875
4.84765625
5.234375
3.7578125
0.40625
0.4296875


10063
1.35546875
9.46484375
7.7890625
8.48046875
2.41015625
2.22265625


10088
13.51953125
16.61328125
16.015625
14.8671875
39.0546875
3.34765625


10102
14.0703125
12.6875
12.18359375
8.62109375
26.78515625
0.37109375


10115
12.91015625
17.87890625
17.328125
16.8125
4.16796875
4.23828125


10014
1.7421875
10.37890625
9.7578125
13.47265625
3.4765625
3.9921875


10085
1.68359375
13.16796875
12.27734375
13.4609375
4.07421875
4.40234375


10047
10.44921875
13.296875
13.19140625
13.6484375
5.421875
4.37890625


10051
2.0703125
14.26953125
15.1484375
14.57421875
5.55078125
4.25


10056
2.9609375
10.66015625
10.25
12.67578125
3.95703125
6.2890625


10057
3.2421875
11.65625
10.91796875
11.52734375
4.44921875
5.7265625


10039
2.38671875
12.875
9.6171875
10.28515625
1.6015625
2.99609375


10067
16.5546875
12.3359375
11.5859375
12.62890625
43.54296875
3.5703125


10071
0.79296875
9.3125
0.125
9.265625
2.3046875
2.046875


10104
2.890625
11.73828125
9.81640625
10.91796875
5.421875
4.91796875


10001
1.73046875
13.00390625
13.96484375
9.8046875
3.3828125
2.984375


10002
17.9375
14.3984375
12.34765625
12.95703125
3.93359375
4.47265625


10003
6.0546875
16.015625
15.16015625
14.0703125
6.3828125
6.1015625


10004
0.828125
16.25
10.51953125
5.234375
2.9609375
1.16796875


10005
1.3203125
11.84375
11.83203125
11.15234375
2.41015625
1.625


10006
1.8828125
14.97265625
13.80078125
10.390625
4.42578125
4.859375


10007
2.140625
11.84375
8.94921875
12.65234375
14.17578125
4.390625


10008
6.11328125
14.10546875
18.55859375
15.34765625
8.9609375
6.8046875


10009
8.55078125
19.51953125
21.13671875
15.55859375
5.03515625
6.453125


10010
34.51953125
10.42578125
12.91015625
10.3671875
4.82421875
3.13671875


10011
8.71484375
13.05078125
13.40234375
13.70703125
5.31640625
5.22265625


10012
1.7421875
12.03125
9.58203125
11.15234375
2.0234375
1.96484375


10015
1.77734375
14.97265625
16.00390625
14.22265625
6.265625
5.36328125


10017
1.96484375
13.77734375
15.2421875
13.02734375
3.78125
3.65234375

















CRT dAmax
CN dAmax
CN + 75tPA dAmax
CN + 150tPA dAmax
CFF dAmax
CFF + TXA dAmax


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10027
0.7734375
1.0078125
0.9375
0.8203125
0.8203125
0.28125


10036
1.078125
0.4921875
0.1875
0.1640625
1.1015625
0.2578125


10013
1.1484375
0.5625
0.515625
0.609375
0.5625
0.421875


10099
0.5390625
0.140625
0.09375
0.046875
0.515625
0.1171875


10107
0.795875
0.4453125
0.5859375
0.7265625
0.7265625
0.46875


10093
0.84375
0.84375
0.8203125
0.84375
0.3515625
0.234375


10044
0.421875
0.3046875
0.3515625
0.0703125
0.1875
0.28125


10068
0.4921875
0.515625
0.5859375
0.4921875
0.140625
0.140625


10030
1.171875
1.40625
1.4765625
1.3125
0.796875
0.8671875


10077
1.5703125
0.9375
1.0546875
1.2421875
0.703125
0.65625


10075
1.7578125
1.03125
1.078125
1.0546875
0.75
0.6328125


10090
0.5390625
0.4921875
0.46875
0.4921875
0.140625
0.234375


10059
1.0078125
0.703125
0.7265625
0.6796875
0.2578125
0.2109375


10061
1.545875
1.078125
1.125
0.984375
0.796875
0.65625


10097
0.9140625
0.9375
1.1953125
0.890625
1.03125
0.703125


10025
1.734375
1.6640625
1.6171875
1.6640625
0.9375
0.9609375


10050
0.75
1.0546875
1.078125
1.0078125
0.515625
0.421875


10060
1.734375
0.3046875
0.890625
0.984375
0.7734375
0.3046875


10032
1.0546875
1.0546875
1.078125
1.078125
0.703125
0.5859375


10106
0.5625
0.3984375
0.375
0.421875
0.140625
0.234375


10063
1.0078125
1.1953125
1.125
1.1953125
0.4453125
0.3515625


10088
0.8671875
0.6328125
0.65625
0.703125
0.5625
0.3515625


10102
0.515625
0.65625
0.5859375
0.5859375
0.1640625
0.2109375


10115
0.8671875
0.7734375
0.890625
0.65625
0.6796875
0.7265625


10014
0.9375
1.1953125
1.40625
0.5859375
0.609375
0.609375


10085
1.6171875
1.4296875
1.4296875
1.265625
1.0546875
0.7265625


10047
7.3828125
1.265625
1.4296875
1.171875
0.609375
0.7265625


10051
1.359375
1.4765625
1.78125
0.9609375
0.8203125
0.609375


10056
1.6875
1.4296875
1.3125
1.2890625
0.7265625
1.125


10057
1.875
1.921875
1.8984375
1.8984375
0.9609375
1.078125


10039
1.2890625
1.03125
1.265625
1.2421875
0.796875
0.7734375


10067
0.75
0.75
0.5625
0.8203125
39.2578125
0.5625


10071
0.7265625
0.515625
0
0.515625
0.234375
0.1875


10104
1.545875
1.3359375
1.7109375
1.6171875
0.984375
0.9140625


10001
1.4296875
0.6796875
0.7265625
0.65625
0.46875
0.515625


10002
0.75
0.984375
1.1484375
1.0078125
0.5390625
0.4921875


10003
1.40625
1.078125
1.3359375
1.3125
0.984375
0.84375


10004
0.703125
0.515625
0.5390625
0.46875
0.75
0.5859375


10005
1.03125
0.984375
1.0546875
1.0078125
1.8515625
1.3125


10006
1.546875
0.9609375
1.1484375
1.21875
0.7734375
0.5625


10007
1.453125
1.171875
1.2890625
1.1953125
2.0859375
0.84375


10008
1.3828125
0.6796875
0.4453125
0.5390625
0.9375
0.609375


10009
1.5703125
1.1015625
1.0078125
0.8671875
0.7265625
0.75


10010
2.2734375
1.0546875
1.1015625
1.078125
0.8203125
1.5703125


10011
1.4296875
0.8671875
0.8671875
1.1484375
0.5390625
0.4921875


10012
0.9375
1.03125
1.0078125
0.9140625
1.5
1.2890625


10015
1.2890625
1.0546875
1.0546875
0.9140625
0.5625
0.5859375


10017
1.3359375
0.7734375
0.890625
0.8671875
0.375
0.2578125





















CN + 75tPA
CN + 150tPA

CFF + TXA




Patient ID
CRT LY30
CN LY30
LY30
LY30
CFF LY30
LY30
CRT CL30
CN CL30





10027
0.032181149
0.036531072
0.610296293
0.877309947
0.001396878
−0.018850402
0.912123336
0.934834755


10036
0.620687849
0.570174492
0.883573059
0.90988339
0.723025145
−0.033342923
0.003840782
0.007555316


10013
0.122440453
0.17333015
0.764863695
0.920766765
0.18963098
−0.028770534
0.593161736
0.525195561


10099
0.700512063
0.676866667
0.862426372
0.803248588
0.741447884
−0.040334207
0.005529027
0.022545455


10107
0.206567617
0.301307892
0.721292673
0.869580028
0.486720653
−0.010193487
0.418545617
0.257952468


10093
0.157658839
0.205500806
0.659639012
0.875379913
0.443278128
−0.036288399
0.524144254
0.459086381


10044
0.795071377
0.8215557
0.874518786
0.844049815
0.814686964
−0.038434343
0.005782436
0.007073716


10068
0.413549604
0.333138705
0.684876616
0.863611367
0.646364594
−0.02922074
0.111365121
0.201390011


10030
0.049018013
0.048666115
0.5668166
0.87458624
0.190315235
−0.015613187
0.874441751
0.840135642


10077
0.104187707
0.107589411
0.630032517
0.814858822
0.300028085
0.030363322
0.632407545
0.656153196


10075
0.013590398
0.005073974
0.66195731
0.882000141
−0.01578034
−0.017857143
0.97717281
0.983767183


10090
0.273513001
0.251932409
0.654669364
0.873151169
0.479155882
−0.01954441
0.329092735
0.370097619


10059
0.403412504
0.205224691
0.634131061
0.750124763
0.628603256
−0.01975195
0.048403708
0.434256785


10061
0.01238212
0.016334176
0.341356822
0.715671685
0.025839479
0.022295783
0.976489723
0.968080862


10097
0.013837838
0.020287418
0.295816654
0.749214506
−0.006116442
−0.006813975
0.967567568
0.959096543


10025
0.020103147
0.020015858
0.301405728
0.60935634
0.018522173
0.001226813
0.951041928
0.950255954


10050
0.017763607
0.016338611
0.239333478
0.692515011
−0.002336723
−0.001073493
0.960532086
0.967506199


10060
0.033260983
−0.087673758
0.297550929
0.694521589
0.009783552
−0.057673629
0.937792388
1.141820024


10032
0.079844138
0.07552534
0.051217676
0.417378452
−0.010187088
−0.006750503
0.859234087
0.875775611


10106
0.037628265
0.009302761
0.455055955
0.935377457
0.003082386
−0.075740851
0.907649254
0.969820205


10063
0.036809352
0.00174796
0.006560459
0.550600117
−0.008719319
−0.015025572
0.932958199
0.987338719


10088
0.033335384
0.038860489
0.074793888
0.391418053
0.013625488
−0.012183384
0.926181102
0.90974212


10102
0.013800905
0.004507344
0.562845152
0.848988812
5.16E−04
0.005384027
0.972002262
0.984717269


10115
−9.07E−04
0.00166233
0.072674562
0.491382863
−0.014777091
−0.013430375
0.99515556
0.991030894


10014
0.036194424
0.0174196
0.016686346
0.239035744
−0.001005868
9.21E−04
0.930642339
0.961792623


10085
0.012515249
0.014965317
0.019434574
0.426500617
−0.00628196
0.00456849
0.971818958
0.965579303


10047
0.015036548
0.023598091
0.31609724
0.653241935
0.028920684
0.002780866
0.961126339
0.940027106


10051
0.051359495
0.036818989
0.129969698
0.588880654
0.003277692
0.00937838
0.900685741
0.916021848


10056
0.040883465
0.030727841
0.049351606
0.304203276
0.009619986
6.10E−04
0.918161152
0.934270222


10057
0.02123211
0.019522923
0.097372578
0.54744863
0.002834147
0.001678309
0.952088879
0.952893983


10039
0.030087314
0.021265554
0.065426612
0.356663192
−8.83E−04 
0.001954369
0.937710034
0.951157111


10067
0.024026887
0.023099042
0.127341193
0.52226187
−0.089839901
−0.023327959
0.949104996
0.947476038


10071
0.029964163
0.015405989
1
0.823419372
0.074108123
0.010054454
0.913000424
0.946266189


10104
0.02263059
0.016736079
0.473321752
0.343410253
0.015296147
0.009525346
0.954550964
0.960018382


10001
0.044339839
0.035448853
0.125558464
0.574256955
0.003027092
0.014933231
0.905992303
0.920365169


10002
0.020561684
0.01556089
0.025736373
0.048507271
−0.026026803
−0.025764865
0.952032722
0.970827762


10003
0.023201246
0.02049543
0.285959784
0.639335257
3.64E−04
−0.006207827
0.950445173
0.953840814


10004
0.673048416
0.667148241
0.766353845
0.823688235
0.835254569
−0.004840428
0.004734528
0.005025126


10005
0.06026761
0.049426
0.075513843
0.383931977
−0.028563488
−0.02444461
0.87859116
0.892052809


10006
0.034280048
0.006880259
0.121344584
0.527154661
0.009525573
0.010931438
0.93723235
0.979279166


10007
0.014223939
0.015482503
0.175179896
0.483857435
−0.017598157
−0.017704437
0.970870113
0.968898951


10008
0.040747338
0.03000636
0.186974559
0.347914843
−0.022982836
−0.014046307
0.914505176
0.936712117


10009
0.026999381
0.014878642
0.07481
0.452688
0.003454802
4.71E−04
0.941683958
0.963065661


10010
0.034516958
0.035916
0.153788562
0.578757411
−0.007364583
7.22E−04
0.926964806
0.919979677


10011
0.023568783
0.021000454
0.034518465
0.19155214
−0.013607937
−0.027164812
0.945896587
0.949952674


10012
0.490499524
0.474602744
0.691469018
0.849708333
0.680998168
−0.020095
0.024932412
0.07380197


10015
0.021365601
0.017188087
0.094819042
0.270578957
−0.007755682
−0.005489257
0.950176317
0.959788241


10017
0.06030463
0.016644911
0.081614091
0.569954211
−0.001500615
−0.048368991
0.883525708
0.958975634




















CFTX dV @ CFF max


Patient ID
CN + 75tPA CL30
CN + 150tPA CL30
CFF CL30
CFF + TXA CL30
(mm/min)





10027
0.003984785
0.006469875
0.98767461
1.029193698
0


10036
0.021917808
0.027303754
0.010680908
1.058688147
0.421875


10013
0.008221549
0.011242604
0.428816467
1.064108155
0.28125


10099
0.038554217
0.13559322
0.202978056
1.086500655
0.28125


10107
0.004039384
0.007588824
0.054554311
1.022652194
0.421875


10093
0.003660181
0.004752005
0.14637224
1.077275329
0.140625


10044
0.010549695
0.05904059
0.027444254
1.084297521
0.28125


10068
0.005203406
0.007383479
0.035827187
1.080028839
0.5625


10030
0.003636965
0.004418605
0.444286728
1.030020013
0.140625


10077
0.002448355
0.003066309
0.254694271
0.922886802
0.28125


10075
0.002786
0.004518498
1.033469691
1.035615354
0


10090
0.00980873
0.006525285
0.119930975
1.036753446
0.28125


10059
0.003016023
0.004130098
0.028277635
1.035095321
0.28125


10061
0.085127479
0.003677316
0.954743547
0.967379867
0.140625


10097
0.217642698
0.003891997
1.013474888
1.011105969
0


10025
0.20271581
0.00240855
0.963967056
0.998988196
0.140625


10050
0.334733488
0.003792368
1.0023465
1.002477291
0


10060
0.236238532
0.003279361
0.991847826
1.103661681
0.140625


10032
0.882370414
0.040428062
1.016809862
1.014486922
0


10106
0.063463515
0.010037641
0.928409091
1.132458234
0


10063
0.974855171
0.00234192
1.00916186
1.022743682
0


10088
0.789926763
0.08699734
0.984132981
1.036474164
0.140625


10102
0.002578566
0.005507745
1.008746356
0.993648553
0


10115
0.776780643
0.017445388
1.048890138
1.028829847
0.140625


10014
0.966520376
0.34714781
1.015088013
0.996856444
0


10085
0.957005804
0.040289118
1.019265073
0.994602375
0


10047
0.18950064
0.002949309
0.914398163
0.999047014
0.140625


10051
0.617421109
0.013085259
0.999068323
0.985399091
0


10056
0.842838196
0.175725987
0.978924863
1.000823497
0.140625


10057
0.667924988
0.003013699
0.995422643
1.001770956
0


10039
0.806439582
0.131063238
0.997866287
0.997877609
0


10067
0.636821074
0.004378284
1.329345531
1.064493013
−0.140625


10071
1
0.009777083
0.761251372
0.982497083
0.140625


10104
0.007070584
0.101463066
0.9706728
0.991066111
0.140625


10001
0.639192221
0.003555389
0.990047917
0.969953775
0


10002
0.939868003
0.883221477
1.070451843
1.076053757
0


10003
0.20441989
0.003322259
0.998214817
1.026160075
0.140625


10004
0.005485087
0.007529412
0.008355091
1.048026806
0.84375


10005
0.809435216
0.128636809
1.04513199
1.037488843
0.140625


10006
0.615618795
0.003166436
0.981231478
0.983039574
0.140625


10007
0.515861524
0.023453839
1.029501748
1.04021197
0.421875


10008
0.529515844
0.214223195
1.054860443
1.038157151
0


10009
0.794978088
0.02848
0.995246897
1.005616475
0.140625


10010
0.568701773
0.005447845
1.0225
1.008807339
0


10011
0.914828998
0.496624048
1.03428042
1.072496025
0


10012
0.003852637
0.004705882
0.007032967
1.0348
0.5625


10015
0.737313794
0.369005265
1.025568182
1.020979021
0


10017
0.768401438
0.002741604
1
1.199683043
0














CN dV @ CN + tPA75 max
CRT dA Integration to Acrit
CN dA Integration to Acrit


Patient ID
(mm/min)
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)





10027
0.84375
4.167663574
85.9520874


10036
3.65625
3.351928711
35.29083252


10013
2.953125
0.851989746
30.48376465


10099
1.6875
0.16973877
7.577270508


10107
1.546875
0.385620117
19.28265381


10093
1.265625
0.853637695
56.30053711


10044
1.96875
0.402099609
18.49493408


10068
1.96875
55.67266846
57.52990723


10030
1.96875
0.866821289
124.614624


10077
0.84375
0.374084473
54.78771973


10075
0.84375
45.57073975
46.79187012


10090
1.40525
13.43243408
25.65362549


10059
1.546875
1.507873535
84.42773438


10061
0.140625
158.5063477
129.7397461


10097
0.28125
7.57232666
77.203125


10025
0.421875
24.0534668
150.218811


10050
0.28125
71.05297852
81.03790283


10060
0.84375
21.12670898
14.2399292


10032
0.5625
144.5267944
95.99468994


10106
0.5625
4.676879883
18.36639404


10063
0.140625
10.36724854
70.71185303


10088
0.140625
108.4498901
94.48846436


10102
0.984375
60.84887695
56.65649414


10115
0.28125
85.81365967
121.9993286


10014
0
13.54943848
111.3931274


10085
0.140625
18.49822998
173.6295776


10047
0.5625
685.0376587
147.9067383


10051
0.28125
22.11547852
186.1671753


10056
0.421875
44.68249512
126.6663208


10057
0.140625
50.58215332
200.618042


10039
0.28125
27.48944092
123.7412109


10067
0.421875
130.4022217
79.40478516


10071
1.125
3.468933105
37.39196777


10104
0.703125
40.84606934
138.3964233


10001
0.28125
18.53118896
75.84356689


10002
0.421875
33.03479004
134.4034424


10003
0.84375
88.00708008
157.7351074


10004
3.65625
0.405395508
75.09375


10005
0.28125
10.16784668
105.791748


10006
0.28125
22.12866211
92.40875244


10007
0.421875
25.69812012
125.6231689


10008
0.421875
79.16253662
75.42169189


10009
0.28125
126.6432495
176.0454712


10010
0.421875
342.4257202
90.99481201


10011
0.140625
120.1107788
102.0822144


10012
2.671875
1.974243164
84.82324219


10015
0.140625
16.7744751
146.3724976


10017
0.28125
21.30633545
94.42584229














CN + 75tPA dA Integration to Acrit
CN + 150tPA dA Integration to Acrit
CFF dA Integration to Acrit


Patient ID
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)





10027
101.4642334
45.04669189
10.11346436


10036
3.318969727
5.532165527
5.04107666


10013
26.18261719
28.65124512
2.231323242


10099
1.272216797
0.019775391
0.260375977


10107
41.2300415
48.57000732
0.393859863


10093
62.28094482
61.1685791
0.271911621


10044
7.592102051
0.552062988
0.052734375


10068
26.35565186
37.64080811
0.046142578


10030
154.8099976
178.7167969
18.28894043


10077
52.32073975
70.82391357
0.283447266


10075
69.48083496
39.81280518
29.9630127


10090
35.08813477
22.11383057
0.177978516


10059
79.0010376
80.16778564
2.480163574


10061
115.2773438
100.2183838
35.8560791


10097
74.16265869
68.04382324
30.8001709


10025
161.7544556
138.9138794
38.51916504


10050
91.74462891
71.90496826
11.390625


10060
119.973999
86.43164063
25.09991455


10032
120.9364014
131.7700195
20.671875


10106
10.99182129
13.90209961
0.385620117


10063
78.4588623
91.31121826
10.2288208


10088
91.61279297
64.3458252
49.21435547


10102
65.57684326
44.1897583
19.89239502


10115
85.35388184
97.12023926
19.7210083


10014
118.4084473
66.15362549
15.51049805


10085
155.5900024
159.0864258
35.84454346


10047
162.7630005
143.6055908
25.88598633


10051
231.9521484
107.1282349
40.11602783


10056
54.03625488
143.7094116
25.6206665


10057
164.661438
188.5501099
38.38238525


10039
88.77832031
101.6867065
10.98852539


10067
48.34094238
90.79046631
103.7993774


10071
0
39.15856934
4.624145508


10104
144.7278442
159.5033569
47.8861084


10001
60.63299561
53.13317871
13.2989502


10002
122.3388062
120.6018677
17.91815186


10003
175.6664429
143.7802734
55.2557373


10004
51.08477783
17.79125977
7.280639648


10005
104.5079956
97.47784424
35.14910889


10006
124.972229
106.2235107
32.91778564


10007
73.32220459
135.4202271
273.8776245


10008
47.03411865
63.8102417
73.72595215


10009
181.0288696
114.6494751
28.65618896


10010
116.6401978
93.13879395
35.91375732


10011
104.9727173
72.57733154
25.35040283


10012
82.31671143
86.3838501
19.26452637


10015
146.1582642
81.92449951
29.44885254


10017
128.0390625
101.446106
12.61669922























CFF + TXA dA














Integration to Acrit


Patient ID
(mm{circumflex over ( )}2)
ID
SBP
HR
OR?
ICU?
Death?
pRBC
FFP
PLT
CRYO
CN Crit Prod





10027
4.268188477
10027
150
Unk
Yes
Yes
Yes
61
12
2
6
9.774993896


10036
3.314025879
10036
0
0
Yes
Yes
No
32
8
3
4
5.292938232


10013
16.37072754
10013
96
100
Yes
Yes
Yes
29
16
5
0
4.790039063


10099
0.087341309
10099
80
120
Yes
Yes
Yes
27
12
4
6
0.937133789


10107
9.271362305
10107
0
130
Yes
Yes
Yes
24
13
2
2
3.150238037


10093
0.557006836
10093
70
140
Yes
Yes
No
23
12
2
2
8.470458984


10044
3.348632813
10044
140
93
Yes
Yes
No
21
12
1
1
1.876922607


10068
18.60534668
10068
160
70
No
Yes
Yes
14
12
2
1
6.747436523


10030
30.75897217
10030
180
40
Yes
Yes
Yes
12
8
2
1
17.94067383


10077
5.164672852
10077
0
110
Yes
Yes
No
11
4
1
0
7.565917969


10075
18.2477417
10075
100
100
Yes
Yes
No
9
4
2
0
5.518798828


10090
0.411987305
10090
Unk
Unk
Yes
Yes
No
9
4
2
2
4.843048096


10059
3.093200684
10059
180
150
Yes
Yes
Yes
8
6
1
2
10.78308105


10061
32.24707031
10061
108
112
Yes
Yes
No
7
6
2
0
15.24536133


10097
5.164672852
10097
104
130
Yes
Yes
No
7
4
1
0
8.840332031


10025
28.14532471
10025
204
102
Yes
Yes
Yes
6
4
1
1
17.07614136


10050
10.31945801
10050
107
89
Yes
Yes
No
6
4
1
0
10.52627563


10060
8.211730957
10060
70
112
Yes
Yes
No
6
3
0
0
1.726959229


10032
13.52142334
10032
0
0
Yes
Yes
No
5
6
1
0
13.8633728


10106
0.639404297
10106
0
122
Yes
Yes
No
5
3
0
0
1.931488037


10063
6.98236084
10063
80
100
Yes
Yes
No
4
2
1
0
11.31344604


10088
11.0725708
10088
102
110
Yes
Yes
No
4
4
1
0
10.51309204


10102
0.430114746
10102
122
90
Yes
Yes
Yes
4
5
2
2
8.326171875


10115
26.19085693
10115
102
130
Yes
Yes
<28 d
4
4
2
0
13.82821655


10014
20.10827637
10014
80
110
Yes
Yes
No
3
1
0
0
12.40603638


10085
24.3583374
10085
132
108
Yes
Yes
No
3
0
0
0
18.82608032


10047
27.24554443
10047
0
120
Yes
Yes
No
2
1
0
0
16.82885742


10051
22.52087402
10051
110
124
Yes
Yes
No
2
0
0
0
21.06985474


10056
60.17321777
10056
108
100
Yes
Yes
No
2
0
0
0
15.24069214


10057
52.54980469
10057
90
130
Yes
Yes
No
2
2
0
0
22.40185547


10039
21.26019287
10039
140
120
Yes
Yes
No
1
0
0
0
13.27734375


10067
16.0378418
10067
100
120
Yes
Yes
No
1
0
0
0
9.251953125


10071
2.059936523
10071
90
80
Yes
Yes
No
1
2
0
1
4.801757813


10104
30.43267822
10104
100
72
Yes
Yes
No
1
0
0
0
15.68161011


10001
13.25280762
10001
132
90
No
0
No
0
0
0
0
8.838592529


10002
20.62738037
10002
110
110
Yes
0
No
0
0
0
0
14.17346191


10003
47.34228516
10003
118
120
Yes
Yes
No
0
0
0
0
17.2668457


10004
5.617858887
10004
0
0
No
Yes
No
0
0
0
0
8.37890625


10005
15.49072266
10005
124
120
Yes
0
No
0
0
0
0
11.65869141


10006
21.35083008
10006
60
86
No
0
No
0
0
0
0
14.38778687


10007
30.1673584
10007
98
66
Yes
Yes
No
0
2
0
0
13.87939453


10008
37.30297852
10008
84
90
Yes
0
No
0
0
0
0
9.587310791


10009
37.08874512
10009
72
112
Yes
Yes
No
0
0
0
0
21.50198364


10010
45.75531006
10010
Walk-in
Walk-in
No
0
No
0
0
0
0
10.99594116


10011
20.23187256
10011
124
72
Yes
0
No
0
0
0
0
11.31747437


10012
20.21868896
10012
0
0
No
Yes
Yes
0
0
0
0
12.40722656


10015
28.83416748
10015
122
112
Yes
Yes
No
0
0
0
0
15.79147339


10017
9.226867676
10017
80
116
Yes
Yes
No
0
0
0
0
10.65591431











Patient ID





10027


10036


10013


10099


10107


10093


10044


10068


10030
Bad HF but good launch and MA


10077


10075


10090
SH but not MH and serious HF


10059


10061


10097


10025


10050


10060
SH but not MH


10032


10106
SH but not MH, also some HF


10063


10088


10102


10115


10014


10085


10047


10051


10056


10057


10039


10067


10071
Low launch, some HF


10104


10001


10002


10003


10004


10005


10006


10007


10008


10009


10010


10011


10012


10015


10017

















CRT Amax
CN Amax
CN + 75tPA Amax
CN + 150tPA Amax
CFF Amax
CFF + TXA Amax


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10019
67.765625
68.9609375
62
52.015625
27.8046875
25.765625


10020
68.9609375
66.2890625
62.890625
51.828125
23.8671875
23.328125


10022
59.890625
64.4140625
59.84375
61.0859375
22.296875
19.7421875


10023
63.1015625
68.4453125
55.6015625
35.3046875
32.234375
32.5390625


10024
62.46875
66.8984375
57.8515625
38.6796875
22.203125
20.46875


10026
51.6875
50.515625
52.7421875
26.5859375
13.90625
13.7890625


10028
64.0390625
69.59375
66.6171875
57.8984375
27.640625
26.84375


10029
65.6796875
65.140625
47.84375
29.421875
25.1328125
26.375


10031
61.8359375
61.1796875
49.0625
33.6640625
23.8203125
24.0078125


10033
62.0234375
66.59375
57.9453125
42.1484375
24.5234375
24.2421875


10034
60.640625
57.6875
43.0625
31.1796875
20.609375
17.8203125


10035
56.65625
60.5
52.6015625
47.0234375
20.046875
19.671875


10037
66.40625
70.53125
66.875
62.46875
25.25
24.6640625


10038
60.8046875
58.625
51.7578125
51.0546875
23.0234375
24.8046875


10040
65.5859375
61.2265625
49.296875
46.6484375
25.8125
23.65625


10041
59.140625
63.546875
55.203125
35.3515625
21.1953125
21.0546875


10042
62.75
63.78125
56.5859375
44.28125
22.9296875
21.4765625


10043
62.8671875
64.015625
54.6640625
36.640625
19.765625
19.6953125


10045
62.65625
63.171875
48.171875
25.6484375
27.9921875
23.703125


10046
49.6953125
55.7890625
51.40625
31.578125
19.15625
17.65625


10048
74.703125
73.8828125
65.890625
56.1171875
31.6953125
34.484375


10049
58.7421875
62.609375
55.4140625
49.859375
19.6484375
17.984375


10052
71.796875
70.2734375
67.0390625
35.234375
31.34375
29.3984375


10053
65.5625
66.359375
62.0703125
57.6171875
24.2421875
23.5859375


10054
59.4453125
59.9375
50.4921875
41.65625
21.4765625
21.1484375


10055
66.40625
66.21875
48.2890625
50.7734375
28.671875
26.84375


10058
57.8984375
58.7890625
50.84375
32.609375
21.6171875
20.84375


10062
62.5859375
64.7421875
63.40625
58.9765625
25.4375
24.4765625


10064
72.78125
71.8671875
72.6640625
66.1953125
36.40625
34.9296875


10065
57.0546875
58.25
49.203125
35.3984375
21.2421875
22.15625


10069
65.5625
69.9921875
70.8125
69.9453125
28.8125
28.4375


10070
48.546875
58.34375
52.9296875
46.1328125
17.2578125
15.6875


10072
67.9765625
64.25
63.8515625
54.921875
21.078125
22.203125


10073
72.078125
73.8828125
71.984375
28.5078125
31.9296875
93.78125


10074
64.7890625
67.7890625
62.328125
51.265625
20.140625
20.515625


10076
63.8984375
66.125
59.84375
49.765625
23.09375
23.375


10078
68.2578125
65.4921875
61.2734375
52.3203125
27.734375
26.28125


10079
70.1328125
71.6328125
67.8828125
41.4921875
40.0390625
31.0625


10080
56.0234375
55.859375
56.75
36.8515625
18.2421875
16.4609375


10081
69.3359375
68.46875
67.296875
62.984375
27.4765625
25.4375


10082
53.703125
51.40625
54.9921875
53.3515625
20.1171875
18.8515625


10083
58.6015625
62.328125
61.6484375
55.15625
25.15625
22.390625


10084
63.640625
65.2578125
63.4765625
57.4765625
27.265625
26.1875


10086
65.65625
64.6953125
62.75
46.3671875
26.234375
24.5703125


10087
70.34375
66.59375
66.6875
59.046875
31.625
33.9453125


10089
63.40625
72.1953125
68.2578125
60.0078125
27.171875
28.4609375


10092
67.90625
69.7578125
68.9140625
61.765625
21.40625
21.2890625


10094
64.671875
65.0703125
63.03125
58.7421875
26.1640625
24.8046875

















CRT Acrit
CN Arit
CN + 75tPA Acrit
CN + 150tPA Acrit
CFF Acrit
CFF + TXA Acrit


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10019
2.36328125
16.12109375
13.66015625
9.0078125
1.484375
4.4140625


10020
2.2109375
16.37890625
14.1171875
13.44921875
4.80078125
5.31640625


10022
1.1796875
11.046875
10.49609375
12.39453125
1.3203125
1.1796875


10023
11.01171875
16.51953125
13.0625
13.0625
4.4140625
6.58203125


10024
1.1796875
6.78125
18.69921875
10.484375
3.921875
3.265625


10026
11.41015625
10.56640625
8.7734375
7.89453125
0.32421875
1.671875


10028
1.484375
14.65625
15.8046875
14
3.4765625
3.67578125


10029
7.09765625
16.47265625
10.625
13.8125
4.14453125
4.21484375


10031
14
12.46484375
12.65234375
11.84375
2.10546875
3.875


10033
1.75390625
13.87109375
15.93359375
13.21484375
5.84375
5.09375


10034
14.33984375
12.69921875
13.84765625
9.16015625
0.8515625
2.609375


10035
1.89453125
10.390625
8.46875
7.84765625
4.35546875
2.85546875


10037
1.859375
14.46875
15.5234375
13.015625
4.19140625
4.58984375


10038
4.28515625
12.265625
16.4375
14.4921875
3.79296875
5.69140625


10040
6.55859375
11.59765625
10.98828125
17.03515625
6.37109375
5.75


10041
1.14453125
14.046875
8.1640625
9.98046875
3.25390625
3.21875


10042
2.1875
14.234375
14.69140625
10.3203125
4.16796875
3.3125


10043
4.77734375
13.30859375
15.3359375
12.44140625
5.31640525
4.56640625


10045
12.1015625
13.2734375
12.0546875
9.40625
7.109375
5.7265625


10046
0.8984375
7.77734375
6.67578125
7.671875
2.3046875
1.90625


10048
7.84765625
14.984375
21.37109375
14.97265625
8.57421875
8.64453125


10049
14.66796875
11.4453125
11.328125
11.71484375
3.83984375
2.9140625


10052
7.578125
15.1953125
18.3359375
11.69140625
6.21875
4.49609375


10053
1.6953125
15.39453125
13.05078125
11.1171875
4.1328125
4.82421875


10054
12.96875
12.11328125
12.0078125
14.3515625
3.9453125
3.6875


10055
6.16015625
13.28515625
9.04296875
12.76953125
7.54296875
6.734375


10058
2.09375
11.69140625
9.5234375
11.1171875
4.42578125
3.04296875


10062
1.28515625
14.4921875
12.30078125
12.0546875
4.109375
4.90625


10064
5.73828125
12.9921875
14.45703125
14.80859375
5.73828125
5.421875


10065
4.15625
12.453125
6.51171875
9.1015625
4.12109375
5.48046875


10069
2.7265625
15.76953125
14.50390625
14.8203125
5.90234375
6.18359375


10070
1.56640625
9.8984375
8.99609375
10.77734375
2.45703125
15.96875


10072
13.26171875
15.55859375
15.125
14.87890625
5.140625
3.60546875


10073
7.0859375
15.37109375
16.859375
20.57421875
7.5078125
46.75390625


10074
1.58984375
11.1875
8.94921875
9.0078125
3.13671875
2.90234375


10076
2.66796875
14.3515625
17.6328125
13.75390625
4.49609375
4.484375


10078
7.765625
19.21484375
14.7734375
15.2421875
6.078125
6.40625


10079
2.48046875
10.98828125
12.11328125
14.2109375
11.046875
5.22265625


10080
11.69140625
12.58203125
10.58984375
12.32421875
4.15625
19.30859375


10081
17.10546875
15.95703125
15.828125
18.55859375
7.4140625
5.24609375


10082
2.1171875
15.2890625
14.85546875
13.8359375
4.87109375
3.875


10083
2.43359375
10.89453125
10.6953125
10.33203125
4.15625
3.46484375


10084
6.23046875
14.65625
12.546875
12.20703125
4.8125
4.70703125


10086
17.796875
17.703125
17.234375
14.2578125
5.796875
4.28515625


10087
14.03515625
19.0625
26.41015625
19.47265625
7.23828125
7.40234375


10089
3.2421875
12.5703125
11.64453125
10.6484375
5.03515625
8.2578125


10092
17.76171875
16.859375
16.70703125
14.65625
3.76953125
3.72265625


10094
2.48046875
12.828125
14.29296875
15.53515625
6.25390625
6.21875

















CRT dAmax
CN dAmax
CN + 75tPA dAmax
CN + 150tPA dAmax
CFF dAmax
CFF + TXA dAmax


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10019
1.6640625
1.1953125
1.1953125
1.125
1.5
0.703125


10020
1.359375
0.8671875
0.890625
0.8203125
0.5390625
0.5390625


10022
0.984375
0.9375
0.8203125
1.0546875
0.9375
0.796875


10023
1.5234375
1.1953125
0.9375
0.46875
1.03125
1.1953125


10024
0.9375
1.171875
0.9140625
1.078125
0.515625
0.421875


10026
0.7265625
0.8203125
0.9375
0.8203125
0.1640625
0.140625


10028
1.40625
1.40625
1.40625
1.40625
0.84375
0.8671875


10029
1.2421875
0.7265625
0.609375
0.421875
0.8671875
0.8671875


10031
1.21875
1.1015625
1.0078125
0.890625
1.1953125
0.46875


10033
1.1015625
0.8671875
0.8671875
0.8203125
0.796875
0.75


10034
0.8203125
0.8203125
0.6328125
0.6796875
0.5625
0.375


10035
1.3828125
1.03125
0.9375
1.0546875
0.8203125
0.6328125


10037
1.546875
1.5
1.5
1.5
0.8671875
0.7734375


10038
1.1484375
0.65625
0.515625
0.609375
0.9140625
1.0546875


10040
1.1484375
0.6796875
0.4453125
0.6796875
0.9609375
0.890625


10041
0.8671875
0.9375
1.03125
0.8203125
0.6328125
0.5625


10042
1.125
1.03125
1.1953125
1.265625
0.8671875
0.703125


10043
0.9609375
1.0546875
0.984375
1.0078125
0.5859375
0.6796875


10045
0.984375
1.03125
0.75
0.703125
1.171875
0.75


10046
0.796875
1.1015625
1.1484375
1.125
0.421875
0.328125


10048
1.9453125
1.640625
1.1015625
1.2421875
0.9609375
1.1484375


10049
0.8671875
0.9375
0.9375
0.8671875
0.5390625
0.375


10052
1.359375
1.21875
1.3125
0.7265625
0.796875
0.5859375


10053
1.6875
1.1015625
1.1953125
1.125
0.65625
0.6796875


10054
0.890625
0.7734375
0.703125
0.75
0.421875
0.421875


10055
1.3359375
1.0546875
1.0546875
1.1953125
1.1484375
0.9375


10058
1.734375
1.0546875
1.125
1.03125
0.6796875
0.4921875


10062
1.1953125
0.796875
0.8671875
0.890625
0.703125
0.65625


10064
1.5234375
1.359375
1.5234375
1.4765625
1.1015625
1.078125


10065
1.03125
0.75
0.9609375
1.03125
0.9140625
0.8203125


10069
2.295875
1.4296875
1.6171875
1.453125
0.9140625
0.8671875


10070
0.8203125
0.984375
0.9609375
1.0078125
0.4453125
1.078125


10072
1.3359375
0.9140625
1.171875
1.1015625
0.46875
0.4921875


10073
4.03125
1.8984375
2.203125
5.0859375
1.171875
3.1640625


10074
1.1015625
1.21875
1.5703125
1.3125
0.5859375
0.5390625


10076
2.0390625
1.171875
1.078125
0.9609375
0.6796875
0.609375


10078
1.875
1.1484375
1.171875
1.078125
1.171875
0.984375


10079
2.2265625
1.9921875
2.1796875
2.296875
2.953125
1.2421875


10080
0.8671875
0.4921875
0.8203125
0.7734375
0.515625
3.1171875


10081
1.4765625
1.0546875
1.171875
1.0078125
0.9375
0.5859375


10082
1.734375
0.515625
0.6796875
0.5625
0.4453125
0.46875


10083
1.7109375
1.0546875
1.40625
1.5703125
1.03125
0.6328125


10084
1.8046875
1.265625
1.3125
1.3828125
0.9375
0.9140625


10086
0.84375
0.703125
0.75
0.609375
0.75
0.5859375


10087
1.2890625
0.796875
0.9609375
0.6328125
0.5390625
0.8671875


10089
1.96875
2.15625
2.2265625
1.453125
1.1015625
2.15625


10092
0.9609375
0.9375
1.0546875
1.125
0.5390625
0.6328125


10094
2.2734375
1.125
1.0546875
1.1015625
1.0078125
0.890625





















CN + 75tPA
CN + 150tPA

CFF + TXA




Patient ID
CRT LY30
CN LY30
LY30
LY30
CFF LY30
LY30
CRT CL30
CN CL30





10019
0.018560257
0.022788509
0.100859305
0.454886769
0.003487637
−0.009435011
0.957804934
0.950039651


10020
0.030007206
0.014039481
0.060452899
0.432118003
−0.003161484
−0.006205347
0.947320721
0.965350619


10022
0.015688864
0.01108298
0.011277198
0.026278403
0.04736335
0.043820077
0.962822854
0.970527592


10023
0.050798564
0.02016465
0.106925905
0.536037656
0.001784416
0.006433573
0.900829516
0.94966328


10024
0.051351544
0.03619448
0.432249981
0.633892143
0.02721235
0.135655746
0.900575288
0.918019386


10026
0.0408322
0.045881663
0.128821656
0.681686502
−0.007343165
−0.002573182
0.912031439
0.903495206


10028
0.036332229
0.01844581
0.070189301
0.48095455
−0.011132702
−0.006824796
0.936318165
0.970026942


10029
0.04213007
0.013138143
0.265292973
0.589190565
0.0284828
−0.018540186
0.911145474
0.962221156


10031
0.075543799
0.097434874
0.609129512
0.6387822
0.367293922
−0.005472394
0.79949463
0.741412336


10033
0.026377517
0.018340861
0.095054717
0.423588199
−4.86E−04 
−0.002458642
0.949741781
0.956710465


10034
0.033425663
0.02512734
0.18634948
0.60229057
0.013688821
0.013426129
0.931203298
0.947183099


10035
0.020279463
0.02175914
0.0364523
0.300278285
−0.013139777
−0.010031109
0.953667954
0.953899793


10037
0.030046405
0.021488548
0.062978323
0.313275214
0.001045534
0.001356773
0.942470588
0.956468764


10038
0.026372114
−0.001829025
0.002257233
0.024505653
−0.004964088
−0.005459318
0.934087113
0.988006397


10040
0.04965042
0.028593531
0.079753038
0.362801457
−0.003030418
−0.015363551
0.906372841
0.931478882


10041
0.041559335
0.021645254
0.072059274
0.468926949
0.01875384
0.003831169
0.914002642
0.943570199


10042
0.028059636
0.027165333
0.159310139
0.555088509
6.02E−04
0.007616406
0.939492032
0.943042626


10043
0.019282548
0.021101822
0.340209296
0.615954158
−0.004230896
−0.006153312
0.954517211
0.947644618


10045
0.010444722
0.012927694
0.233396854
0.717038532
−0.026521072
−0.031434025
0.975311721
0.969577047


10046
0.020347299
0.019610932
0.229340172
0.645899307
−0.015154296
−0.010567847
0.953309228
0.952947766


10048
0.020143973
0.015210808
0.060154171
0.495028192
0.013921412
0.010570533
0.950428781
0.969546368


10049
0.040608237
0.031604588
0.075264933
0.473617858
7.89E−04
0.004389299
0.911823381
0.92887447


10052
0.017503627
0.013801031
0.157126695
0.32081578
−0.006094217
−0.007797413
0.956909684
0.972984992


10053
0.011311864
0.015675281
0.046222991
0.305119209
−0.011028306
−0.012549685
0.972473785
0.96362138


10054
0.054953929
0.027473823
0.167679483
0.604487059
0.017146639
0.007753048
0.889998686
0.934306569


10055
0.015969118
0.017118432
0.101571797
0.302263169
−0.002832652
−0.012365396
0.960823529
0.956111373


10058
0.029763752
0.026953488
0.492045474
0.728459911
0.010215637
0.009807596
0.934421805
0.93461794


10062
0.021739726
0.016778287
0.018351097
0.420841429
5.95E−04
−0.006456804
0.955436275
0.960178593


10064
0.026595224
0.023099733
0.078911616
0.501083179
5.00E−04
0.003245918
0.945577501
0.952060007


10065
0.018600233
0.025373115
0.662967521
0.860495292
−0.003749847
−0.016334626
0.956045461
0.947290773


10069
0.013138008
0.011164596
0.068198674
0.405900722
−0.021435512
−0.05345696
0.968898951
0.978569037


10070
0.022669018
0.016251562
0.166666052
0.620378916
0.027281701
0.026450448
0.955101384
0.963042314


10072
0.026998812
0.019600661
0.100680595
0.428920697
−0.005763529
0.001426519
0.937938168
0.952942607


10073
0.032281957
0.033183973
0.030185044
0.277177537
0.0096862
0.963302857
0.928463039
0.927038173


10074
0.024875899
0.031321629
0.480037116
0.733005689
0.043781786
0.007443196
0.937417099
0.921170912


10076
0.045710899
0.028091361
0.164391319
0.455341226
0.015017479
0.009141971
0.910869299
0.940808129


10078
0.03587902
0.036731083
0.051553756
0.569544199
0.005193271
0.007651688
0.927206135
0.920553501


10079
0.012896383
0.004602465
0.445629052
0.813086048
−0.057418699
−0.009947183
0.970925699
0.996073727


10080
0.028764003
0.019558275
0.224187202
0.704488199
0.030031525
−0.024219533
0.934737136
0.95048951


10081
0.03960892
0.020360281
0.024098689
0.183163642
0.006851246
0.018016738
0.918197183
0.949680511


10082
0.03400434
0.026273852
0.028358471
0.054769895
−0.160043689
−0.015227126
0.924934536
0.945744681


10083
0.02385182
0.019988301
0.277498451
0.702136449
0.020317892
0.010942952
0.945607252
0.953371772


10084
0.009423337
0.021685821
0.224975897
0.606549884
0.018206383
0.00716612
0.970905966
0.946845445


10086
0.036625251
0.023212273
0.025188655
0.276866049
−0.109540649
−0.524623741
0.932175155
0.947470112


10087
0.024173361
0.017043544
0.044756847
0.265357348
−0.111567441
−0.048439778
0.95302088
0.964453308


10089
0.020497577
0.025572178
0.048802507
0.569068155
−0.004630295
0.004302772
0.950468211
0.941240126


10092
0.02308093
0.009447213
0.061420505
0.423262923
−1.74E−04 
−0.029998471
0.95478601
0.973457274


10094
0.029986443
0.02516742
0.093868782
0.476873587
−0.017023738
−0.002700787
0.938390916
0.947052467




















CFTX dV @ CFF max


Patient ID
CN + 75tPA CL30
CN + 150tPA CL30
CFF CL30
CFF + TXA CL30
(mm/min)





10019
0.691532258
0.013667768
0.983984265
1.018192844
0.28125


10020
0.849068323
0.102351522
1.00589198
1.015070328
0


10022
0.967101828
0.933623225
0.90119131
0.909774436
0.28125


10023
0.72179289
0.028103563
0.993456132
0.987755102
0


10024
0.019986496
0.003837609
0.933497537
0.966793893
0.28125


10026
0.658717227
0.004701734
1.001685393
0.996600567
0


10028
0.773777413
0.004587775
1.014414924
1.010477299
0


10029
0.398922273
0.00424854
0.917003419
1.042654028
0.140625


10031
0.002547771
0.003713159
0.128238767
1.015619915
0.421875


10033
0.732236753
0.125857275
1
1.012568482
0.140625


10034
0.460087083
0.007767477
0.977255497
0.978956598
0.140625


10035
0.904203178
0.145705267
1.018706157
1.016679905
0.140625


10037
0.834579439
0.129564782
0.993502475
0.994298385
0


10038
0.985962264
0.952716144
1.007125891
1.011338583
0.140625


10040
0.806022187
0.176519845
1.006355932
1.052509908
0


10041
0.799179168
0.114254144
0.950239587
0.99109462
0.140625


10042
0.521192876
0.002822865
1
0.99454347
0


10043
0.184936401
0.004690832
1.008300395
1.020230067
−0.140625


10045
0.378203049
0.004873591
1.060284678
1.070204351
−0.140625


10046
0.37218845
0.003958435
1.024469821
1.015929204
0


10048
0.82712829
0.027286649
0.96672418
0.980969642
0.140625


10049
0.805864937
0.016139141
0.992842942
0.990877498
0


10052
0.563337606
0.26097561
1.011964108
1.014350252
0


10053
0.874260541
0.198237288
1.016435707
1.02285525
0


10054
0.543710351
0.00300075
0.973808658
0.992242335
0.140625


10055
0.729655396
0.224957686
1.004087193
1.023573923
0


10058
0.015826675
0.003833253
0.976147452
0.982008996
0.140625


10062
0.957121735
0.065704067
1.011977887
1.016278327
0


10064
0.756800344
0.004366812
1.018669528
0.999329009
−6.00E−15


10065
0.002540489
0.003531229
1.005516734
1.029619182
0


10069
0.781553398
0.068803753
1.087039046
1.212637363
−0.140625


10070
0.493874539
0.003725656
0.95382526
0.947709163
0.140625


10072
0.690566499
0.006970128
1.015567087
1.001055595
−0.140625


10073
0.920555676
0.259249109
0.983117201
0.001582806
2.109375


10074
0.017798947
0.002438281
0.867339022
0.99428789
0.140625


10076
0.53002611
0.096232339
0.967523681
0.987967914
0.28125


10078
0.851969909
0.002389129
0.998309859
0.991973841
0.140625


10079
0.007710899
0.035209942
1.164487805
1.018108652
0.140625


10080
0.304102423
0.003391986
0.944753747
1.316089226
0.140625


10081
0.948804272
0.434383528
0.981234006
0.962223587
0.140625


10082
0.941184827
0.858544443
1.481165049
1.103191048
0


10083
0.251805855
0.002266289
0.961801242
0.988485694
0.140625


10084
0.3472
0.0021748
0.976790831
0.99552506
0.140625


10086
0.945094622
0.358550969
1.363609291
2.398410175
0.28125


10087
0.880506092
0.307356444
1.343873518
1.18296893
−0.140625


10089
0.835213803
0.002083062
1.024151811
0.996706012
0.140625


10092
0.8234894
0.033898305
1.048175182
1.153027523
0.140625


10094
0.704015865
0.025269318
1.058226336
1.009448819
0














CN dV @ CN + tPA75 max
CRT dA Integration to Acrit
CN dA Integration to Acrit


Patient ID
(mm/min)
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)





10019
0.5625
31.7411499
176.0718384


10020
0.140625
24.37976074
108.4432983


10022
0.140625
8.127685547
89.33532715


10023
0.140625
146.5043335
175.1193237


10024
0.421875
7.781616211
66.48486328


10026
0.421875
83.27911377
72.15545654


10028
0.140625
14.05371094
177.543457


10029
0.84375
87.20123291
108.4235229


10031
0.984375
161.4298096
104.6365356


10033
0.421875
15.75604248
107.480896


10034
0.84375
88.0713501
91.47601318


10035
0.421875
20.97674561
93.51123047


10037
0.28125
20.60925293
194.5535889


10038
0
46.12445068
64.14477539


10040
0.28125
73.39471436
60.17816162


10041
0.421875
6.969177246
111.1772461


10042
0.421875
22.359375
139.6043701


10043
0.5625
31.41156006
120.5161743


10045
0.5625
110.9465332
121.7636719


10046
0.28125
4.541748047
76.05780029


10048
0.28125
105.1243286
179.8571777


10049
0.28125
130.3511353
96.63244629


10052
0.28125
80.39025879
158.8392334


10053
0.140625
19.06677246
161.8994751


10054
0.421875
106.6256104
81.1038208


10055
0.28125
76.30169678
120.0481567


10058
0.703125
27.76794434
110.1373901


10062
0.140625
10.21893311
93.27392578


10064
0.140625
78.70770264
116.4210205


10065
1.265625
41.66015625
77.69421387


10069
0.140625
47.99816895
197.9401245


10070
0.421875
11.39886475
91.3392334


10072
0.28125
169.7272339
128.9833374


10073
0
266.918335
257.6453247


10074
0.703125
13.6137085
120.9594727


10076
0.5625
42.14959717
142.8343506


10078
0.28125
104.5129395
177.0441284


10079
0.5625
40.72576904
186.0320435


10080
0.984375
80.52703857
36.67181396


10081
0.140625
273.0470581
143.079895


10082
0.140625
28.32495117
68.89086914


10083
0.28125
34.64154053
100.2694702


10084
0.140625
100.7177124
178.5157471


10086
0.140625
128.4246826
100.1524658


10087
0.28125
138.6172485
140.5206299


10089
0.140625
53.89782715
196.9431152


10092
0.28125
155.1560669
153.1142578


10094
0.703125
41.04217529
112.9405518














CN + 75tPA dA Integration to Acrit
CN + 150tPA dA Integration to Acrit
CFF dA Integration to Acrit


Patient ID
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)





10019
131.9265747
77.90844727
14.46240234


10020
107.7000732
88.54925537
21.88970947


10022
71.53582764
119.2175903
8.803344727


10023
96.00292969
48.77600098
45.24279785


10024
171.0027466
99.48999023
17.62646484


10026
69.8104248
50.5178833
0.278503418


10028
192.3255615
163.6281738
24.4588623


10029
49.97900391
52.5201416
30.09979248


10031
95.62884521
86.88647461
1.105773926


10033
101.4098511
85.96856689
42.42150879


10034
77.46844482
49.8883667
3.371704102


10035
68.41296387
68.36846924
34.21307373


10037
209.1115723
169.8145752
34.14385986


10038
73.65673828
75.53210449
30.17559814


10040
37.54193115
100.8495483
53.66217041


10041
30.91552734
69.57476807
18.02032471


10042
149.2036743
113.6920166
24.84283447


10043
126.173584
105.0518188
29.10772705


10045
73.59741211
55.30517578
70.72998047


10046
48.24041748
76.40222168
7.864013672


10048
184.911438
147.2590942
56.56915283


10049
91.41833496
94.50164795
16.1416626


10052
190.2095947
46.33209229
34.28393555


10053
101.8580933
103.1022949
20.61584473


10054
66.59692383
82.92810059
15.07543945


10055
55.00360107
129.8139038
59.88153076


10058
89.20019531
79.67834473
26.85992432


10062
81.41363525
100.6468506
23.73046875


10064
205.6195679
207.8245239
56.35821533


10065
48.6260376
74.17749023
31.25335693


10069
188.4710083
182.1873779
48.08880615


10070
58.20062256
104.883728
8.679748535


10072
158.1075439
152.0348511
17.0859375


10073
311.8677979
98.69732666
62.96813965


10074
96.13311768
108.487793
11.56365967


10076
103.7120361
111.0997925
26.94232178


10078
124.2784424
139.541748
59.2701416


10079
230.6552124
201.6463623
238.847168


10080
79.13616943
87.91644287
15.51708984


10081
147.1552734
149.0718384
61.43225098


10082
87.04962158
64.06237793
18.13897705


10083
137.142334
149.5794067
38.19287109


10084
151.3707275
155.8811646
42.3951416


10086
110.9432373
68.44262695
35.31884766


10087
191.46698
111.8084106
32.47283936


10089
151.2372437
114.6115723
50.00042725


10092
148.8806763
155.2236328
14.43109131


10094
119.8833618
155.0736694
54.3147583























CFF + TXA dA














Integration to Acrit


Patient ID
(mm{circumflex over ( )}2)
ID
SBP
HR
OR?
ICU?
Death?
pRBC
FFP
PLT
CRYO
CN Crit Prod





10019
28.41064453
10019
86
90
Yes
Yes
No
0
0
0
0
19.26974487


10020
22.59503174
10020
136
100
Yes
0
No
0
0
0
0
14.20358276


10022
6.862060547
10022
138
88
No
Yes
No
0
0
0
0
10.35644531


10023
76.33795166
10023
106
120
Yes
0
No
0
0
0
0
19.7460022


10024
8.737426758
10024
150
108
Yes
Yes
No
0
0
0
0
7.946777344


10026
1.496337891
10026
116
100
Yes
Yes
No
0
0
1
0
8.667755127


10028
26.37213135
10028
102
100
No
Yes
No
0
0
0
0
20.61035156


10029
31.25994873
10029
62
120
Yes
Yes
No
0
0
0
0
11.96841431


10031
15.78076172
10031
Uto
Uto
Yes
Yes
No
0
0
0
0
13.73080444


10033
34.27734375
10033
110
94
Yes
Yes
No
0
0
0
0
12.02883911


10034
7.218017578
10034
140
100
Yes
Yes
No
0
0
0
0
10.41732788


10035
14.93206787
10035
80
70
Yes
Yes
No
0
0
0
0
10.71533203


10037
33.68243408
10037
180
120
No
Yes
No
0
0
0
0
21.703125


10038
40.28082275
10038
128
120
Yes
Yes
No
0
0
0
0
8.049316406


10040
27.57348633
10040
162
108
No
0
No
0
0
0
0
7.882781982


10041
15.65222168
10041
88
70
Yes
Yes
No
0
2
1
0
13.16894531


10042
19.11621094
10042
100
90
Yes
Yes
No
0
0
0
0
14.67919922


10043
26.66546631
10043
90
60
Yes
Yes
No
0
0
0
0
14.03640747


10045
37.99841309
10045
100
58
No
Yes
Yes
0
0
0
0
13.68823242


10046
5.115234375
10046
130
90
No
0
No
0
0
0
0
8.567230225


10048
80.21722412
10048
88
112
No
0
No
0
0
0
0
24.58374023


10049
9.149414062
10049
Walk-in
Walk-in
No
0
No
0
0
0
0
10.72998047


10052
21.70184326
10052
100
100
Yes
Yes
No
0
0
0
0
18.51928711


10053
28.09588623
10053
116
110
Yes
Yes
No
0
0
0
0
16.95803833


10054
13.2989502
10054
108
124
Yes
Yes
No
0
0
0
0
9.368865967


10055
55.71386719
10055
136
78
No
Yes
No
0
0
0
0
14.01158823


10058
11.59661865
10058
118
110
Yes
Yes
No
0
0
0
0
12.33078003


10062
25.08178711
10062
86
60
No
0
No
0
0
0
0
11.54846191


10064
51.12597656
10064
118
72
No
0
No
0
0
0
0
17.66125488


10065
38.93609619
10065
140
120
No
Yes
No
0
0
0
0
9.33984375


10069
39.92816162
10069
90
140
Yes
Yes
No
0
0
0
0
22.54550171


10070
20.0291748
10070
160
92
Yes
0
No
0
0
0
0
9.743774414


10072
14.16412354
10072
Unk
Unk
No
0
No
0
0
0
0
14.2215271


10073
963.953064
10073
156
114
Yes
Yes
No
0
0
0
0
29.18106079


10074
13.36651611
10074
81
100
Yes
Yes
No
0
0
0
0
13.63476563


10076
20.18408203
10076
170
60
Yes
Yes
No
0
0
1
0
16.8182373


10078
55.34472656
10078
96
60
Yes
Yes
No
0
0
0
0
22.06704712


10079
49.64117432
10079
82
112
No
Yes
No
0
0
0
0
21.89071655


10080
96.45941162
10080
98
112
No
0
No
0
0
0
0
6.192718506


10081
24.95159912
10081
Walk-in
Walk-in
Yes
Yes
No
0
0
0
0
16.8296814


10082
11.51916504
10082
138
120
No
0
No
0
0
0
0
7.883422852


10083
19.47052002
10083
142
70
Yes
Yes
No
0
0
0
0
11.49032593


10084
29.05499268
10084
170
104
No
Yes
No
0
0
0
0
18.54931641


10086
18.47186279
10086
100
120
Yes
0
No
0
0
0
0
12.44750977


10087
53.8895874
10087
162
120
No
0
No
0
0
0
0
15.19042969


10089
125.1551514
10089
120
80
Yes
Yes
No
0
0
0
0
27.10473633


10092
20.99981689
10092
210
128
No
0
No
0
0
0
0
15.80556406


10094
50.6184082
10094
128
100
Yes
Yes
No
0
0
0
0
14.43154063










Patient ID





10019


10020


10022


10023


10024


10026


10028


10029


10031


10033


10034


10035


10037


10038


10040


10041


10042


10043


10045


10046


10048


10049


10052


10053


10054


10055


10058


10062


10064


10065


10069


10070


10072


10073


10074


10076


10078


10079


10080


10081


10082


10083


10084


10086


10087


10089


10092


10094

















CRT Amax
CN Amax
CN + 75tPA Amax
CN + 150tPA Amax
CFF Amax
CFF + TXA Amax


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10096
63.640625
65.1875
64.7421875
65.1875
24.6171875
24.8984375


10098
59.703125
66.171875
62.5625
61.625
19.296875
19.953125


10100
66.734375
71.65625
67.6015625
54.125
26.0703125
26.65625


10101
63.0546875
66.6640625
64.1328125
55.25
24.3359375
24.3359375


10103
66.4296875
68.46875
63.7109375
46.484375
28.390625
26.65625


10105
56.7734375
60.4296875
62.140625
52.203125
26.5625
24.5


10108
52.2265625
65.375
58.765625
59
20.2578125
18.734375


10109
62.8671875
66.3828125
63.546875
58.8359375
24.359375
24.0546875


10110
65.84375
64.15625
66.78125
65.5625
22.7890625
21.9921875


10111
67.6015625
73.5078125
71.1875
68.6796875
26.6328125
26.65625


10112
82.1328125
62.5625
60.03125
54.4765625
29.2578125
0.125


10113
50.3046875
48.125
28.6015625
23.5625
15.9921875
14.65625

















CRT Acrit
CN Arit
CN + 75tPA Acrit
CN + 150tPA Acrit
CFF Acrit
CFF + TXA Acrit


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10096
18.40625
16.15625
13.9765625
13.75390625
3.67578125
4.71875


10098
1.84765625
6.41796875
7.09765625
8.19921875
1.56640625
2.19921875


10100
2.29296875
13.15625
16.82421875
16.765625
4.390625
5.7734375


10101
2.1640625
10.1796875
10.4609375
8.78515625
4.109375
3.91015625


10103
10.51953125
11.26953125
9.9453125
8.38671875
4.4375
27.875


10105
1.84765625
14.328125
15.18359375
12.8515625
5.609375
4.96484375


10108
1.35546875
9.640625
10.15625
8.3515625
1.390625
2.0703125


10109
2.66796875
14.10546875
9.7578125
10.49609375
2.92578125
3.72265625


10110
1.6953125
11.41015625
9.41796875
10.2734375
3.546875
3.359375


10111
15.5703125
13.90625
11.8203125
14.84375
4.578125
4.89453125


10112
11.8203125
19.7890625
17.75
16.6953125
5.65625
0.16015625


10113
11.375
14.57421875
12.0546875
0.359375
11.22265625
1.7890625

















CRT dAmax
CN dAmax
CN + 75tPA dAmax
CN + 150tPA dAmax
CFF dAmax
CFF + TXA dAmax


Patient ID
(mm)
(mm)
(mm)
(mm)
(mm)
(mm)





10096
0.984375
1.03125
1.03125
1.1015625
0.5390625
0.609375


10098
1.1953125
1.4296875
1.3359375
1.2421875
0.5390625
0.3984375


10100
1.7578125
1.265625
1.0078125
0.984375
0.65625
0.703125


10101
1.40525
1.453125
1.359375
1.3828125
0.9375
0.8203125


10103
1.3828125
1.4296875
1.3125
0.7265625
1.125
1.921875


10105
1.6640625
0.9375
1.2421875
1.453125
0.75
0.6796875


10108
0.9140625
1.3125
1.359375
1.5
0.65625
0.375


10109
1.8515625
1.1953125
1.640625
1.3828125
0.8203125
0.7265625


10110
1.828125
1.0546875
1.3359375
1.40625
0.84375
0.75


10111
1.78125
1.734375
1.734375
1.96875
1.078125
0.8203125


10112
3.84375
0.75
0.5625
0.84375
0.890625
0.0703125


10113
0.703125
0.3515625
0.234375
0.46875
4.1015625
0.28125





















CN + 75tPA
CN + 150tPA

CFF + TXA




Patient ID
CRT LY30
CN LY30
LY30
LY30
CFF LY30
LY30
CRT CL30
CN CL30





10096
0.02673739
0.023091276
0.022254736
0.04494031
0.002878275
−8.86E−04
0.94254849
0.94822627


10098
0.028060208
0.025009675
0.019210477
0.024390248
−0.011732456
−0.002473245
0.940722324
0.950413223


10100
0.032283943
0.019990945
0.064302843
0.563915151
−0.011968085
−0.023366468
0.93889019
0.960423027


10101
0.023396867
0.017267276
0.079153977
0.54122007
−0.005733012
−0.005837346
0.953537356
0.957810852


10103
0.019735192
0.020560912
0.068618434
0.441085434
0.011639684
−9.79E−04
0.955545102
0.951049749


10105
0.0298312
0.028208719
0.241447525
0.672740198
0.004960784
−0.00922619
0.934773634
0.940271493


10108
0.021454126
0.024958008
0.562259963
0.618193856
0.022240969
0.017528496
0.949289454
0.946223709


10109
0.022353396
0.012313169
0.035683892
0.524804696
−0.006783194
−2.86E−04
0.955635641
0.967517948


10110
0.022358013
0.020903184
0.021046184
0.180870505
0.016776178
0.009773535
0.940199336
0.954335119


10111
0.022739705
0.01260451
0.021232989
0.247648005
−0.016114207
−0.018321366
0.955622328
0.96779679


10112
0.879012492
0.027216533
0.072425928
0.479522205
0.002217401
0
0.001807286
0.932567433


10113
0.046618911
0.009909361
0.266667805
0.752061229
0.024084025
0.009252843
0.902624631
0.960064935




















CFTX dV @ CFF max


Patient ID
CN + 75tPA CL30
CN + 150tPA CL30
CFF CL30
CFF + TXA CL30
(mm/min)





10096
0.946060094
0.883149569
1.012377023
1.001882648
0.140625


10098
0.95467033
0.951698783
1.025506073
1.002349256
−0.140625


10100
0.812434994
0.002742494
1.042253521
1.110785463
0


10101
0.764648556
0.003959275
1.013483146
1.009630819
0.140625


10103
0.800613121
0.050084034
0.987616951
1.175849941
0.140625


10105
0.317701785
0.002394493
0.990294118
1.015306122
0.140625


10108
0.002127094
0.002118644
0.952564597
0.962468724
0.140625


10109
0.890828621
0.002124552
1.011545863
1.000974342
−0.140625


10110
0.955077211
0.406577693
0.977374014
0.988277087
0.28125


10111
0.955553117
0.240700717
1.036960986
1.055392732
0


10112
0.805960437
0.014771261
0.999198932
1
0


10113
0.328871893
0.00530504
0.935515388
0.984008529
−0.140625














CN dV @ CN + tPA75 max
CRT dA Integration to Acrit
CN dA Integration to Acrit


Patient ID
(mm/min)
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)





10096
0.28125
137.9168701
152.5968018


10098
0.140625
18.10931396
85.04241943


10100
0.28125
30.77545166
142.5476074


10101
0.28125
24.70935059
126.7272949


10103
0.140625
148.2346802
139.7114868


10105
0.28125
21.95892334
119.911377


10108
0.703125
9.876159668
112.7658691


10109
0.140625
41.13446045
152.0645142


10110
0.140625
19.80834961
116.5907593


10111
0.140625
248.6063232
218.4060059


10112
0.140625
332.9483643
130.4747314


10113
0.5625
74.6619873
36.29608154














CN + 75tPA dA Integration to Acrit
CN + 150tPA dA Integration to Acrit
CFF dA Integration to Acrit


Patient ID
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)
(mm{circumflex over ( )}2)





10096
114.3511963
138.5315552
17.31170654


10098
88.23614502
99.55096436
6.07598877


10100
103.4598999
133.3125
24.56433105


10101
113.6920166
106.6964722
35.62536621


10103
101.5993652
47.87127686
44.81103516


10105
157.7796021
169.5179443
29.953125


10108
135.2076416
114.6643066
8.041992187


10109
124.2454834
133.0438843
18.23126221


10110
93.62493896
127.8973389
25.58605957


10111
173.4334717
267.8873291
41.30090332


10112
66.29699707
118.8896484
39.0135498


10113
14.78869629
0.046142578
11.96575928























CFF + TXA dA














Integration to Acrit


Patient ID
(mm{circumflex over ( )}2)
ID
SBP
HR
OR?
ICU?
Death?
pRBC
FFP
PLT
CRYO
CN Crit Prod





10096
22.05615234
10096
100
96
Yes
Yes
No
0
0
0
0
16.66113281


10098
8.37322998
10098
108
112
No
Yes
No
0
0
0
0
9.175689697


10100
35.33862305
10100
Unk
Unk
Yes
0
No
0
0
0
0
16.65087891


10101
27.97064209
10101
110
110
Yes
0
No
0
0
0
0
14.7923584


10103
134.5023193
10103
123
92
No
0
No
0
0
0
0
16.11190796


10105
20.06707764
10105
0
0
Yes
Yes
No
0
0
0
0
13.43261719


10108
7.827758789
10108
150
90
No
Yes
No
0
0
0
0
12.65332031


10109
18.26751709
10109
92
110
Yes
Yes
No
0
2
0
0
16.86044312


10110
21.515625
10110
100
92
Yes
Yes
No
0
0
0
0
12.03414917


10111
29.56256104
10111
115
70
No
Yes
No
0
0
0
0
24.11865234


10112
0.014831543
10112
210
142
No
Yes
No
0
0
0
0
14.84179688


10113
3.978149414
10113
110
110
No
Yes
No
0
0
0
0
5.123748779










Patient ID





10096


10098


10100


10101


10103


10105


10108


10109


10110


10111


10112


10113








Claims
  • 1. An in vitro method for identifying a patient as requiring a transfusion of at least six units of blood in six hours or less, the method comprising (a) analyzing a sample of blood from the patient with a viscoelastic analysis assay to obtain a patient coagulation characteristic value that is independent of time,
  • 2. The method of claim 1, wherein the control coagulation characteristic value is obtained by analyzing a sample of blood from a control with a viscoelastic analysis assay.
  • 3. The method of claim 2, wherein the control is a healthy volunteer.
  • 4. The method of claim 2, wherein the control is a population of patients and the control coagulation characteristic value is the mean coagulation characteristic value of the population.
  • 5. The method of claim 1, wherein the sample of blood is not supplemented with a clotting factor or an enhancer of clot formation.
  • 6. The method of claim 1, wherein the patient or control coagulation characteristic value is Acrit,
  • 7. The method of claim 1, wherein the patient or control coagulation characteristic value is dAmax,
  • 8. The method of claim 1, wherein the patient coagulation characteristic value is obtained not more than twenty minutes after the start of the viscoelastic analysis of the sample of blood from the patient.
  • 9. The method of claim 1, wherein the patient coagulation characteristic value is obtained not more than fifteen minutes after the start of the viscoelastic analysis of the sample of blood from the patient.
  • 10. (canceled)
  • 11. The method of claim 1, wherein the patient coagulation characteristic value is obtained not more than five minutes after the start of the viscoelastic analysis of the sample of blood from the patient.
  • 12. The method of claim 1, wherein the patient coagulation characteristic value is obtained not more than fifteen minutes after the start of clot formation in the sample of blood from the patient.
  • 13. (canceled)
  • 14. The method of claim 1, wherein the patient coagulation characteristic value is obtained not more than five minutes after the start of clot formation in the sample of blood from the patient.
  • 15. (canceled)
  • 16. (canceled)
  • 17. The method of claim 1, wherein the viscoelastic assay is performed using a thromboelastography analyzer system.
  • 18. The method of claim 1, wherein the viscoelastic assay is performed using a thromboelastometry analyzer system.
  • 19. The method of claim 1, wherein the patient coagulation characteristic value is at least 1.5 times lower than the control coagulation characteristic value.
  • 20. The method of claim 1, wherein identifying comprises identifying the patient as requiring a transfusion of at least ten units of blood in six hours or less.
  • 21. The method of claim 1, wherein the patient coagulation characteristic value is obtained by fitting a tracing from the viscoelastic analysis assay of the same sample of blood from the patient to a tracing from the model dA/dT=aA2/(ebA−1).
  • 22. The method of claim 1, wherein the patient coagulation characteristic value is obtained by taking an area under a tracing from the viscoelastic analysis assay of the same sample of blood from the patient from a start of clot formation to a maximum amplitude.
  • 23. An in vitro method for determining an amount of fibrinogen in a patient comprising: (a) analyzing a sample of blood from a patient with a viscoelastic analysis assay to obtain a patient coagulation characteristic value that is independent of time and(b) plotting the patient coagulation characteristic value against a standard table of coagulation characteristic values of blood samples of healthy volunteers with known amounts of fibrinogen to determine the amount of fibrinogen in the sample of blood from the patient.
  • 24. (canceled)
  • 25. (canceled)
  • 26. An in vitro method for determining a quantity of platelets in a patient comprising: (a) analyzing a sample of blood from a patient with a viscoelastic analysis assay to obtain a patient coagulation characteristic value that is independent of time and(b) plotting the patient coagulation characteristic value against a standard table of coagulation characteristic values of blood samples of healthy volunteers with known quantities of platelets to determine the quantity of platelets in the sample of blood from the patient.
  • 27. (canceled)
  • 28. (canceled)
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. provisional patent application No. 62/172,535 filed Jun. 8, 2015 and to U.S. provisional patent application No. 62/172,951 filed Jun. 9, 2015, the entire contents of which are hereby incorporated by reference.

PCT Information
Filing Document Filing Date Country Kind
PCT/US16/36143 6/7/2016 WO 00
Provisional Applications (2)
Number Date Country
62172535 Jun 2015 US
62172951 Jun 2015 US